US8551991B2 - 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity - Google Patents
1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity Download PDFInfo
- Publication number
- US8551991B2 US8551991B2 US12/225,010 US22501007A US8551991B2 US 8551991 B2 US8551991 B2 US 8551991B2 US 22501007 A US22501007 A US 22501007A US 8551991 B2 US8551991 B2 US 8551991B2
- Authority
- US
- United States
- Prior art keywords
- group
- dihydro
- quinoxalin
- trimethyl
- substituent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related, expires
Links
- HORKYAIEVBUXGM-UHFFFAOYSA-N 1,2,3,4-tetrahydroquinoxaline Chemical class C1=CC=C2NCCNC2=C1 HORKYAIEVBUXGM-UHFFFAOYSA-N 0.000 title abstract description 10
- 230000027455 binding Effects 0.000 title description 18
- 102000003676 Glucocorticoid Receptors Human genes 0.000 title description 16
- 108090000079 Glucocorticoid Receptors Proteins 0.000 title description 16
- 125000000623 heterocyclic group Chemical group 0.000 claims abstract description 300
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 189
- 125000003118 aryl group Chemical group 0.000 claims abstract description 129
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 112
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 105
- 125000000753 cycloalkyl group Chemical group 0.000 claims abstract description 85
- 125000003342 alkenyl group Chemical group 0.000 claims abstract description 70
- 125000004448 alkyl carbonyl group Chemical group 0.000 claims abstract description 57
- 125000005129 aryl carbonyl group Chemical group 0.000 claims abstract description 46
- 125000000304 alkynyl group Chemical group 0.000 claims abstract description 40
- 125000002947 alkylene group Chemical group 0.000 claims abstract description 10
- 150000001875 compounds Chemical class 0.000 claims description 719
- 125000001424 substituent group Chemical group 0.000 claims description 355
- -1 thiophenecarbonyl group Chemical group 0.000 claims description 192
- 150000001408 amides Chemical group 0.000 claims description 141
- 125000003277 amino group Chemical group 0.000 claims description 134
- 150000002148 esters Chemical class 0.000 claims description 116
- 125000003282 alkyl amino group Chemical group 0.000 claims description 108
- 125000005843 halogen group Chemical group 0.000 claims description 105
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 95
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 80
- 125000001769 aryl amino group Chemical group 0.000 claims description 63
- 125000006310 cycloalkyl amino group Chemical group 0.000 claims description 57
- 150000003839 salts Chemical class 0.000 claims description 57
- 125000004104 aryloxy group Chemical group 0.000 claims description 44
- 125000000000 cycloalkoxy group Chemical group 0.000 claims description 40
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 claims description 40
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 39
- 125000004414 alkyl thio group Chemical group 0.000 claims description 37
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 34
- 125000003302 alkenyloxy group Chemical group 0.000 claims description 31
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims description 30
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 28
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 27
- 125000003396 thiol group Chemical group [H]S* 0.000 claims description 23
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims description 22
- 125000005133 alkynyloxy group Chemical group 0.000 claims description 13
- ISOWIHLLQQKVNP-UHFFFAOYSA-N 8-[(5-fluoro-2-methylphenoxy)methyl]-7-(4-hydroxy-2-methoxyphenyl)-1,3,3-trimethyl-4h-quinoxalin-2-one Chemical compound COC1=CC(O)=CC=C1C1=CC=C(NC(C)(C)C(=O)N2C)C2=C1COC1=CC(F)=CC=C1C ISOWIHLLQQKVNP-UHFFFAOYSA-N 0.000 claims description 9
- PYAPIKAIRWHOPQ-UHFFFAOYSA-N [4-[5-[(5-fluoro-2-methylphenoxy)methyl]-2,2,4-trimethyl-3-oxo-1h-quinoxalin-6-yl]-3-methoxyphenyl] morpholine-4-carboxylate Chemical compound C=1C=C(C=2C(=C3N(C)C(=O)C(C)(C)NC3=CC=2)COC=2C(=CC=C(F)C=2)C)C(OC)=CC=1OC(=O)N1CCOCC1 PYAPIKAIRWHOPQ-UHFFFAOYSA-N 0.000 claims description 5
- ZYHIFVAKCXZECO-UHFFFAOYSA-N 3-o-[4-[5-[(5-fluoro-2-methylphenoxy)methyl]-2,2,4-trimethyl-3-oxo-1h-quinoxalin-6-yl]-3-methoxyphenyl] 1-o-methyl benzene-1,3-dicarboxylate Chemical compound COC(=O)C1=CC=CC(C(=O)OC=2C=C(OC)C(=CC=2)C=2C(=C3N(C)C(=O)C(C)(C)NC3=CC=2)COC=2C(=CC=C(F)C=2)C)=C1 ZYHIFVAKCXZECO-UHFFFAOYSA-N 0.000 claims description 4
- LHZSDFUVZYVAIM-UHFFFAOYSA-N 7-(5-chloro-2-methoxyphenyl)-8-[[2-(2-hydroxyethyl)phenoxy]methyl]-1,3,3-trimethyl-4h-quinoxalin-2-one Chemical compound COC1=CC=C(Cl)C=C1C1=CC=C(NC(C)(C)C(=O)N2C)C2=C1COC1=CC=CC=C1CCO LHZSDFUVZYVAIM-UHFFFAOYSA-N 0.000 claims description 4
- NAPDISGDWOPXIQ-UHFFFAOYSA-N 7-(5-fluoro-2-methoxyphenyl)-1,3,3-trimethyl-8-(phenoxymethyl)-4h-quinoxalin-2-one Chemical compound COC1=CC=C(F)C=C1C1=CC=C(NC(C)(C)C(=O)N2C)C2=C1COC1=CC=CC=C1 NAPDISGDWOPXIQ-UHFFFAOYSA-N 0.000 claims description 4
- JKGZPCIOSBCCKR-UHFFFAOYSA-N 8-[(5-fluoro-2-methylphenoxy)methyl]-7-(2-methoxy-5-nitrophenyl)-1,3,3-trimethyl-4h-quinoxalin-2-one Chemical compound COC1=CC=C([N+]([O-])=O)C=C1C1=CC=C(NC(C)(C)C(=O)N2C)C2=C1COC1=CC(F)=CC=C1C JKGZPCIOSBCCKR-UHFFFAOYSA-N 0.000 claims description 4
- UDTADUDTSUMNOB-UHFFFAOYSA-N 8-[(5-fluoro-2-methylphenoxy)methyl]-7-[5-(hydroxymethyl)-2-methoxyphenyl]-1,3,3-trimethyl-4h-quinoxalin-2-one Chemical compound COC1=CC=C(CO)C=C1C1=CC=C(NC(C)(C)C(=O)N2C)C2=C1COC1=CC(F)=CC=C1C UDTADUDTSUMNOB-UHFFFAOYSA-N 0.000 claims description 4
- NCCJTMQFJNOXBG-UHFFFAOYSA-N [3-methoxy-4-[5-[(2-methoxy-5-nitrophenoxy)methyl]-2,2-dimethyl-3-oxo-1,4-dihydroquinoxalin-6-yl]phenyl] 2-methylbenzoate Chemical compound COC1=CC=C([N+]([O-])=O)C=C1OCC1=C(NC(=O)C(C)(C)N2)C2=CC=C1C(C(=C1)OC)=CC=C1OC(=O)C1=CC=CC=C1C NCCJTMQFJNOXBG-UHFFFAOYSA-N 0.000 claims description 4
- RGPPWPHBZBQGIJ-UHFFFAOYSA-N [3-methoxy-4-[5-[(4-methoxybenzoyl)oxymethyl]-2,2,4-trimethyl-3-oxo-1h-quinoxalin-6-yl]phenyl] 2-methylbenzoate Chemical compound C1=CC(OC)=CC=C1C(=O)OCC1=C(C=2C(=CC(OC(=O)C=3C(=CC=CC=3)C)=CC=2)OC)C=CC2=C1N(C)C(=O)C(C)(C)N2 RGPPWPHBZBQGIJ-UHFFFAOYSA-N 0.000 claims description 4
- DIEWTUYDSQBLFJ-UHFFFAOYSA-N [4-[5-[(5-fluoro-2-methylphenoxy)methyl]-2,2,4-trimethyl-3-oxo-1h-quinoxalin-6-yl]-3-methoxyphenyl] 6-methylpyridine-3-carboxylate Chemical compound C=1C=C(C=2C(=C3N(C)C(=O)C(C)(C)NC3=CC=2)COC=2C(=CC=C(F)C=2)C)C(OC)=CC=1OC(=O)C1=CC=C(C)N=C1 DIEWTUYDSQBLFJ-UHFFFAOYSA-N 0.000 claims description 4
- KZOMBYKUHCWPNV-UHFFFAOYSA-N [4-[5-[(5-fluoro-2-methylphenoxy)methyl]-2,2,4-trimethyl-3-oxo-1h-quinoxalin-6-yl]-3-methoxyphenyl] benzoate Chemical compound C=1C=C(C=2C(=C3N(C)C(=O)C(C)(C)NC3=CC=2)COC=2C(=CC=C(F)C=2)C)C(OC)=CC=1OC(=O)C1=CC=CC=C1 KZOMBYKUHCWPNV-UHFFFAOYSA-N 0.000 claims description 4
- QSTQQMOGBLFBAT-UHFFFAOYSA-N [6-(4-fluoro-2-methoxyphenyl)-2,2,4-trimethyl-3-oxo-1h-quinoxalin-5-yl]methyl 5-bromothiophene-2-carboxylate Chemical compound COC1=CC(F)=CC=C1C1=CC=C(NC(C)(C)C(=O)N2C)C2=C1COC(=O)C1=CC=C(Br)S1 QSTQQMOGBLFBAT-UHFFFAOYSA-N 0.000 claims description 4
- SOMWVEXIEOWEHI-UHFFFAOYSA-N [6-(5-fluoro-2-methoxyphenyl)-2,2,4-trimethyl-3-oxo-1h-quinoxalin-5-yl]methyl benzoate Chemical compound COC1=CC=C(F)C=C1C1=CC=C(NC(C)(C)C(=O)N2C)C2=C1COC(=O)C1=CC=CC=C1 SOMWVEXIEOWEHI-UHFFFAOYSA-N 0.000 claims description 4
- KWYJWXZUAPZJSP-UHFFFAOYSA-N [6-[4-(2-fluorobenzoyl)oxy-2-methoxyphenyl]-2,2,4-trimethyl-3-oxo-1h-quinoxalin-5-yl]methyl 5-methylthiophene-2-carboxylate Chemical compound C=1C=C(C=2C(=C3N(C)C(=O)C(C)(C)NC3=CC=2)COC(=O)C=2SC(C)=CC=2)C(OC)=CC=1OC(=O)C1=CC=CC=C1F KWYJWXZUAPZJSP-UHFFFAOYSA-N 0.000 claims description 4
- MNAUCOSDXCXAOS-UHFFFAOYSA-N n-[4-[5-[(5-fluoro-2-methylphenoxy)methyl]-2,2,4-trimethyl-3-oxo-1h-quinoxalin-6-yl]-3-methoxyphenyl]pyridine-4-carboxamide Chemical compound C=1C=C(C=2C(=C3N(C)C(=O)C(C)(C)NC3=CC=2)COC=2C(=CC=C(F)C=2)C)C(OC)=CC=1NC(=O)C1=CC=NC=C1 MNAUCOSDXCXAOS-UHFFFAOYSA-N 0.000 claims description 4
- SISZVQOFIMQUFW-UHFFFAOYSA-N 1-[4-[5-[(5-fluoro-2-methylphenoxy)methyl]-2,2,4-trimethyl-3-oxo-1h-quinoxalin-6-yl]-3-methoxyphenyl]-3-phenylurea Chemical compound C=1C=C(C=2C(=C3N(C)C(=O)C(C)(C)NC3=CC=2)COC=2C(=CC=C(F)C=2)C)C(OC)=CC=1NC(=O)NC1=CC=CC=C1 SISZVQOFIMQUFW-UHFFFAOYSA-N 0.000 claims description 3
- VUJGPIJGHUSZGH-UHFFFAOYSA-N 1-benzyl-3-[4-[5-[(5-fluoro-2-methylphenoxy)methyl]-2,2,4-trimethyl-3-oxo-1h-quinoxalin-6-yl]-3-methoxyphenyl]urea Chemical compound C=1C=C(C=2C(=C3N(C)C(=O)C(C)(C)NC3=CC=2)COC=2C(=CC=C(F)C=2)C)C(OC)=CC=1NC(=O)NCC1=CC=CC=C1 VUJGPIJGHUSZGH-UHFFFAOYSA-N 0.000 claims description 3
- WMHQGZXFJDIZFM-UHFFFAOYSA-N 2-chloro-n-[4-[5-[(5-fluoro-2-methylphenoxy)methyl]-2,2,4-trimethyl-3-oxo-1h-quinoxalin-6-yl]-3-methoxyphenyl]benzamide Chemical compound C=1C=C(C=2C(=C3N(C)C(=O)C(C)(C)NC3=CC=2)COC=2C(=CC=C(F)C=2)C)C(OC)=CC=1NC(=O)C1=CC=CC=C1Cl WMHQGZXFJDIZFM-UHFFFAOYSA-N 0.000 claims description 3
- ASURUEOONUCAIC-UHFFFAOYSA-N 3-o-[3-methoxy-4-[2,2,4-trimethyl-5-[(5-methylthiophene-2-carbonyl)oxymethyl]-3-oxo-1h-quinoxalin-6-yl]phenyl] 1-o-methyl benzene-1,3-dicarboxylate Chemical compound COC(=O)C1=CC=CC(C(=O)OC=2C=C(OC)C(=CC=2)C=2C(=C3N(C)C(=O)C(C)(C)NC3=CC=2)COC(=O)C=2SC(C)=CC=2)=C1 ASURUEOONUCAIC-UHFFFAOYSA-N 0.000 claims description 3
- CPPFMZYLWIPDTK-UHFFFAOYSA-N 7-(2-chlorophenyl)-8-[(5-fluoro-2-methylphenoxy)methyl]-1,3,3-trimethyl-4h-quinoxalin-2-one Chemical compound C=12N(C)C(=O)C(C)(C)NC2=CC=C(C=2C(=CC=CC=2)Cl)C=1COC1=CC(F)=CC=C1C CPPFMZYLWIPDTK-UHFFFAOYSA-N 0.000 claims description 3
- RNBPLESEHMHXPR-UHFFFAOYSA-N 7-(2-fluoro-6-methoxyphenyl)-8-[(5-fluoro-2-methylphenoxy)methyl]-1,3,3-trimethyl-4h-quinoxalin-2-one Chemical compound COC1=CC=CC(F)=C1C1=CC=C(NC(C)(C)C(=O)N2C)C2=C1COC1=CC(F)=CC=C1C RNBPLESEHMHXPR-UHFFFAOYSA-N 0.000 claims description 3
- HADYSGKRMGAARV-UHFFFAOYSA-N 7-(4-amino-2-methoxyphenyl)-8-[(5-fluoro-2-methylphenoxy)methyl]-1,3,3-trimethyl-4h-quinoxalin-2-one Chemical compound COC1=CC(N)=CC=C1C1=CC=C(NC(C)(C)C(=O)N2C)C2=C1COC1=CC(F)=CC=C1C HADYSGKRMGAARV-UHFFFAOYSA-N 0.000 claims description 3
- ANUSDXDTSMRJEU-UHFFFAOYSA-N 7-(4-fluoro-2-methoxyphenyl)-1,3,3-trimethyl-8-[(2-methyl-5-nitrophenoxy)methyl]-4h-quinoxalin-2-one Chemical compound COC1=CC(F)=CC=C1C1=CC=C(NC(C)(C)C(=O)N2C)C2=C1COC1=CC([N+]([O-])=O)=CC=C1C ANUSDXDTSMRJEU-UHFFFAOYSA-N 0.000 claims description 3
- NZRFWNPTRZZHJQ-UHFFFAOYSA-N 7-(4-fluoro-2-methoxyphenyl)-8-[(2-methoxy-5-methylanilino)methyl]-1,3,3-trimethyl-4h-quinoxalin-2-one Chemical compound COC1=CC=C(C)C=C1NCC1=C(C=2C(=CC(F)=CC=2)OC)C=CC2=C1N(C)C(=O)C(C)(C)N2 NZRFWNPTRZZHJQ-UHFFFAOYSA-N 0.000 claims description 3
- RFTDOFSYTUNSAW-UHFFFAOYSA-N 7-(4-fluoro-2-methoxyphenyl)-8-[(2-methoxy-5-nitrophenoxy)methyl]-1,3,3-trimethyl-4h-quinoxalin-2-one Chemical compound COC1=CC=C([N+]([O-])=O)C=C1OCC1=C(C=2C(=CC(F)=CC=2)OC)C=CC2=C1N(C)C(=O)C(C)(C)N2 RFTDOFSYTUNSAW-UHFFFAOYSA-N 0.000 claims description 3
- WSFPMTSQSIXYFN-UHFFFAOYSA-N 7-(4-fluoro-2-methoxyphenyl)-8-[(2-methoxyanilino)methyl]-1,3,3-trimethyl-4h-quinoxalin-2-one Chemical compound COC1=CC=CC=C1NCC1=C(C=2C(=CC(F)=CC=2)OC)C=CC2=C1N(C)C(=O)C(C)(C)N2 WSFPMTSQSIXYFN-UHFFFAOYSA-N 0.000 claims description 3
- ZFXUROBKXZUPGR-UHFFFAOYSA-N 7-(4-fluoro-2-methoxyphenyl)-8-[(5-fluoro-2-methylphenoxy)methyl]-1,3,3-trimethyl-4h-quinoxalin-2-one Chemical compound COC1=CC(F)=CC=C1C1=CC=C(NC(C)(C)C(=O)N2C)C2=C1COC1=CC(F)=CC=C1C ZFXUROBKXZUPGR-UHFFFAOYSA-N 0.000 claims description 3
- KFGYYNIETYFXRY-UHFFFAOYSA-N 7-(4-hydroxy-2-methoxyphenyl)-8-[(2-methoxyanilino)methyl]-1,3,3-trimethyl-4h-quinoxalin-2-one Chemical compound COC1=CC=CC=C1NCC1=C(C=2C(=CC(O)=CC=2)OC)C=CC2=C1N(C)C(=O)C(C)(C)N2 KFGYYNIETYFXRY-UHFFFAOYSA-N 0.000 claims description 3
- ZPNNWHQHIPRHQF-UHFFFAOYSA-N 7-(5-chloro-2-methoxyphenyl)-8-[(5-fluoro-2-methylanilino)methyl]-1,3,3-trimethyl-4h-quinoxalin-2-one Chemical compound COC1=CC=C(Cl)C=C1C1=CC=C(NC(C)(C)C(=O)N2C)C2=C1CNC1=CC(F)=CC=C1C ZPNNWHQHIPRHQF-UHFFFAOYSA-N 0.000 claims description 3
- GOHXAUAGUGYPNJ-UHFFFAOYSA-N 7-(5-chloro-2-methoxyphenyl)-8-[(5-fluoro-2-methylphenoxy)methyl]-1,3,3-trimethyl-4h-quinoxalin-2-one Chemical compound COC1=CC=C(Cl)C=C1C1=CC=C(NC(C)(C)C(=O)N2C)C2=C1COC1=CC(F)=CC=C1C GOHXAUAGUGYPNJ-UHFFFAOYSA-N 0.000 claims description 3
- LCAFRVQLMMWOOV-UHFFFAOYSA-N 8-(anilinomethyl)-7-(5-fluoro-2-methoxyphenyl)-1,3,3-trimethyl-4h-quinoxalin-2-one Chemical compound COC1=CC=C(F)C=C1C1=CC=C(NC(C)(C)C(=O)N2C)C2=C1CNC1=CC=CC=C1 LCAFRVQLMMWOOV-UHFFFAOYSA-N 0.000 claims description 3
- MSDMOVAEMKHGLF-UHFFFAOYSA-N 8-[(5-chloro-2-methylphenoxy)methyl]-7-(4-fluoro-2-methoxyphenyl)-1,3,3-trimethyl-4h-quinoxalin-2-one Chemical compound COC1=CC(F)=CC=C1C1=CC=C(NC(C)(C)C(=O)N2C)C2=C1COC1=CC(Cl)=CC=C1C MSDMOVAEMKHGLF-UHFFFAOYSA-N 0.000 claims description 3
- FLGGSLBRPICHFQ-UHFFFAOYSA-N 8-[(5-fluoro-2-methylphenoxy)methyl]-1,3,3-trimethyl-7-(2-methylphenyl)-4h-quinoxalin-2-one Chemical compound C=12N(C)C(=O)C(C)(C)NC2=CC=C(C=2C(=CC=CC=2)C)C=1COC1=CC(F)=CC=C1C FLGGSLBRPICHFQ-UHFFFAOYSA-N 0.000 claims description 3
- RXBNFFCJYAGRNA-UHFFFAOYSA-N 8-[(5-fluoro-2-methylphenoxy)methyl]-1,3,3-trimethyl-7-(2-methylsulfanylphenyl)-4h-quinoxalin-2-one Chemical compound CSC1=CC=CC=C1C1=CC=C(NC(C)(C)C(=O)N2C)C2=C1COC1=CC(F)=CC=C1C RXBNFFCJYAGRNA-UHFFFAOYSA-N 0.000 claims description 3
- OXFYVNVNBRUIJT-UHFFFAOYSA-N 8-[(5-fluoro-2-methylphenoxy)methyl]-7-(2-methoxyphenyl)-1,3,3-trimethyl-4h-quinoxalin-2-one Chemical compound COC1=CC=CC=C1C1=CC=C(NC(C)(C)C(=O)N2C)C2=C1COC1=CC(F)=CC=C1C OXFYVNVNBRUIJT-UHFFFAOYSA-N 0.000 claims description 3
- ZUIYGMPCDVNYEK-UHFFFAOYSA-N 8-[(5-fluoro-2-methylphenoxy)methyl]-7-[2-methoxy-5-(trifluoromethyl)phenyl]-1,3,3-trimethyl-4h-quinoxalin-2-one Chemical compound COC1=CC=C(C(F)(F)F)C=C1C1=CC=C(NC(C)(C)C(=O)N2C)C2=C1COC1=CC(F)=CC=C1C ZUIYGMPCDVNYEK-UHFFFAOYSA-N 0.000 claims description 3
- LAKLDPCBRLNAGS-UHFFFAOYSA-N [3-[5-[(5-fluoro-2-methylphenoxy)methyl]-2,2,4-trimethyl-3-oxo-1h-quinoxalin-6-yl]-4-methoxyphenyl] benzoate Chemical compound C1=C(C=2C(=C3N(C)C(=O)C(C)(C)NC3=CC=2)COC=2C(=CC=C(F)C=2)C)C(OC)=CC=C1OC(=O)C1=CC=CC=C1 LAKLDPCBRLNAGS-UHFFFAOYSA-N 0.000 claims description 3
- OXQLAMYARDAESV-UHFFFAOYSA-N [3-methoxy-4-[2,2,4-trimethyl-5-[(5-methylthiophene-2-carbonyl)oxymethyl]-3-oxo-1h-quinoxalin-6-yl]phenyl] 3-methylfuran-2-carboxylate Chemical compound C=1C=C(C=2C(=C3N(C)C(=O)C(C)(C)NC3=CC=2)COC(=O)C=2SC(C)=CC=2)C(OC)=CC=1OC(=O)C=1OC=CC=1C OXQLAMYARDAESV-UHFFFAOYSA-N 0.000 claims description 3
- KXKNSCCOIUKQFZ-UHFFFAOYSA-N [3-methoxy-4-[2,2,4-trimethyl-5-[(5-methylthiophene-2-carbonyl)oxymethyl]-3-oxo-1h-quinoxalin-6-yl]phenyl] furan-2-carboxylate Chemical compound C=1C=C(C=2C(=C3N(C)C(=O)C(C)(C)NC3=CC=2)COC(=O)C=2SC(C)=CC=2)C(OC)=CC=1OC(=O)C1=CC=CO1 KXKNSCCOIUKQFZ-UHFFFAOYSA-N 0.000 claims description 3
- VICVWPAULKEWLE-UHFFFAOYSA-N [3-methoxy-4-[5-[(2-methoxy-5-nitrophenoxy)methyl]-2,2,4-trimethyl-3-oxo-1h-quinoxalin-6-yl]phenyl] 2-methylbenzoate Chemical compound COC1=CC=C([N+]([O-])=O)C=C1OCC1=C(C=2C(=CC(OC(=O)C=3C(=CC=CC=3)C)=CC=2)OC)C=CC2=C1N(C)C(=O)C(C)(C)N2 VICVWPAULKEWLE-UHFFFAOYSA-N 0.000 claims description 3
- VSKZUOGLEVTSKT-UHFFFAOYSA-N [3-methoxy-4-[5-[(2-methoxyanilino)methyl]-2,2,4-trimethyl-3-oxo-1h-quinoxalin-6-yl]phenyl] 1,3-thiazole-4-carboxylate Chemical compound COC1=CC=CC=C1NCC1=C(C=2C(=CC(OC(=O)C=3N=CSC=3)=CC=2)OC)C=CC2=C1N(C)C(=O)C(C)(C)N2 VSKZUOGLEVTSKT-UHFFFAOYSA-N 0.000 claims description 3
- PZUUKMWNTOKMJB-UHFFFAOYSA-N [3-methoxy-4-[5-[(2-methoxyanilino)methyl]-2,2,4-trimethyl-3-oxo-1h-quinoxalin-6-yl]phenyl] 2-methoxybenzoate Chemical compound COC1=CC=CC=C1NCC1=C(C=2C(=CC(OC(=O)C=3C(=CC=CC=3)OC)=CC=2)OC)C=CC2=C1N(C)C(=O)C(C)(C)N2 PZUUKMWNTOKMJB-UHFFFAOYSA-N 0.000 claims description 3
- VCCKPXZGRWRRTE-UHFFFAOYSA-N [3-methoxy-4-[5-[(2-methoxyanilino)methyl]-2,2,4-trimethyl-3-oxo-1h-quinoxalin-6-yl]phenyl] 2-methylbenzoate Chemical compound COC1=CC=CC=C1NCC1=C(C=2C(=CC(OC(=O)C=3C(=CC=CC=3)C)=CC=2)OC)C=CC2=C1N(C)C(=O)C(C)(C)N2 VCCKPXZGRWRRTE-UHFFFAOYSA-N 0.000 claims description 3
- KYHLVKXTFACQHD-UHFFFAOYSA-N [3-methoxy-4-[5-[(2-methoxyanilino)methyl]-2,2,4-trimethyl-3-oxo-1h-quinoxalin-6-yl]phenyl] 2-methylpyridine-3-carboxylate Chemical compound COC1=CC=CC=C1NCC1=C(C=2C(=CC(OC(=O)C=3C(=NC=CC=3)C)=CC=2)OC)C=CC2=C1N(C)C(=O)C(C)(C)N2 KYHLVKXTFACQHD-UHFFFAOYSA-N 0.000 claims description 3
- BGIIMVADAGWMLR-UHFFFAOYSA-N [3-methoxy-4-[5-[(2-methoxyanilino)methyl]-2,2,4-trimethyl-3-oxo-1h-quinoxalin-6-yl]phenyl] butanoate Chemical compound COC1=CC(OC(=O)CCC)=CC=C1C1=CC=C(NC(C)(C)C(=O)N2C)C2=C1CNC1=CC=CC=C1OC BGIIMVADAGWMLR-UHFFFAOYSA-N 0.000 claims description 3
- BLECQFUHYPMCOB-UHFFFAOYSA-N [3-methoxy-4-[5-[(2-methoxyanilino)methyl]-2,2,4-trimethyl-3-oxo-1h-quinoxalin-6-yl]phenyl] thiophene-3-carboxylate Chemical compound COC1=CC=CC=C1NCC1=C(C=2C(=CC(OC(=O)C3=CSC=C3)=CC=2)OC)C=CC2=C1N(C)C(=O)C(C)(C)N2 BLECQFUHYPMCOB-UHFFFAOYSA-N 0.000 claims description 3
- NLWRRVLESPPEFH-UHFFFAOYSA-N [4-[5-[(3-fluorobenzoyl)oxymethyl]-2,2,4-trimethyl-3-oxo-1h-quinoxalin-6-yl]-3-methoxyphenyl] 2-methylbenzoate Chemical compound C=1C=C(C=2C(=C3N(C)C(=O)C(C)(C)NC3=CC=2)COC(=O)C=2C=C(F)C=CC=2)C(OC)=CC=1OC(=O)C1=CC=CC=C1C NLWRRVLESPPEFH-UHFFFAOYSA-N 0.000 claims description 3
- PDWMEUODPGFTHY-UHFFFAOYSA-N [4-[5-[(5-fluoro-2-methylphenoxy)methyl]-2,2,4-trimethyl-3-oxo-1h-quinoxalin-6-yl]-3-methoxyphenyl] 1,3-oxazole-4-carboxylate Chemical compound C=1C=C(C=2C(=C3N(C)C(=O)C(C)(C)NC3=CC=2)COC=2C(=CC=C(F)C=2)C)C(OC)=CC=1OC(=O)C1=COC=N1 PDWMEUODPGFTHY-UHFFFAOYSA-N 0.000 claims description 3
- VJGZLEGPBAWYQL-UHFFFAOYSA-N [4-[5-[(5-fluoro-2-methylphenoxy)methyl]-2,2,4-trimethyl-3-oxo-1h-quinoxalin-6-yl]-3-methoxyphenyl] 2-acetyloxybenzoate Chemical compound C=1C=C(C=2C(=C3N(C)C(=O)C(C)(C)NC3=CC=2)COC=2C(=CC=C(F)C=2)C)C(OC)=CC=1OC(=O)C1=CC=CC=C1OC(C)=O VJGZLEGPBAWYQL-UHFFFAOYSA-N 0.000 claims description 3
- KCSWTZMOXXTUTG-UHFFFAOYSA-N [4-[5-[(5-fluoro-2-methylphenoxy)methyl]-2,2,4-trimethyl-3-oxo-1h-quinoxalin-6-yl]-3-methoxyphenyl] 2-chlorobenzoate Chemical compound C=1C=C(C=2C(=C3N(C)C(=O)C(C)(C)NC3=CC=2)COC=2C(=CC=C(F)C=2)C)C(OC)=CC=1OC(=O)C1=CC=CC=C1Cl KCSWTZMOXXTUTG-UHFFFAOYSA-N 0.000 claims description 3
- YFTBOBZCJNNLQW-UHFFFAOYSA-N [4-[5-[(5-fluoro-2-methylphenoxy)methyl]-2,2,4-trimethyl-3-oxo-1h-quinoxalin-6-yl]-3-methoxyphenyl] 2-methoxypyridine-3-carboxylate Chemical compound C=1C=C(C=2C(=C3N(C)C(=O)C(C)(C)NC3=CC=2)COC=2C(=CC=C(F)C=2)C)C(OC)=CC=1OC(=O)C1=CC=CN=C1OC YFTBOBZCJNNLQW-UHFFFAOYSA-N 0.000 claims description 3
- JZWPDBFJUNWDOT-UHFFFAOYSA-N [4-[5-[(5-fluoro-2-methylphenoxy)methyl]-2,2,4-trimethyl-3-oxo-1h-quinoxalin-6-yl]-3-methoxyphenyl] 2-methylpyridine-3-carboxylate Chemical compound C=1C=C(C=2C(=C3N(C)C(=O)C(C)(C)NC3=CC=2)COC=2C(=CC=C(F)C=2)C)C(OC)=CC=1OC(=O)C1=CC=CN=C1C JZWPDBFJUNWDOT-UHFFFAOYSA-N 0.000 claims description 3
- CLYGYXQXPKIBPM-UHFFFAOYSA-N [4-[5-[(5-fluoro-2-methylphenoxy)methyl]-2,2,4-trimethyl-3-oxo-1h-quinoxalin-6-yl]-3-methoxyphenyl] 3-acetylbenzoate Chemical compound C=1C=C(C=2C(=C3N(C)C(=O)C(C)(C)NC3=CC=2)COC=2C(=CC=C(F)C=2)C)C(OC)=CC=1OC(=O)C1=CC=CC(C(C)=O)=C1 CLYGYXQXPKIBPM-UHFFFAOYSA-N 0.000 claims description 3
- CAGKDPZRAPHIKW-UHFFFAOYSA-N [4-[5-[(5-fluoro-2-methylphenoxy)methyl]-2,2,4-trimethyl-3-oxo-1h-quinoxalin-6-yl]-3-methoxyphenyl] 3-chlorothiophene-2-carboxylate Chemical compound C=1C=C(C=2C(=C3N(C)C(=O)C(C)(C)NC3=CC=2)COC=2C(=CC=C(F)C=2)C)C(OC)=CC=1OC(=O)C=1SC=CC=1Cl CAGKDPZRAPHIKW-UHFFFAOYSA-N 0.000 claims description 3
- NKUFZIARNOLGCX-UHFFFAOYSA-N [4-[5-[(5-fluoro-2-methylphenoxy)methyl]-2,2,4-trimethyl-3-oxo-1h-quinoxalin-6-yl]-3-methoxyphenyl] 4-methoxybenzoate Chemical compound C1=CC(OC)=CC=C1C(=O)OC1=CC=C(C=2C(=C3N(C)C(=O)C(C)(C)NC3=CC=2)COC=2C(=CC=C(F)C=2)C)C(OC)=C1 NKUFZIARNOLGCX-UHFFFAOYSA-N 0.000 claims description 3
- XXXRXSHVXYNIBO-UHFFFAOYSA-N [4-[5-[(5-fluoro-2-methylphenoxy)methyl]-2,2,4-trimethyl-3-oxo-1h-quinoxalin-6-yl]-3-methoxyphenyl] furan-3-carboxylate Chemical compound C=1C=C(C=2C(=C3N(C)C(=O)C(C)(C)NC3=CC=2)COC=2C(=CC=C(F)C=2)C)C(OC)=CC=1OC(=O)C=1C=COC=1 XXXRXSHVXYNIBO-UHFFFAOYSA-N 0.000 claims description 3
- XTISCFZYHWGMFQ-UHFFFAOYSA-N [4-[5-[(5-fluoro-2-methylphenoxy)methyl]-2,2,4-trimethyl-3-oxo-1h-quinoxalin-6-yl]-3-methoxyphenyl] methyl carbonate Chemical compound COC1=CC(OC(=O)OC)=CC=C1C1=CC=C(NC(C)(C)C(=O)N2C)C2=C1COC1=CC(F)=CC=C1C XTISCFZYHWGMFQ-UHFFFAOYSA-N 0.000 claims description 3
- GCCQYVKIWIQAJV-UHFFFAOYSA-N [4-[5-[(5-fluoro-2-methylphenoxy)methyl]-2,2,4-trimethyl-3-oxo-1h-quinoxalin-6-yl]-3-methoxyphenyl] n,n-dimethylcarbamate Chemical compound COC1=CC(OC(=O)N(C)C)=CC=C1C1=CC=C(NC(C)(C)C(=O)N2C)C2=C1COC1=CC(F)=CC=C1C GCCQYVKIWIQAJV-UHFFFAOYSA-N 0.000 claims description 3
- LLQZOWBPPOPWGX-UHFFFAOYSA-N [4-[5-[(5-fluoro-2-methylphenoxy)methyl]-2,2,4-trimethyl-3-oxo-1h-quinoxalin-6-yl]-3-methoxyphenyl] n-pyridin-3-ylcarbamate Chemical compound C=1C=C(C=2C(=C3N(C)C(=O)C(C)(C)NC3=CC=2)COC=2C(=CC=C(F)C=2)C)C(OC)=CC=1OC(=O)NC1=CC=CN=C1 LLQZOWBPPOPWGX-UHFFFAOYSA-N 0.000 claims description 3
- XBBKPJWOCHZWMJ-UHFFFAOYSA-N [4-[5-[(5-fluoro-2-methylphenoxy)methyl]-2,2,4-trimethyl-3-oxo-1h-quinoxalin-6-yl]-3-methoxyphenyl] phenyl carbonate Chemical compound C=1C=C(C=2C(=C3N(C)C(=O)C(C)(C)NC3=CC=2)COC=2C(=CC=C(F)C=2)C)C(OC)=CC=1OC(=O)OC1=CC=CC=C1 XBBKPJWOCHZWMJ-UHFFFAOYSA-N 0.000 claims description 3
- XRDBYVYRENNWDE-UHFFFAOYSA-N [4-[5-[(5-fluoro-2-methylphenoxy)methyl]-2,2,4-trimethyl-3-oxo-1h-quinoxalin-6-yl]-3-methoxyphenyl] prop-2-enoate Chemical compound COC1=CC(OC(=O)C=C)=CC=C1C1=CC=C(NC(C)(C)C(=O)N2C)C2=C1COC1=CC(F)=CC=C1C XRDBYVYRENNWDE-UHFFFAOYSA-N 0.000 claims description 3
- LZSZIUGZHVQLLI-UHFFFAOYSA-N [4-ethyl-6-(5-fluoro-2-methoxyphenyl)-2,2-dimethyl-3-oxo-1h-quinoxalin-5-yl]methyl 4-methylbenzoate Chemical compound C=12N(CC)C(=O)C(C)(C)NC2=CC=C(C=2C(=CC=C(F)C=2)OC)C=1COC(=O)C1=CC=C(C)C=C1 LZSZIUGZHVQLLI-UHFFFAOYSA-N 0.000 claims description 3
- RZZDLZFZEORTBR-UHFFFAOYSA-N [6-(4-benzoyloxy-2-methoxyphenyl)-2,2,4-trimethyl-3-oxo-1h-quinoxalin-5-yl]methyl 5-methylthiophene-2-carboxylate Chemical compound C=1C=C(C=2C(=C3N(C)C(=O)C(C)(C)NC3=CC=2)COC(=O)C=2SC(C)=CC=2)C(OC)=CC=1OC(=O)C1=CC=CC=C1 RZZDLZFZEORTBR-UHFFFAOYSA-N 0.000 claims description 3
- QLMYOWNISUUMPH-UHFFFAOYSA-N [6-(4-fluoro-2-methoxyphenyl)-2,2,4-trimethyl-3-oxo-1h-quinoxalin-5-yl]methyl 5-methylthiophene-2-carboxylate Chemical compound COC1=CC(F)=CC=C1C1=CC=C(NC(C)(C)C(=O)N2C)C2=C1COC(=O)C1=CC=C(C)S1 QLMYOWNISUUMPH-UHFFFAOYSA-N 0.000 claims description 3
- OPYUFZOLDLHNKT-UHFFFAOYSA-N [6-(4-hydroxy-2-methoxyphenyl)-2,2,4-trimethyl-3-oxo-1h-quinoxalin-5-yl]methyl 5-methylthiophene-2-carboxylate Chemical compound COC1=CC(O)=CC=C1C1=CC=C(NC(C)(C)C(=O)N2C)C2=C1COC(=O)C1=CC=C(C)S1 OPYUFZOLDLHNKT-UHFFFAOYSA-N 0.000 claims description 3
- VWKKKVMEHUSWQJ-UHFFFAOYSA-N [6-(5-fluoro-2-methoxyphenyl)-2,2-dimethyl-3-oxo-1,4-dihydroquinoxalin-5-yl]methyl 4-methylbenzoate Chemical compound COC1=CC=C(F)C=C1C1=CC=C(NC(C)(C)C(=O)N2)C2=C1COC(=O)C1=CC=C(C)C=C1 VWKKKVMEHUSWQJ-UHFFFAOYSA-N 0.000 claims description 3
- YMSFVBYWSXWXNB-UHFFFAOYSA-N [6-(5-fluoro-2-methoxyphenyl)-2,2-dimethyl-3-oxo-4-prop-2-enyl-1h-quinoxalin-5-yl]methyl 4-methylbenzoate Chemical compound COC1=CC=C(F)C=C1C1=CC=C(NC(C)(C)C(=O)N2CC=C)C2=C1COC(=O)C1=CC=C(C)C=C1 YMSFVBYWSXWXNB-UHFFFAOYSA-N 0.000 claims description 3
- HDILGJIUHYJODX-UHFFFAOYSA-N [6-[2-methoxy-4-(2-methoxybenzoyl)oxyphenyl]-2,2,4-trimethyl-3-oxo-1h-quinoxalin-5-yl]methyl 5-methylthiophene-2-carboxylate Chemical compound COC1=CC=CC=C1C(=O)OC1=CC=C(C=2C(=C3N(C)C(=O)C(C)(C)NC3=CC=2)COC(=O)C=2SC(C)=CC=2)C(OC)=C1 HDILGJIUHYJODX-UHFFFAOYSA-N 0.000 claims description 3
- CRAPLIBJLAEXLQ-UHFFFAOYSA-N [6-[2-methoxy-4-(phenylcarbamoyloxy)phenyl]-2,2,4-trimethyl-3-oxo-1h-quinoxalin-5-yl]methyl 5-methylthiophene-2-carboxylate Chemical compound C=1C=C(C=2C(=C3N(C)C(=O)C(C)(C)NC3=CC=2)COC(=O)C=2SC(C)=CC=2)C(OC)=CC=1OC(=O)NC1=CC=CC=C1 CRAPLIBJLAEXLQ-UHFFFAOYSA-N 0.000 claims description 3
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- MNLIRDXMCHRYIJ-UHFFFAOYSA-N n-[4-[5-[(5-fluoro-2-methylphenoxy)methyl]-2,2,4-trimethyl-3-oxo-1h-quinoxalin-6-yl]-3-methoxyphenyl]-n-methylacetamide Chemical compound COC1=CC(N(C)C(C)=O)=CC=C1C1=CC=C(NC(C)(C)C(=O)N2C)C2=C1COC1=CC(F)=CC=C1C MNLIRDXMCHRYIJ-UHFFFAOYSA-N 0.000 claims description 3
- IAPYSMFYKRNSBD-UHFFFAOYSA-N phenyl n-[4-[5-[(5-fluoro-2-methylphenoxy)methyl]-2,2,4-trimethyl-3-oxo-1h-quinoxalin-6-yl]-3-methoxyphenyl]carbamate Chemical compound C=1C=C(C=2C(=C3N(C)C(=O)C(C)(C)NC3=CC=2)COC=2C(=CC=C(F)C=2)C)C(OC)=CC=1NC(=O)OC1=CC=CC=C1 IAPYSMFYKRNSBD-UHFFFAOYSA-N 0.000 claims description 3
- HZJYHCHWLPXZHW-UHFFFAOYSA-N 8-[(2-methoxyanilino)methyl]-7-[2-methoxy-5-(trifluoromethyl)phenyl]-1,3,3-trimethyl-4h-quinoxalin-2-one Chemical compound COC1=CC=CC=C1NCC1=C(C=2C(=CC=C(C=2)C(F)(F)F)OC)C=CC2=C1N(C)C(=O)C(C)(C)N2 HZJYHCHWLPXZHW-UHFFFAOYSA-N 0.000 claims description 2
- SMKUMDCFDMOEQA-UHFFFAOYSA-N 9h-fluoren-9-ylmethyl n-(5-fluoro-2-methylphenyl)-n-[[6-(4-hydroxy-2-methoxyphenyl)-2,2,4-trimethyl-3-oxo-1h-quinoxalin-5-yl]methyl]carbamate Chemical compound COC1=CC(O)=CC=C1C1=CC=C(NC(C)(C)C(=O)N2C)C2=C1CN(C=1C(=CC=C(F)C=1)C)C(=O)OCC1C2=CC=CC=C2C2=CC=CC=C21 SMKUMDCFDMOEQA-UHFFFAOYSA-N 0.000 claims description 2
- OWXPJHYRLJHHKY-UHFFFAOYSA-N [3-methoxy-4-[5-[(4-methoxybenzoyl)oxymethyl]-2,2-dimethyl-3-oxo-1,4-dihydroquinoxalin-6-yl]phenyl] 2-methylbenzoate Chemical compound C1=CC(OC)=CC=C1C(=O)OCC1=C(NC(=O)C(C)(C)N2)C2=CC=C1C(C(=C1)OC)=CC=C1OC(=O)C1=CC=CC=C1C OWXPJHYRLJHHKY-UHFFFAOYSA-N 0.000 claims description 2
- KNTQJVNDXRMIPM-UHFFFAOYSA-N [6-[2-methoxy-4-(2-methylbenzenecarbothioyl)oxyphenyl]-2,2,4-trimethyl-3-oxo-1h-quinoxalin-5-yl]methyl 5-methylthiophene-2-carboxylate Chemical compound C=1C=C(C=2C(=C3N(C)C(=O)C(C)(C)NC3=CC=2)COC(=O)C=2SC(C)=CC=2)C(OC)=CC=1OC(=S)C1=CC=CC=C1C KNTQJVNDXRMIPM-UHFFFAOYSA-N 0.000 claims description 2
- MZTOWMNRZQMAIZ-UHFFFAOYSA-N o-[4-[5-[(5-fluoro-2-methylphenoxy)methyl]-2,2,4-trimethyl-3-oxo-1h-quinoxalin-6-yl]-3-methoxyphenyl] 2-methylbenzenecarbothioate Chemical compound C=1C=C(C=2C(=C3N(C)C(=O)C(C)(C)NC3=CC=2)COC=2C(=CC=C(F)C=2)C)C(OC)=CC=1OC(=S)C1=CC=CC=C1C MZTOWMNRZQMAIZ-UHFFFAOYSA-N 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- CXWUVFKSXDUQEB-UHFFFAOYSA-N [3-methoxy-4-[5-[2-(2-methoxyanilino)ethyl]-2,2,4-trimethyl-3-oxo-1h-quinoxalin-6-yl]phenyl] pyridine-3-carboxylate Chemical compound COC1=CC=CC=C1NCCC1=C(C=2C(=CC(OC(=O)C=3C=NC=CC=3)=CC=2)OC)C=CC2=C1N(C)C(=O)C(C)(C)N2 CXWUVFKSXDUQEB-UHFFFAOYSA-N 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 abstract description 8
- 230000009471 action Effects 0.000 abstract description 7
- 230000000144 pharmacologic effect Effects 0.000 abstract description 6
- 229910052736 halogen Inorganic materials 0.000 abstract description 4
- 229910052760 oxygen Inorganic materials 0.000 abstract description 3
- 150000002367 halogens Chemical group 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 150000002431 hydrogen Chemical group 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 553
- 238000005160 1H NMR spectroscopy Methods 0.000 description 345
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 162
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 133
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 109
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 80
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 76
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 73
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 60
- 239000000203 mixture Substances 0.000 description 59
- 239000002904 solvent Substances 0.000 description 55
- 230000002829 reductive effect Effects 0.000 description 54
- 239000011541 reaction mixture Substances 0.000 description 53
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 50
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 46
- 238000000034 method Methods 0.000 description 46
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 46
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 43
- 238000010898 silica gel chromatography Methods 0.000 description 42
- 125000000542 sulfonic acid group Chemical group 0.000 description 40
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 38
- 239000012044 organic layer Substances 0.000 description 35
- 239000007787 solid Substances 0.000 description 34
- 239000000243 solution Substances 0.000 description 34
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 32
- FFRYUAVNPBUEIC-UHFFFAOYSA-N quinoxalin-2-ol Chemical compound C1=CC=CC2=NC(O)=CN=C21 FFRYUAVNPBUEIC-UHFFFAOYSA-N 0.000 description 30
- 239000003960 organic solvent Substances 0.000 description 29
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 27
- 239000002585 base Substances 0.000 description 27
- 0 CC.CC.[3*]N1C2=CC=C(C3=CC=CC=C3)C(*[7*])=C2N([6*])C(=C)C1([4*])[5*] Chemical compound CC.CC.[3*]N1C2=CC=C(C3=CC=CC=C3)C(*[7*])=C2N([6*])C(=C)C1([4*])[5*] 0.000 description 25
- 238000006243 chemical reaction Methods 0.000 description 25
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 24
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 23
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 22
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 21
- 125000006254 cycloalkyl carbonyl group Chemical group 0.000 description 21
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 20
- 125000004391 aryl sulfonyl group Chemical group 0.000 description 20
- 125000005144 cycloalkylsulfonyl group Chemical group 0.000 description 20
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 20
- 229910000027 potassium carbonate Inorganic materials 0.000 description 19
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 18
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 17
- 239000000047 product Substances 0.000 description 17
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 16
- 238000001816 cooling Methods 0.000 description 16
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 16
- 235000017557 sodium bicarbonate Nutrition 0.000 description 16
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 16
- 238000012360 testing method Methods 0.000 description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 125000005090 alkenylcarbonyl group Chemical group 0.000 description 15
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 14
- 125000005110 aryl thio group Chemical group 0.000 description 14
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 14
- 125000005366 cycloalkylthio group Chemical group 0.000 description 14
- 201000010099 disease Diseases 0.000 description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 14
- 125000004149 thio group Chemical group *S* 0.000 description 14
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 14
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 13
- 125000005161 aryl oxy carbonyl group Chemical group 0.000 description 13
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 13
- YNHIGQDRGKUECZ-UHFFFAOYSA-N dichloropalladium;triphenylphosphanium Chemical compound Cl[Pd]Cl.C1=CC=CC=C1[PH+](C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1[PH+](C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-N 0.000 description 13
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 12
- 125000005087 alkynylcarbonyl group Chemical group 0.000 description 12
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 12
- 229910000024 caesium carbonate Inorganic materials 0.000 description 12
- 238000002360 preparation method Methods 0.000 description 12
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 11
- 150000001412 amines Chemical class 0.000 description 11
- 150000004820 halides Chemical class 0.000 description 11
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 10
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 10
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 10
- 125000005089 alkenylaminocarbonyl group Chemical group 0.000 description 10
- 125000005092 alkenyloxycarbonyl group Chemical group 0.000 description 10
- 125000005137 alkenylsulfonyl group Chemical group 0.000 description 10
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 description 10
- 125000005095 alkynylaminocarbonyl group Chemical group 0.000 description 10
- 125000005225 alkynyloxycarbonyl group Chemical group 0.000 description 10
- 125000005100 aryl amino carbonyl group Chemical group 0.000 description 10
- 125000005167 cycloalkylaminocarbonyl group Chemical group 0.000 description 10
- 125000005170 cycloalkyloxycarbonyl group Chemical group 0.000 description 10
- 239000012046 mixed solvent Substances 0.000 description 10
- 125000005740 oxycarbonyl group Chemical group [*:1]OC([*:2])=O 0.000 description 10
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 10
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 9
- 239000003795 chemical substances by application Substances 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- RMVRSNDYEFQCLF-UHFFFAOYSA-N thiophenol Chemical compound SC1=CC=CC=C1 RMVRSNDYEFQCLF-UHFFFAOYSA-N 0.000 description 9
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 8
- 125000005139 alkynylsulfonyl group Chemical group 0.000 description 8
- 239000000872 buffer Substances 0.000 description 8
- 125000004432 carbon atom Chemical group C* 0.000 description 8
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 8
- 125000004433 nitrogen atom Chemical group N* 0.000 description 8
- 229920006395 saturated elastomer Polymers 0.000 description 8
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 7
- YNHIGQDRGKUECZ-UHFFFAOYSA-L PdCl2(PPh3)2 Substances [Cl-].[Cl-].[Pd+2].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-L 0.000 description 7
- 239000002253 acid Substances 0.000 description 7
- 239000003054 catalyst Substances 0.000 description 7
- 238000002875 fluorescence polarization Methods 0.000 description 7
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 7
- 125000002950 monocyclic group Chemical group 0.000 description 7
- 229910052757 nitrogen Inorganic materials 0.000 description 7
- 229910000029 sodium carbonate Inorganic materials 0.000 description 7
- 235000017550 sodium carbonate Nutrition 0.000 description 7
- 125000004204 2-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C(OC([H])([H])[H])C([H])=C1[H] 0.000 description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 6
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 6
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- 229960004132 diethyl ether Drugs 0.000 description 6
- 230000013632 homeostatic process Effects 0.000 description 6
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 6
- 239000012280 lithium aluminium hydride Substances 0.000 description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 6
- GURKXMPUBXRMKK-UHFFFAOYSA-N methyl 6-bromo-2,2-dimethyl-3-oxo-1,4-dihydroquinoxaline-5-carboxylate Chemical compound N1C(C)(C)C(=O)NC2=C1C=CC(Br)=C2C(=O)OC GURKXMPUBXRMKK-UHFFFAOYSA-N 0.000 description 6
- 238000012216 screening Methods 0.000 description 6
- 239000012312 sodium hydride Substances 0.000 description 6
- 229910000104 sodium hydride Inorganic materials 0.000 description 6
- 125000000626 sulfinic acid group Chemical group 0.000 description 6
- 229910000404 tripotassium phosphate Inorganic materials 0.000 description 6
- 235000019798 tripotassium phosphate Nutrition 0.000 description 6
- RUDBPQBLQRHVJF-UHFFFAOYSA-N 7-bromo-8-[(5-fluoro-2-methylphenoxy)methyl]-1,3,3-trimethyl-4h-quinoxalin-2-one Chemical compound C=12N(C)C(=O)C(C)(C)NC2=CC=C(Br)C=1COC1=CC(F)=CC=C1C RUDBPQBLQRHVJF-UHFFFAOYSA-N 0.000 description 5
- 208000023275 Autoimmune disease Diseases 0.000 description 5
- 208000024172 Cardiovascular disease Diseases 0.000 description 5
- 208000010412 Glaucoma Diseases 0.000 description 5
- 229940117965 Glucocorticoid receptor modulator Drugs 0.000 description 5
- 208000026935 allergic disease Diseases 0.000 description 5
- 125000002619 bicyclic group Chemical group 0.000 description 5
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 description 5
- 208000015114 central nervous system disease Diseases 0.000 description 5
- NXQGGXCHGDYOHB-UHFFFAOYSA-L cyclopenta-1,4-dien-1-yl(diphenyl)phosphane;dichloropalladium;iron(2+) Chemical compound [Fe+2].Cl[Pd]Cl.[CH-]1C=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1.[CH-]1C=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 NXQGGXCHGDYOHB-UHFFFAOYSA-L 0.000 description 5
- 239000003889 eye drop Substances 0.000 description 5
- 208000027866 inflammatory disease Diseases 0.000 description 5
- 239000010410 layer Substances 0.000 description 5
- 208000030159 metabolic disease Diseases 0.000 description 5
- 125000004430 oxygen atom Chemical group O* 0.000 description 5
- 235000011056 potassium acetate Nutrition 0.000 description 5
- 125000004434 sulfur atom Chemical group 0.000 description 5
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 4
- OOHQMQJQBLXGCO-UHFFFAOYSA-N 7-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)-8-[(5-fluoro-2-methylphenoxy)methyl]-1,3,3-trimethyl-4h-quinoxalin-2-one Chemical compound C=1C(F)=CC=C(C)C=1OCC1=C2N(C)C(=O)C(C)(C)NC2=CC=C1B1OCC(C)(C)CO1 OOHQMQJQBLXGCO-UHFFFAOYSA-N 0.000 description 4
- 208000024827 Alzheimer disease Diseases 0.000 description 4
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 4
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 4
- 206010010744 Conjunctivitis allergic Diseases 0.000 description 4
- 206010012438 Dermatitis atopic Diseases 0.000 description 4
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 4
- 208000004232 Enteritis Diseases 0.000 description 4
- 208000037147 Hypercalcaemia Diseases 0.000 description 4
- 206010060378 Hyperinsulinaemia Diseases 0.000 description 4
- 208000031226 Hyperlipidaemia Diseases 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 4
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical group C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 4
- 208000008589 Obesity Diseases 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 206010039085 Rhinitis allergic Diseases 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- KKEYFWRCBNTPAC-UHFFFAOYSA-N Terephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-N 0.000 description 4
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 4
- 230000005856 abnormality Effects 0.000 description 4
- 229960000583 acetic acid Drugs 0.000 description 4
- 150000007933 aliphatic carboxylic acids Chemical class 0.000 description 4
- 208000002205 allergic conjunctivitis Diseases 0.000 description 4
- 201000010105 allergic rhinitis Diseases 0.000 description 4
- 206010003246 arthritis Diseases 0.000 description 4
- 208000006673 asthma Diseases 0.000 description 4
- 208000024998 atopic conjunctivitis Diseases 0.000 description 4
- 201000008937 atopic dermatitis Diseases 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 4
- 208000018631 connective tissue disease Diseases 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000003862 glucocorticoid Substances 0.000 description 4
- 229940124750 glucocorticoid receptor agonist Drugs 0.000 description 4
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 4
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 4
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 4
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 4
- 230000000148 hypercalcaemia Effects 0.000 description 4
- 208000030915 hypercalcemia disease Diseases 0.000 description 4
- 230000003451 hyperinsulinaemic effect Effects 0.000 description 4
- 201000008980 hyperinsulinism Diseases 0.000 description 4
- VWBZGNWNFAFBFT-UHFFFAOYSA-N methyl 3-acetamido-6-bromo-2-nitrobenzoate Chemical compound COC(=O)C1=C(Br)C=CC(NC(C)=O)=C1[N+]([O-])=O VWBZGNWNFAFBFT-UHFFFAOYSA-N 0.000 description 4
- DCDLZEKAQLUDLK-UHFFFAOYSA-N methyl 3-amino-6-bromo-2-nitrobenzoate Chemical compound COC(=O)C1=C(Br)C=CC(N)=C1[N+]([O-])=O DCDLZEKAQLUDLK-UHFFFAOYSA-N 0.000 description 4
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 4
- 235000020824 obesity Nutrition 0.000 description 4
- RDOWQLZANAYVLL-UHFFFAOYSA-N phenanthridine Chemical compound C1=CC=C2C3=CC=CC=C3C=NC2=C1 RDOWQLZANAYVLL-UHFFFAOYSA-N 0.000 description 4
- 230000003449 preventive effect Effects 0.000 description 4
- 208000020016 psychiatric disease Diseases 0.000 description 4
- 235000011150 stannous chloride Nutrition 0.000 description 4
- 208000011117 substance-related disease Diseases 0.000 description 4
- 229940124597 therapeutic agent Drugs 0.000 description 4
- AXZWODMDQAVCJE-UHFFFAOYSA-L tin(II) chloride (anhydrous) Chemical compound [Cl-].[Cl-].[Sn+2] AXZWODMDQAVCJE-UHFFFAOYSA-L 0.000 description 4
- GKHHRIKNJHEVTE-UHFFFAOYSA-N (4-acetyl-2-methoxyphenyl) trifluoromethanesulfonate Chemical compound COC1=CC(C(C)=O)=CC=C1OS(=O)(=O)C(F)(F)F GKHHRIKNJHEVTE-UHFFFAOYSA-N 0.000 description 3
- KXKCTSZYNCDFFG-UHFFFAOYSA-N 2-Methoxy-5-nitrophenol Chemical compound COC1=CC=C([N+]([O-])=O)C=C1O KXKCTSZYNCDFFG-UHFFFAOYSA-N 0.000 description 3
- RITMZBMLKKLFFI-UHFFFAOYSA-N 7-(5-chloro-2-hydroxyphenyl)-8-(hydroxymethyl)-1,3,3-trimethyl-4h-quinoxalin-2-one Chemical compound OCC1=C2N(C)C(=O)C(C)(C)NC2=CC=C1C1=CC(Cl)=CC=C1O RITMZBMLKKLFFI-UHFFFAOYSA-N 0.000 description 3
- XVXFKYHATUHXQB-UHFFFAOYSA-N 7-(5-chloro-2-methoxyphenyl)-8-(hydroxymethyl)-1,3,3-trimethyl-4h-quinoxalin-2-one Chemical compound COC1=CC=C(Cl)C=C1C1=CC=C(NC(C)(C)C(=O)N2C)C2=C1CO XVXFKYHATUHXQB-UHFFFAOYSA-N 0.000 description 3
- RRMDWGVISOKWGX-UHFFFAOYSA-N 7-bromo-8-(chloromethyl)-1,3,3-trimethyl-4h-quinoxalin-2-one Chemical compound C1=C(Br)C(CCl)=C2N(C)C(=O)C(C)(C)NC2=C1 RRMDWGVISOKWGX-UHFFFAOYSA-N 0.000 description 3
- ZWAUVYAZHLHKFI-UHFFFAOYSA-N 7-bromo-8-(hydroxymethyl)-1,3,3-trimethyl-4h-quinoxalin-2-one Chemical compound C1=C(Br)C(CO)=C2N(C)C(=O)C(C)(C)NC2=C1 ZWAUVYAZHLHKFI-UHFFFAOYSA-N 0.000 description 3
- YXCXIYOCKUAILC-UHFFFAOYSA-N 7-bromo-8-(hydroxymethyl)-3,3-dimethyl-1,4-dihydroquinoxalin-2-one Chemical compound C1=C(Br)C(CO)=C2NC(=O)C(C)(C)NC2=C1 YXCXIYOCKUAILC-UHFFFAOYSA-N 0.000 description 3
- WABUATROFWHSHZ-UHFFFAOYSA-N 8-(chloromethyl)-7-(4-fluoro-2-methoxyphenyl)-3,3-dimethyl-1,4-dihydroquinoxalin-2-one Chemical compound COC1=CC(F)=CC=C1C1=CC=C(NC(C)(C)C(=O)N2)C2=C1CCl WABUATROFWHSHZ-UHFFFAOYSA-N 0.000 description 3
- FIBGZDBZAZTTCO-UHFFFAOYSA-N 8-(chloromethyl)-7-(5-fluoro-2-methoxyphenyl)-3,3-dimethyl-1,4-dihydroquinoxalin-2-one Chemical compound COC1=CC=C(F)C=C1C1=CC=C(NC(C)(C)C(=O)N2)C2=C1CCl FIBGZDBZAZTTCO-UHFFFAOYSA-N 0.000 description 3
- QSOGFRDTRQHSFS-UHFFFAOYSA-N 8-(hydroxymethyl)-7-(2-methoxyphenyl)-3,3-dimethyl-1,4-dihydroquinoxalin-2-one Chemical compound COC1=CC=CC=C1C1=CC=C(NC(C)(C)C(=O)N2)C2=C1CO QSOGFRDTRQHSFS-UHFFFAOYSA-N 0.000 description 3
- FBFFANHXMRMCRE-UHFFFAOYSA-N 9-chloro-2,2,4-trimethyl-1h-chromeno[4,3-h]quinoxaline-3,5-dione Chemical compound ClC1=CC=C2OC(=O)C3=C4N(C)C(=O)C(C)(C)NC4=CC=C3C2=C1 FBFFANHXMRMCRE-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 3
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 3
- 102000007399 Nuclear hormone receptor Human genes 0.000 description 3
- 108020005497 Nuclear hormone receptor Proteins 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- HZSHKBJRRWXHLK-UHFFFAOYSA-N [3-methoxy-4-[5-[(2-methoxyanilino)methyl]-2,2,4-trimethyl-3-oxo-1h-quinoxalin-6-yl]phenyl] pyridine-3-carboxylate Chemical compound COC1=CC=CC=C1NCC1=C(C=2C(=CC(OC(=O)C=3C=NC=CC=3)=CC=2)OC)C=CC2=C1N(C)C(=O)C(C)(C)N2 HZSHKBJRRWXHLK-UHFFFAOYSA-N 0.000 description 3
- UFCQKGRBJBMHIP-UHFFFAOYSA-N [4-[5-(hydroxymethyl)-2,2-dimethyl-3-oxo-1,4-dihydroquinoxalin-6-yl]-3-methoxyphenyl] 2-methylbenzoate Chemical compound C=1C=C(C=2C(=C3NC(=O)C(C)(C)NC3=CC=2)CO)C(OC)=CC=1OC(=O)C1=CC=CC=C1C UFCQKGRBJBMHIP-UHFFFAOYSA-N 0.000 description 3
- XDHLRCNRCSUBGV-UHFFFAOYSA-N [4-[5-[(5-fluoro-2-methylphenoxy)methyl]-2,2,4-trimethyl-3-oxo-1h-quinoxalin-6-yl]-3-methoxyphenyl] 2-methylbenzoate Chemical compound C=1C=C(C=2C(=C3N(C)C(=O)C(C)(C)NC3=CC=2)COC=2C(=CC=C(F)C=2)C)C(OC)=CC=1OC(=O)C1=CC=CC=C1C XDHLRCNRCSUBGV-UHFFFAOYSA-N 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- XSCHRSMBECNVNS-UHFFFAOYSA-N benzopyrazine Natural products N1=CC=NC2=CC=CC=C21 XSCHRSMBECNVNS-UHFFFAOYSA-N 0.000 description 3
- 125000001231 benzoyloxy group Chemical group C(C1=CC=CC=C1)(=O)O* 0.000 description 3
- 235000015165 citric acid Nutrition 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- ZOCHARZZJNPSEU-UHFFFAOYSA-N diboron Chemical compound B#B ZOCHARZZJNPSEU-UHFFFAOYSA-N 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 239000003850 glucocorticoid receptor antagonist Substances 0.000 description 3
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 description 3
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 3
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 235000019359 magnesium stearate Nutrition 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- CANRDMJQIIVBNT-UHFFFAOYSA-N methyl 3-[5-[(5-fluoro-2-methylphenoxy)methyl]-2,2,4-trimethyl-3-oxo-1h-quinoxalin-6-yl]-4-methoxybenzoate Chemical compound COC(=O)C1=CC=C(OC)C(C=2C(=C3N(C)C(=O)C(C)(C)NC3=CC=2)COC=2C(=CC=C(F)C=2)C)=C1 CANRDMJQIIVBNT-UHFFFAOYSA-N 0.000 description 3
- WZEICCRWPIHKCK-UHFFFAOYSA-N methyl 5-acetamido-2-bromobenzoate Chemical compound COC(=O)C1=CC(NC(C)=O)=CC=C1Br WZEICCRWPIHKCK-UHFFFAOYSA-N 0.000 description 3
- OFDWPQOLEQDJIX-UHFFFAOYSA-N methyl 5-amino-2-bromobenzoate Chemical compound COC(=O)C1=CC(N)=CC=C1Br OFDWPQOLEQDJIX-UHFFFAOYSA-N 0.000 description 3
- WCYZPLVUSDWELQ-UHFFFAOYSA-N methyl 6-(2-methoxyphenyl)-2,2-dimethyl-3-oxo-1,4-dihydroquinoxaline-5-carboxylate Chemical compound COC(=O)C1=C2NC(=O)C(C)(C)NC2=CC=C1C1=CC=CC=C1OC WCYZPLVUSDWELQ-UHFFFAOYSA-N 0.000 description 3
- SVUIMJYEQCFHQD-UHFFFAOYSA-N methyl 6-(5-chloro-2-methoxyphenyl)-2,2,4-trimethyl-3-oxo-1h-quinoxaline-5-carboxylate Chemical compound C1=CC=2NC(C)(C)C(=O)N(C)C=2C(C(=O)OC)=C1C1=CC(Cl)=CC=C1OC SVUIMJYEQCFHQD-UHFFFAOYSA-N 0.000 description 3
- DADAFFGCUSVKMH-UHFFFAOYSA-N methyl 6-bromo-2,2,4-trimethyl-3-oxo-1h-quinoxaline-5-carboxylate Chemical compound N1C(C)(C)C(=O)N(C)C2=C1C=CC(Br)=C2C(=O)OC DADAFFGCUSVKMH-UHFFFAOYSA-N 0.000 description 3
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical group C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 3
- 229910017604 nitric acid Inorganic materials 0.000 description 3
- 239000012299 nitrogen atmosphere Substances 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- 125000003367 polycyclic group Chemical group 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- TUQOTMZNTHZOKS-UHFFFAOYSA-N tributylphosphine Chemical compound CCCCP(CCCC)CCCC TUQOTMZNTHZOKS-UHFFFAOYSA-N 0.000 description 3
- VUBQHLAIBFMXSA-UHFFFAOYSA-N (2-methoxy-4-methylphenyl) trifluoromethanesulfonate Chemical compound COC1=CC(C)=CC=C1OS(=O)(=O)C(F)(F)F VUBQHLAIBFMXSA-UHFFFAOYSA-N 0.000 description 2
- FUPWIVCAJNLSGK-UHFFFAOYSA-N (2-methoxy-4-nitrophenyl)boronic acid Chemical compound COC1=CC([N+]([O-])=O)=CC=C1B(O)O FUPWIVCAJNLSGK-UHFFFAOYSA-N 0.000 description 2
- WWTBZEKOSBFBEM-SPWPXUSOSA-N (2s)-2-[[2-benzyl-3-[hydroxy-[(1r)-2-phenyl-1-(phenylmethoxycarbonylamino)ethyl]phosphoryl]propanoyl]amino]-3-(1h-indol-3-yl)propanoic acid Chemical compound N([C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)O)C(=O)C(CP(O)(=O)[C@H](CC=1C=CC=CC=1)NC(=O)OCC=1C=CC=CC=1)CC1=CC=CC=C1 WWTBZEKOSBFBEM-SPWPXUSOSA-N 0.000 description 2
- DCTQSLXBOFQVTM-UHFFFAOYSA-N (3-bromo-4-methoxyphenyl) benzoate Chemical compound C1=C(Br)C(OC)=CC=C1OC(=O)C1=CC=CC=C1 DCTQSLXBOFQVTM-UHFFFAOYSA-N 0.000 description 2
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 description 2
- AJRFMMMDOQRNAU-UHFFFAOYSA-N (4-benzoyloxy-2-methoxyphenyl)boronic acid Chemical compound C1=C(B(O)O)C(OC)=CC(OC(=O)C=2C=CC=CC=2)=C1 AJRFMMMDOQRNAU-UHFFFAOYSA-N 0.000 description 2
- ZYGUHXFVEJMPCU-UHFFFAOYSA-N (4-cyano-2-methoxyphenyl) trifluoromethanesulfonate Chemical compound COC1=CC(C#N)=CC=C1OS(=O)(=O)C(F)(F)F ZYGUHXFVEJMPCU-UHFFFAOYSA-N 0.000 description 2
- HSKWTSUGNMIDCE-UHFFFAOYSA-N (4-iodo-3-methoxyphenyl) benzoate Chemical compound C1=C(I)C(OC)=CC(OC(=O)C=2C=CC=CC=2)=C1 HSKWTSUGNMIDCE-UHFFFAOYSA-N 0.000 description 2
- PMRMHHUTWZPFIY-UHFFFAOYSA-N (4-methoxyphenyl) benzoate Chemical compound C1=CC(OC)=CC=C1OC(=O)C1=CC=CC=C1 PMRMHHUTWZPFIY-UHFFFAOYSA-N 0.000 description 2
- XUKVFGXOLYUEGA-UHFFFAOYSA-N (5-benzoyloxy-2-methoxyphenyl)boronic acid Chemical compound C1=C(B(O)O)C(OC)=CC=C1OC(=O)C1=CC=CC=C1 XUKVFGXOLYUEGA-UHFFFAOYSA-N 0.000 description 2
- MROIVWKVBXFEMP-UHFFFAOYSA-N (5-chloro-4-fluoro-2-methoxyphenyl)boronic acid Chemical compound COC1=CC(F)=C(Cl)C=C1B(O)O MROIVWKVBXFEMP-UHFFFAOYSA-N 0.000 description 2
- KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 description 2
- UWYZHKAOTLEWKK-UHFFFAOYSA-N 1,2,3,4-tetrahydroisoquinoline Chemical compound C1=CC=C2CNCCC2=C1 UWYZHKAOTLEWKK-UHFFFAOYSA-N 0.000 description 2
- LBUJPTNKIBCYBY-UHFFFAOYSA-N 1,2,3,4-tetrahydroquinoline Chemical compound C1=CC=C2CCCNC2=C1 LBUJPTNKIBCYBY-UHFFFAOYSA-N 0.000 description 2
- FCEHBMOGCRZNNI-UHFFFAOYSA-N 1-benzothiophene Chemical compound C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 description 2
- WAEQYJXXGZMKDX-UHFFFAOYSA-N 1-bromo-2-methoxy-4-(methoxymethoxy)benzene Chemical compound COCOC1=CC=C(Br)C(OC)=C1 WAEQYJXXGZMKDX-UHFFFAOYSA-N 0.000 description 2
- NVSMLSKXNOHPFW-UHFFFAOYSA-N 1-bromo-5-chloro-4-fluoro-2-methoxybenzene Chemical compound COC1=CC(F)=C(Cl)C=C1Br NVSMLSKXNOHPFW-UHFFFAOYSA-N 0.000 description 2
- HBEDSQVIWPRPAY-UHFFFAOYSA-N 2,3-dihydrobenzofuran Chemical compound C1=CC=C2OCCC2=C1 HBEDSQVIWPRPAY-UHFFFAOYSA-N 0.000 description 2
- KEELNSUUMIKFPE-UHFFFAOYSA-N 2-(2-methoxy-4-nitrophenyl)-5,5-dimethyl-1,3,2-dioxaborinane Chemical compound COC1=CC([N+]([O-])=O)=CC=C1B1OCC(C)(C)CO1 KEELNSUUMIKFPE-UHFFFAOYSA-N 0.000 description 2
- CREPKPMKJLOPOO-UHFFFAOYSA-N 2-(2-methoxy-5-nitrophenyl)-5,5-dimethyl-1,3,2-dioxaborinane Chemical compound COC1=CC=C([N+]([O-])=O)C=C1B1OCC(C)(C)CO1 CREPKPMKJLOPOO-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- BDKQJDLQSVQTFP-UHFFFAOYSA-N 3-[5-[(5-fluoro-2-methylphenoxy)methyl]-2,2,4-trimethyl-3-oxo-1h-quinoxalin-6-yl]-4-methoxybenzoic acid Chemical compound COC1=CC=C(C(O)=O)C=C1C1=CC=C(NC(C)(C)C(=O)N2C)C2=C1COC1=CC(F)=CC=C1C BDKQJDLQSVQTFP-UHFFFAOYSA-N 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- OFCHGCVDLQXXFD-UHFFFAOYSA-N 4-iodo-3-methoxyphenol Chemical compound COC1=CC(O)=CC=C1I OFCHGCVDLQXXFD-UHFFFAOYSA-N 0.000 description 2
- ORIONTBOMZNQIE-UHFFFAOYSA-N 5-bromothiophene-2-carbonyl chloride Chemical compound ClC(=O)C1=CC=C(Br)S1 ORIONTBOMZNQIE-UHFFFAOYSA-N 0.000 description 2
- YEOYTKNTPGEKNA-UHFFFAOYSA-N 7-(4-fluoro-2-hydroxyphenyl)-8-(hydroxymethyl)-1,3,3-trimethyl-4h-quinoxalin-2-one Chemical compound OCC1=C2N(C)C(=O)C(C)(C)NC2=CC=C1C1=CC=C(F)C=C1O YEOYTKNTPGEKNA-UHFFFAOYSA-N 0.000 description 2
- PNXREMGMCWCJMU-UHFFFAOYSA-N 7-(4-fluoro-2-methoxyphenyl)-3,3-dimethyl-8-(phenoxymethyl)-1,4-dihydroquinoxalin-2-one Chemical compound COC1=CC(F)=CC=C1C1=CC=C(NC(C)(C)C(=O)N2)C2=C1COC1=CC=CC=C1 PNXREMGMCWCJMU-UHFFFAOYSA-N 0.000 description 2
- SSDZPIXBRTZXKL-UHFFFAOYSA-N 7-(4-fluoro-2-methoxyphenyl)-8-(hydroxymethyl)-1,3,3-trimethyl-4h-quinoxalin-2-one Chemical compound COC1=CC(F)=CC=C1C1=CC=C(NC(C)(C)C(=O)N2C)C2=C1CO SSDZPIXBRTZXKL-UHFFFAOYSA-N 0.000 description 2
- QFEWFEUCFOZRIA-UHFFFAOYSA-N 7-(4-fluoro-2-methoxyphenyl)-8-(hydroxymethyl)-3,3-dimethyl-1,4-dihydroquinoxalin-2-one Chemical compound COC1=CC(F)=CC=C1C1=CC=C(NC(C)(C)C(=O)N2)C2=C1CO QFEWFEUCFOZRIA-UHFFFAOYSA-N 0.000 description 2
- FLPSJWQLGJMUCH-UHFFFAOYSA-N 7-(4-hydroxy-2-methoxyphenyl)-8-(hydroxymethyl)-3,3-dimethyl-1,4-dihydroquinoxalin-2-one Chemical compound COC1=CC(O)=CC=C1C1=CC=C(NC(C)(C)C(=O)N2)C2=C1CO FLPSJWQLGJMUCH-UHFFFAOYSA-N 0.000 description 2
- ODOCAGQZSMOQAR-UHFFFAOYSA-N 7-(5-amino-2-methoxyphenyl)-8-[(5-fluoro-2-methylphenoxy)methyl]-1,3,3-trimethyl-4h-quinoxalin-2-one Chemical compound COC1=CC=C(N)C=C1C1=CC=C(NC(C)(C)C(=O)N2C)C2=C1COC1=CC(F)=CC=C1C ODOCAGQZSMOQAR-UHFFFAOYSA-N 0.000 description 2
- SADCNGNXMNCPQZ-UHFFFAOYSA-N 7-(5-chloro-2-methoxyphenyl)-1,3,3-trimethyl-8-[(2-propan-2-ylanilino)methyl]-4h-quinoxalin-2-one Chemical compound COC1=CC=C(Cl)C=C1C1=CC=C(NC(C)(C)C(=O)N2C)C2=C1CNC1=CC=CC=C1C(C)C SADCNGNXMNCPQZ-UHFFFAOYSA-N 0.000 description 2
- APWVJUMOQGJEMH-UHFFFAOYSA-N 7-(5-chloro-2-methoxyphenyl)-8-(chloromethyl)-1,3,3-trimethyl-4h-quinoxalin-2-one Chemical compound COC1=CC=C(Cl)C=C1C1=CC=C(NC(C)(C)C(=O)N2C)C2=C1CCl APWVJUMOQGJEMH-UHFFFAOYSA-N 0.000 description 2
- YAICMMLRWLEQCC-UHFFFAOYSA-N 7-(5-fluoro-2-methoxyphenyl)-3,3-dimethyl-8-[(4-methylanilino)methyl]-1,4-dihydroquinoxalin-2-one Chemical compound COC1=CC=C(F)C=C1C1=CC=C(NC(C)(C)C(=O)N2)C2=C1CNC1=CC=C(C)C=C1 YAICMMLRWLEQCC-UHFFFAOYSA-N 0.000 description 2
- OTNQORFESHLUIX-UHFFFAOYSA-N 8-(chloromethyl)-7-(4-fluoro-2-methoxyphenyl)-1,3,3-trimethyl-4h-quinoxalin-2-one Chemical compound COC1=CC(F)=CC=C1C1=CC=C(NC(C)(C)C(=O)N2C)C2=C1CCl OTNQORFESHLUIX-UHFFFAOYSA-N 0.000 description 2
- UGOYVJBTUJMJLW-UHFFFAOYSA-N 8-[(5-fluoro-2-methylphenoxy)methyl]-1,3,3-trimethyl-7-(2-nitrophenyl)-4h-quinoxalin-2-one Chemical compound C=12N(C)C(=O)C(C)(C)NC2=CC=C(C=2C(=CC=CC=2)[N+]([O-])=O)C=1COC1=CC(F)=CC=C1C UGOYVJBTUJMJLW-UHFFFAOYSA-N 0.000 description 2
- BMRGBZROUHKXIX-UHFFFAOYSA-N 8-[(5-fluoro-2-methylphenoxy)methyl]-1,3,3-trimethyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-4h-quinoxalin-2-one Chemical compound C=1C(F)=CC=C(C)C=1OCC1=C2N(C)C(=O)C(C)(C)NC2=CC=C1B1OC(C)(C)C(C)(C)O1 BMRGBZROUHKXIX-UHFFFAOYSA-N 0.000 description 2
- FPRBFBUESPIPQK-UHFFFAOYSA-N 8-[(5-fluoro-2-methylphenoxy)methyl]-7-[2-methoxy-4-(trifluoromethoxy)phenyl]-1,3,3-trimethyl-4h-quinoxalin-2-one Chemical compound COC1=CC(OC(F)(F)F)=CC=C1C1=CC=C(NC(C)(C)C(=O)N2C)C2=C1COC1=CC(F)=CC=C1C FPRBFBUESPIPQK-UHFFFAOYSA-N 0.000 description 2
- UJOBWOGCFQCDNV-UHFFFAOYSA-N 9H-carbazole Chemical compound C1=CC=C2C3=CC=CC=C3NC2=C1 UJOBWOGCFQCDNV-UHFFFAOYSA-N 0.000 description 2
- HPJKTRAHVWGNGO-UHFFFAOYSA-N 9h-fluoren-9-ylmethyl n-[[6-(4-hydroxy-2-methoxyphenyl)-2,2,4-trimethyl-3-oxo-1h-quinoxalin-5-yl]methyl]-n-(2-methoxyphenyl)carbamate Chemical compound COC1=CC=CC=C1N(C(=O)OCC1C2=CC=CC=C2C2=CC=CC=C21)CC1=C(C=2C(=CC(O)=CC=2)OC)C=CC2=C1N(C)C(=O)C(C)(C)N2 HPJKTRAHVWGNGO-UHFFFAOYSA-N 0.000 description 2
- ZAEUBRGEXFRXSP-UHFFFAOYSA-N 9h-fluoren-9-ylmethyl n-[[6-[2-methoxy-4-(methoxymethoxy)phenyl]-2,2,4-trimethyl-3-oxo-1h-quinoxalin-5-yl]methyl]-n-(2-methoxyphenyl)carbamate Chemical compound COC1=CC(OCOC)=CC=C1C1=CC=C(NC(C)(C)C(=O)N2C)C2=C1CN(C=1C(=CC=CC=1)OC)C(=O)OCC1C2=CC=CC=C2C2=CC=CC=C21 ZAEUBRGEXFRXSP-UHFFFAOYSA-N 0.000 description 2
- VVJKKWFAADXIJK-UHFFFAOYSA-N Allylamine Chemical compound NCC=C VVJKKWFAADXIJK-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 2
- KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- UIRBBVCVTRRAGL-UHFFFAOYSA-N CCCNC(=O)OC1=CC=C(C2=CC=C3NC(C)(C)C(=O)N(C)C3=C2COC2=C(C)C=CC(F)=C2)C(OC)=C1 Chemical compound CCCNC(=O)OC1=CC=C(C2=CC=C3NC(C)(C)C(=O)N(C)C3=C2COC2=C(C)C=CC(F)=C2)C(OC)=C1 UIRBBVCVTRRAGL-UHFFFAOYSA-N 0.000 description 2
- WXROFUAWLUYPJV-UHFFFAOYSA-N COC(=O)C1=CC=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC(=O)C1=CC=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 WXROFUAWLUYPJV-UHFFFAOYSA-N 0.000 description 2
- IAHSSNVHHACBDI-UHFFFAOYSA-N COC(=O)OC1=CC=C(C2=CC=C3NC(C)(C)C(=O)N(C)C3=C2COC(=O)C2=CC=C(C)S2)C(OC)=C1 Chemical compound COC(=O)OC1=CC=C(C2=CC=C3NC(C)(C)C(=O)N(C)C3=C2COC(=O)C2=CC=C(C)S2)C(OC)=C1 IAHSSNVHHACBDI-UHFFFAOYSA-N 0.000 description 2
- VYZKHVULLGIBMD-UHFFFAOYSA-N COC1=CC(NC(=O)C2=NC=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(NC(=O)C2=NC=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 VYZKHVULLGIBMD-UHFFFAOYSA-N 0.000 description 2
- LJKMPCDTUGZJJR-UHFFFAOYSA-N COC1=CC(OC(=O)C2=C(C)N=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC=C(C)S1 Chemical compound COC1=CC(OC(=O)C2=C(C)N=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC=C(C)S1 LJKMPCDTUGZJJR-UHFFFAOYSA-N 0.000 description 2
- FAXYANKEXGIULI-UHFFFAOYSA-N COC1=CC(OC(=O)C2=C(Cl)C=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC=C(C)S1 Chemical compound COC1=CC(OC(=O)C2=C(Cl)C=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC=C(C)S1 FAXYANKEXGIULI-UHFFFAOYSA-N 0.000 description 2
- GEXSLQPJUXJHGF-UHFFFAOYSA-N COC1=CC(OC(=O)C2=C(OC)C=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(OC(=O)C2=C(OC)C=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 GEXSLQPJUXJHGF-UHFFFAOYSA-N 0.000 description 2
- IQOLEPMRFNWZAT-UHFFFAOYSA-N COC1=CC(OC(=O)C2=COC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1CNC1=C(OC)C=CC=C1 Chemical compound COC1=CC(OC(=O)C2=COC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1CNC1=C(OC)C=CC=C1 IQOLEPMRFNWZAT-UHFFFAOYSA-N 0.000 description 2
- RVSIBRAZMRDTJH-UHFFFAOYSA-N COC1=CC=C(Cl)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC=C(Cl)S1 Chemical compound COC1=CC=C(Cl)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC=C(Cl)S1 RVSIBRAZMRDTJH-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical compound C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- WRYCSMQKUKOKBP-UHFFFAOYSA-N Imidazolidine Chemical compound C1CNCN1 WRYCSMQKUKOKBP-UHFFFAOYSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- QIAFMBKCNZACKA-UHFFFAOYSA-N N-benzoylglycine Chemical compound OC(=O)CNC(=O)C1=CC=CC=C1 QIAFMBKCNZACKA-UHFFFAOYSA-N 0.000 description 2
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 2
- SAHIZENKTPRYSN-UHFFFAOYSA-N [2-[3-(phenoxymethyl)phenoxy]-6-(trifluoromethyl)pyridin-4-yl]methanamine Chemical compound O(C1=CC=CC=C1)CC=1C=C(OC2=NC(=CC(=C2)CN)C(F)(F)F)C=CC=1 SAHIZENKTPRYSN-UHFFFAOYSA-N 0.000 description 2
- YHIRWBPAEVCPES-UHFFFAOYSA-N [2-methoxy-4-(methoxymethoxy)phenyl]boronic acid Chemical compound COCOC1=CC=C(B(O)O)C(OC)=C1 YHIRWBPAEVCPES-UHFFFAOYSA-N 0.000 description 2
- XDEIRWQJFDDSHX-UHFFFAOYSA-N [4-[5-[(5-fluoro-2-methylphenoxy)methyl]-2,2,4-trimethyl-3-oxo-1h-quinoxalin-6-yl]-3-methoxyphenyl] butanoate Chemical compound COC1=CC(OC(=O)CCC)=CC=C1C1=CC=C(NC(C)(C)C(=O)N2C)C2=C1COC1=CC(F)=CC=C1C XDEIRWQJFDDSHX-UHFFFAOYSA-N 0.000 description 2
- XTVSRUVVFBQXLV-UHFFFAOYSA-N [4-[5-[(5-fluoro-2-methylphenoxy)methyl]-2,2,4-trimethyl-3-oxo-1h-quinoxalin-6-yl]-3-methoxyphenyl] n-(3-chlorophenyl)carbamate Chemical compound C=1C=C(C=2C(=C3N(C)C(=O)C(C)(C)NC3=CC=2)COC=2C(=CC=C(F)C=2)C)C(OC)=CC=1OC(=O)NC1=CC=CC(Cl)=C1 XTVSRUVVFBQXLV-UHFFFAOYSA-N 0.000 description 2
- PURMXYKJZRHCJZ-UHFFFAOYSA-N [4-[5-[(5-fluoro-2-methylphenoxy)methyl]-2,2,4-trimethyl-3-oxo-1h-quinoxalin-6-yl]-3-methoxyphenyl] n-methyl-n-phenylcarbamate Chemical compound C=1C=C(C=2C(=C3N(C)C(=O)C(C)(C)NC3=CC=2)COC=2C(=CC=C(F)C=2)C)C(OC)=CC=1OC(=O)N(C)C1=CC=CC=C1 PURMXYKJZRHCJZ-UHFFFAOYSA-N 0.000 description 2
- ADDKHVCUONRSEN-UHFFFAOYSA-N [6-(2-methoxyphenyl)-2,2-dimethyl-3-oxo-1,4-dihydroquinoxalin-5-yl]methyl benzoate Chemical compound COC1=CC=CC=C1C1=CC=C(NC(C)(C)C(=O)N2)C2=C1COC(=O)C1=CC=CC=C1 ADDKHVCUONRSEN-UHFFFAOYSA-N 0.000 description 2
- DRKUGXJIDMRVHA-UHFFFAOYSA-N [6-(5-fluoro-2-methoxyphenyl)-2,2-dimethyl-3-oxo-1,4-dihydroquinoxalin-5-yl]methyl 5-methylthiophene-2-carboxylate Chemical compound COC1=CC=C(F)C=C1C1=CC=C(NC(C)(C)C(=O)N2)C2=C1COC(=O)C1=CC=C(C)S1 DRKUGXJIDMRVHA-UHFFFAOYSA-N 0.000 description 2
- BEQDNMNOABBXPZ-UHFFFAOYSA-N [6-(5-fluoro-2-methoxyphenyl)-2,2-dimethyl-3-oxo-1,4-dihydroquinoxalin-5-yl]methyl benzoate Chemical compound COC1=CC=C(F)C=C1C1=CC=C(NC(C)(C)C(=O)N2)C2=C1COC(=O)C1=CC=CC=C1 BEQDNMNOABBXPZ-UHFFFAOYSA-N 0.000 description 2
- 235000011054 acetic acid Nutrition 0.000 description 2
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 2
- DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 125000005108 alkenylthio group Chemical group 0.000 description 2
- 125000004644 alkyl sulfinyl group Chemical group 0.000 description 2
- 125000005109 alkynylthio group Chemical group 0.000 description 2
- XXROGKLTLUQVRX-UHFFFAOYSA-N allyl alcohol Chemical compound OCC=C XXROGKLTLUQVRX-UHFFFAOYSA-N 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- 125000005135 aryl sulfinyl group Chemical group 0.000 description 2
- 238000003149 assay kit Methods 0.000 description 2
- HONIICLYMWZJFZ-UHFFFAOYSA-N azetidine Chemical compound C1CNC1 HONIICLYMWZJFZ-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical compound C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 2
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 2
- 235000019445 benzyl alcohol Nutrition 0.000 description 2
- 229960004217 benzyl alcohol Drugs 0.000 description 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- IPWKHHSGDUIRAH-UHFFFAOYSA-N bis(pinacolato)diboron Chemical compound O1C(C)(C)C(C)(C)OB1B1OC(C)(C)C(C)(C)O1 IPWKHHSGDUIRAH-UHFFFAOYSA-N 0.000 description 2
- UORVGPXVDQYIDP-UHFFFAOYSA-N borane Chemical compound B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 2
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 2
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- GZUXJHMPEANEGY-UHFFFAOYSA-N bromomethane Chemical compound BrC GZUXJHMPEANEGY-UHFFFAOYSA-N 0.000 description 2
- 229940084030 carboxymethylcellulose calcium Drugs 0.000 description 2
- OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 2
- 229940126208 compound 22 Drugs 0.000 description 2
- NZNMSOFKMUBTKW-UHFFFAOYSA-N cyclohexanecarboxylic acid Chemical compound OC(=O)C1CCCCC1 NZNMSOFKMUBTKW-UHFFFAOYSA-N 0.000 description 2
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 2
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 2
- JBDSSBMEKXHSJF-UHFFFAOYSA-N cyclopentanecarboxylic acid Chemical compound OC(=O)C1CCCC1 JBDSSBMEKXHSJF-UHFFFAOYSA-N 0.000 description 2
- 229960003957 dexamethasone Drugs 0.000 description 2
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 2
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical class OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 2
- DMBHHRLKUKUOEG-UHFFFAOYSA-N diphenylamine Chemical compound C=1C=CC=CC=1NC1=CC=CC=C1 DMBHHRLKUKUOEG-UHFFFAOYSA-N 0.000 description 2
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 229960001484 edetic acid Drugs 0.000 description 2
- IRXSLJNXXZKURP-UHFFFAOYSA-N fluorenylmethyloxycarbonyl chloride Chemical compound C1=CC=C2C(COC(=O)Cl)C3=CC=CC=C3C2=C1 IRXSLJNXXZKURP-UHFFFAOYSA-N 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 2
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 2
- TWBYWOBDOCUKOW-UHFFFAOYSA-N isonicotinic acid Chemical compound OC(=O)C1=CC=NC=C1 TWBYWOBDOCUKOW-UHFFFAOYSA-N 0.000 description 2
- QQVIHTHCMHWDBS-UHFFFAOYSA-N isophthalic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=C1 QQVIHTHCMHWDBS-UHFFFAOYSA-N 0.000 description 2
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 229960003511 macrogol Drugs 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- CVJAPUJKDOWTFT-UHFFFAOYSA-N methyl 4-methoxy-3-(trifluoromethylsulfonyloxy)benzoate Chemical compound COC(=O)C1=CC=C(OC)C(OS(=O)(=O)C(F)(F)F)=C1 CVJAPUJKDOWTFT-UHFFFAOYSA-N 0.000 description 2
- HLROQFNKOXJZSP-UHFFFAOYSA-N methyl 6-bromo-3-[(4-ethoxy-4-oxobutan-2-yl)amino]-2-nitrobenzoate Chemical compound CCOC(=O)CC(C)NC1=CC=C(Br)C(C(=O)OC)=C1[N+]([O-])=O HLROQFNKOXJZSP-UHFFFAOYSA-N 0.000 description 2
- OQJBFFCUFALWQL-UHFFFAOYSA-N n-(piperidine-1-carbonylimino)piperidine-1-carboxamide Chemical compound C1CCCCN1C(=O)N=NC(=O)N1CCCCC1 OQJBFFCUFALWQL-UHFFFAOYSA-N 0.000 description 2
- JMVSUKKYERINKE-UHFFFAOYSA-N n-[4-[5-[(5-fluoro-2-methylphenoxy)methyl]-2,2,4-trimethyl-3-oxo-1h-quinoxalin-6-yl]-3-methoxyphenyl]-n-methylpyridine-4-carboxamide Chemical compound COC1=CC(N(C)C(=O)C=2C=CN=CC=2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=CC(F)=CC=C1C JMVSUKKYERINKE-UHFFFAOYSA-N 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- RZXMPPFPUUCRFN-UHFFFAOYSA-N p-toluidine Chemical compound CC1=CC=C(N)C=C1 RZXMPPFPUUCRFN-UHFFFAOYSA-N 0.000 description 2
- DPBLXKKOBLCELK-UHFFFAOYSA-N pentan-1-amine Chemical compound CCCCCN DPBLXKKOBLCELK-UHFFFAOYSA-N 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- 102000054765 polymorphisms of proteins Human genes 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 235000019260 propionic acid Nutrition 0.000 description 2
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- USPWKWBDZOARPV-UHFFFAOYSA-N pyrazolidine Chemical compound C1CNNC1 USPWKWBDZOARPV-UHFFFAOYSA-N 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 2
- 102000005962 receptors Human genes 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- CPRMKOQKXYSDML-UHFFFAOYSA-M rubidium hydroxide Chemical compound [OH-].[Rb+] CPRMKOQKXYSDML-UHFFFAOYSA-M 0.000 description 2
- 229920002050 silicone resin Polymers 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000011684 sodium molybdate Substances 0.000 description 2
- TVXXNOYZHKPKGW-UHFFFAOYSA-N sodium molybdate (anhydrous) Chemical compound [Na+].[Na+].[O-][Mo]([O-])(=O)=O TVXXNOYZHKPKGW-UHFFFAOYSA-N 0.000 description 2
- 229960002920 sorbitol Drugs 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- QACWAKIDWOOGLN-UHFFFAOYSA-N tert-butyl n-[2-[4-[5-[(5-fluoro-2-methylphenoxy)methyl]-2,2,4-trimethyl-3-oxo-1h-quinoxalin-6-yl]-3-methoxyanilino]-2-oxoethyl]carbamate Chemical compound COC1=CC(NC(=O)CNC(=O)OC(C)(C)C)=CC=C1C1=CC=C(NC(C)(C)C(=O)N2C)C2=C1COC1=CC(F)=CC=C1C QACWAKIDWOOGLN-UHFFFAOYSA-N 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- IMNIMPAHZVJRPE-UHFFFAOYSA-N triethylenediamine Chemical compound C1CN2CCN1CC2 IMNIMPAHZVJRPE-UHFFFAOYSA-N 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 2
- AIFRHYZBTHREPW-UHFFFAOYSA-N β-carboline Chemical compound N1=CC=C2C3=CC=CC=C3NC2=C1 AIFRHYZBTHREPW-UHFFFAOYSA-N 0.000 description 2
- ROEQGIFOWRQYHD-UHFFFAOYSA-N (2-methoxyphenyl)boronic acid Chemical compound COC1=CC=CC=C1B(O)O ROEQGIFOWRQYHD-UHFFFAOYSA-N 0.000 description 1
- FMBVAOHFMSQDGT-UHFFFAOYSA-N (5-chloro-2-methoxyphenyl)boronic acid Chemical compound COC1=CC=C(Cl)C=C1B(O)O FMBVAOHFMSQDGT-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- OQJBFFCUFALWQL-BUHFOSPRSA-N (ne)-n-(piperidine-1-carbonylimino)piperidine-1-carboxamide Chemical compound C1CCCCN1C(=O)\N=N\C(=O)N1CCCCC1 OQJBFFCUFALWQL-BUHFOSPRSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- WXRSSOIHEAVYLL-UHFFFAOYSA-N 1,2,3,4-tetrahydrocinnoline Chemical compound C1=CC=C2NNCCC2=C1 WXRSSOIHEAVYLL-UHFFFAOYSA-N 0.000 description 1
- STIWEDICJHIFJT-UHFFFAOYSA-N 1,2,3,4-tetrahydrophthalazine Chemical compound C1=CC=C2CNNCC2=C1 STIWEDICJHIFJT-UHFFFAOYSA-N 0.000 description 1
- OQJVXNHMUWQQEW-UHFFFAOYSA-N 1,2,3,4-tetrahydropyrazine Chemical compound C1CNC=CN1 OQJVXNHMUWQQEW-UHFFFAOYSA-N 0.000 description 1
- JQIZHNLEFQMDCQ-UHFFFAOYSA-N 1,2,3,4-tetrahydropyridazine Chemical compound C1CC=CNN1 JQIZHNLEFQMDCQ-UHFFFAOYSA-N 0.000 description 1
- OTPDWCMLUKMQNO-UHFFFAOYSA-N 1,2,3,4-tetrahydropyrimidine Chemical compound C1NCC=CN1 OTPDWCMLUKMQNO-UHFFFAOYSA-N 0.000 description 1
- PKORYTIUMAOPED-UHFFFAOYSA-N 1,2,3,4-tetrahydroquinazoline Chemical compound C1=CC=C2NCNCC2=C1 PKORYTIUMAOPED-UHFFFAOYSA-N 0.000 description 1
- UUZJJNBYJDFQHL-UHFFFAOYSA-N 1,2,3-triazolidine Chemical compound C1CNNN1 UUZJJNBYJDFQHL-UHFFFAOYSA-N 0.000 description 1
- CSNIZNHTOVFARY-UHFFFAOYSA-N 1,2-benzothiazole Chemical compound C1=CC=C2C=NSC2=C1 CSNIZNHTOVFARY-UHFFFAOYSA-N 0.000 description 1
- KTZQTRPPVKQPFO-UHFFFAOYSA-N 1,2-benzoxazole Chemical compound C1=CC=C2C=NOC2=C1 KTZQTRPPVKQPFO-UHFFFAOYSA-N 0.000 description 1
- QRDNXAYNXUKMOO-UHFFFAOYSA-N 1,2-dihydrocinnoline Chemical compound C1=CC=C2C=CNNC2=C1 QRDNXAYNXUKMOO-UHFFFAOYSA-N 0.000 description 1
- IOEPOEDBBPRAEI-UHFFFAOYSA-N 1,2-dihydroisoquinoline Chemical compound C1=CC=C2CNC=CC2=C1 IOEPOEDBBPRAEI-UHFFFAOYSA-N 0.000 description 1
- QYMGRIFMUQCAJW-UHFFFAOYSA-N 1,2-dihydropyrazine Chemical compound C1NC=CN=C1 QYMGRIFMUQCAJW-UHFFFAOYSA-N 0.000 description 1
- BKWQKVJYXODDAC-UHFFFAOYSA-N 1,2-dihydropyridazine Chemical compound N1NC=CC=C1 BKWQKVJYXODDAC-UHFFFAOYSA-N 0.000 description 1
- WCFAPJDPAPDDAQ-UHFFFAOYSA-N 1,2-dihydropyrimidine Chemical compound C1NC=CC=N1 WCFAPJDPAPDDAQ-UHFFFAOYSA-N 0.000 description 1
- IRFSXVIRXMYULF-UHFFFAOYSA-N 1,2-dihydroquinoline Chemical compound C1=CC=C2C=CCNC2=C1 IRFSXVIRXMYULF-UHFFFAOYSA-N 0.000 description 1
- XXBQLHATYQHJQC-UHFFFAOYSA-N 1,2-dihydroquinoxaline Chemical compound C1=CC=C2N=CCNC2=C1 XXBQLHATYQHJQC-UHFFFAOYSA-N 0.000 description 1
- CIISBYKBBMFLEZ-UHFFFAOYSA-N 1,2-oxazolidine Chemical compound C1CNOC1 CIISBYKBBMFLEZ-UHFFFAOYSA-N 0.000 description 1
- CZSRXHJVZUBEGW-UHFFFAOYSA-N 1,2-thiazolidine Chemical compound C1CNSC1 CZSRXHJVZUBEGW-UHFFFAOYSA-N 0.000 description 1
- BCMCBBGGLRIHSE-UHFFFAOYSA-N 1,3-benzoxazole Chemical compound C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 description 1
- DKYBVKMIZODYKL-UHFFFAOYSA-N 1,3-diazinane Chemical compound C1CNCNC1 DKYBVKMIZODYKL-UHFFFAOYSA-N 0.000 description 1
- OGYGFUAIIOPWQD-UHFFFAOYSA-N 1,3-thiazolidine Chemical compound C1CSCN1 OGYGFUAIIOPWQD-UHFFFAOYSA-N 0.000 description 1
- YNGDWRXWKFWCJY-UHFFFAOYSA-N 1,4-Dihydropyridine Chemical compound C1C=CNC=C1 YNGDWRXWKFWCJY-UHFFFAOYSA-N 0.000 description 1
- FQUYSHZXSKYCSY-UHFFFAOYSA-N 1,4-diazepane Chemical group C1CNCCNC1 FQUYSHZXSKYCSY-UHFFFAOYSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- MUVQKFGNPGZBII-UHFFFAOYSA-N 1-anthrol Chemical compound C1=CC=C2C=C3C(O)=CC=CC3=CC2=C1 MUVQKFGNPGZBII-UHFFFAOYSA-N 0.000 description 1
- FAVMSTGWFRDCRR-UHFFFAOYSA-N 1-chloro-2-fluoro-4-methoxybenzene Chemical compound COC1=CC=C(Cl)C(F)=C1 FAVMSTGWFRDCRR-UHFFFAOYSA-N 0.000 description 1
- HHIRBXHEYVDUAM-UHFFFAOYSA-N 1-chloro-3-isocyanatobenzene Chemical compound ClC1=CC=CC(N=C=O)=C1 HHIRBXHEYVDUAM-UHFFFAOYSA-N 0.000 description 1
- QHDHNVFIKWGRJR-UHFFFAOYSA-N 1-cyclohexenol Chemical compound OC1=CCCCC1 QHDHNVFIKWGRJR-UHFFFAOYSA-N 0.000 description 1
- JXMZUNPWVXQADG-UHFFFAOYSA-N 1-iodo-2-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1I JXMZUNPWVXQADG-UHFFFAOYSA-N 0.000 description 1
- LNETULKMXZVUST-UHFFFAOYSA-N 1-naphthoic acid Chemical compound C1=CC=C2C(C(=O)O)=CC=CC2=C1 LNETULKMXZVUST-UHFFFAOYSA-N 0.000 description 1
- KJCVRFUGPWSIIH-UHFFFAOYSA-N 1-naphthol Chemical compound C1=CC=C2C(O)=CC=CC2=C1 KJCVRFUGPWSIIH-UHFFFAOYSA-N 0.000 description 1
- RUFPHBVGCFYCNW-UHFFFAOYSA-N 1-naphthylamine Chemical compound C1=CC=C2C(N)=CC=CC2=C1 RUFPHBVGCFYCNW-UHFFFAOYSA-N 0.000 description 1
- GTBXZWADMKOZQJ-UHFFFAOYSA-N 1-phenanthrol Chemical compound C1=CC2=CC=CC=C2C2=C1C(O)=CC=C2 GTBXZWADMKOZQJ-UHFFFAOYSA-N 0.000 description 1
- WJFKNYWRSNBZNX-UHFFFAOYSA-N 10H-phenothiazine Chemical compound C1=CC=C2NC3=CC=CC=C3SC2=C1 WJFKNYWRSNBZNX-UHFFFAOYSA-N 0.000 description 1
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 1
- BAXOFTOLAUCFNW-UHFFFAOYSA-N 1H-indazole Chemical compound C1=CC=C2C=NNC2=C1 BAXOFTOLAUCFNW-UHFFFAOYSA-N 0.000 description 1
- MFJCPDOGFAYSTF-UHFFFAOYSA-N 1H-isochromene Chemical compound C1=CC=C2COC=CC2=C1 MFJCPDOGFAYSTF-UHFFFAOYSA-N 0.000 description 1
- XYHKNCXZYYTLRG-UHFFFAOYSA-N 1h-imidazole-2-carbaldehyde Chemical compound O=CC1=NC=CN1 XYHKNCXZYYTLRG-UHFFFAOYSA-N 0.000 description 1
- HCKPQVQJKBSTHP-UHFFFAOYSA-N 1h-isothiochromene Chemical compound C1=CC=C2CSC=CC2=C1 HCKPQVQJKBSTHP-UHFFFAOYSA-N 0.000 description 1
- OXBLVCZKDOZZOJ-UHFFFAOYSA-N 2,3-Dihydrothiophene Chemical compound C1CC=CS1 OXBLVCZKDOZZOJ-UHFFFAOYSA-N 0.000 description 1
- FJRPOHLDJUJARI-UHFFFAOYSA-N 2,3-dihydro-1,2-oxazole Chemical compound C1NOC=C1 FJRPOHLDJUJARI-UHFFFAOYSA-N 0.000 description 1
- YTQQIHUQLOZOJI-UHFFFAOYSA-N 2,3-dihydro-1,2-thiazole Chemical compound C1NSC=C1 YTQQIHUQLOZOJI-UHFFFAOYSA-N 0.000 description 1
- HRCMXYXVAWHBTH-UHFFFAOYSA-N 2,3-dihydro-1,3-benzoxazole Chemical compound C1=CC=C2OCNC2=C1 HRCMXYXVAWHBTH-UHFFFAOYSA-N 0.000 description 1
- ZABMHLDQFJHDSC-UHFFFAOYSA-N 2,3-dihydro-1,3-oxazole Chemical compound C1NC=CO1 ZABMHLDQFJHDSC-UHFFFAOYSA-N 0.000 description 1
- OYJGEOAXBALSMM-UHFFFAOYSA-N 2,3-dihydro-1,3-thiazole Chemical compound C1NC=CS1 OYJGEOAXBALSMM-UHFFFAOYSA-N 0.000 description 1
- YJUFGFXVASPYFQ-UHFFFAOYSA-N 2,3-dihydro-1-benzothiophene Chemical compound C1=CC=C2SCCC2=C1 YJUFGFXVASPYFQ-UHFFFAOYSA-N 0.000 description 1
- LWTIGYSPAXKMDG-UHFFFAOYSA-N 2,3-dihydro-1h-imidazole Chemical compound C1NC=CN1 LWTIGYSPAXKMDG-UHFFFAOYSA-N 0.000 description 1
- QDKGOMZIPXGDDJ-UHFFFAOYSA-N 2,3-dihydro-1h-indazole Chemical compound C1=CC=C2CNNC2=C1 QDKGOMZIPXGDDJ-UHFFFAOYSA-N 0.000 description 1
- KEQTWHPMSVAFDA-UHFFFAOYSA-N 2,3-dihydro-1h-pyrazole Chemical compound C1NNC=C1 KEQTWHPMSVAFDA-UHFFFAOYSA-N 0.000 description 1
- SNTWKPAKVQFCCF-UHFFFAOYSA-N 2,3-dihydro-1h-triazole Chemical compound N1NC=CN1 SNTWKPAKVQFCCF-UHFFFAOYSA-N 0.000 description 1
- JKTCBAGSMQIFNL-UHFFFAOYSA-N 2,3-dihydrofuran Chemical compound C1CC=CO1 JKTCBAGSMQIFNL-UHFFFAOYSA-N 0.000 description 1
- VEPOHXYIFQMVHW-XOZOLZJESA-N 2,3-dihydroxybutanedioic acid (2S,3S)-3,4-dimethyl-2-phenylmorpholine Chemical compound OC(C(O)C(O)=O)C(O)=O.C[C@H]1[C@@H](OCCN1C)c1ccccc1 VEPOHXYIFQMVHW-XOZOLZJESA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- WXHLLJAMBQLULT-UHFFFAOYSA-N 2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-n-(2-methyl-6-sulfanylphenyl)-1,3-thiazole-5-carboxamide;hydrate Chemical compound O.C=1C(N2CCN(CCO)CC2)=NC(C)=NC=1NC(S1)=NC=C1C(=O)NC1=C(C)C=CC=C1S WXHLLJAMBQLULT-UHFFFAOYSA-N 0.000 description 1
- QGNCISDEJMUGQT-UHFFFAOYSA-N 2-amino-n-[4-[5-[(5-fluoro-2-methylphenoxy)methyl]-2,2,4-trimethyl-3-oxo-1h-quinoxalin-6-yl]-3-methoxyphenyl]acetamide;hydrochloride Chemical compound Cl.COC1=CC(NC(=O)CN)=CC=C1C1=CC=C(NC(C)(C)C(=O)N2C)C2=C1COC1=CC(F)=CC=C1C QGNCISDEJMUGQT-UHFFFAOYSA-N 0.000 description 1
- ICSNLGPSRYBMBD-UHFFFAOYSA-N 2-aminopyridine Chemical compound NC1=CC=CC=N1 ICSNLGPSRYBMBD-UHFFFAOYSA-N 0.000 description 1
- UXGVMFHEKMGWMA-UHFFFAOYSA-N 2-benzofuran Chemical compound C1=CC=CC2=COC=C21 UXGVMFHEKMGWMA-UHFFFAOYSA-N 0.000 description 1
- LYTMVABTDYMBQK-UHFFFAOYSA-N 2-benzothiophene Chemical compound C1=CC=CC2=CSC=C21 LYTMVABTDYMBQK-UHFFFAOYSA-N 0.000 description 1
- JMUDXQVNBZCQRF-UHFFFAOYSA-N 2-bromo-1-methoxy-4-nitrobenzene Chemical compound COC1=CC=C([N+]([O-])=O)C=C1Br JMUDXQVNBZCQRF-UHFFFAOYSA-N 0.000 description 1
- SMNDYUVBFMFKNZ-UHFFFAOYSA-N 2-furoic acid Chemical compound OC(=O)C1=CC=CO1 SMNDYUVBFMFKNZ-UHFFFAOYSA-N 0.000 description 1
- OPBFFNZNNJKRCS-UHFFFAOYSA-N 2-hydroxy-4,4-dimethylpentanoic acid Chemical compound CC(C)(C)CC(O)C(O)=O OPBFFNZNNJKRCS-UHFFFAOYSA-N 0.000 description 1
- 125000006020 2-methyl-1-propenyl group Chemical group 0.000 description 1
- 125000006029 2-methyl-2-butenyl group Chemical group 0.000 description 1
- GPZXFICWCMCQPF-UHFFFAOYSA-N 2-methylbenzoyl chloride Chemical compound CC1=CC=CC=C1C(Cl)=O GPZXFICWCMCQPF-UHFFFAOYSA-N 0.000 description 1
- VSWICNJIUPRZIK-UHFFFAOYSA-N 2-piperideine Chemical compound C1CNC=CC1 VSWICNJIUPRZIK-UHFFFAOYSA-N 0.000 description 1
- RSEBUVRVKCANEP-UHFFFAOYSA-N 2-pyrroline Chemical compound C1CC=CN1 RSEBUVRVKCANEP-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- UJVBZCCNLAAMOV-UHFFFAOYSA-N 2h-1,2-benzothiazine Chemical compound C1=CC=C2C=CNSC2=C1 UJVBZCCNLAAMOV-UHFFFAOYSA-N 0.000 description 1
- CMLFRMDBDNHMRA-UHFFFAOYSA-N 2h-1,2-benzoxazine Chemical compound C1=CC=C2C=CNOC2=C1 CMLFRMDBDNHMRA-UHFFFAOYSA-N 0.000 description 1
- BCHZICNRHXRCHY-UHFFFAOYSA-N 2h-oxazine Chemical group N1OC=CC=C1 BCHZICNRHXRCHY-UHFFFAOYSA-N 0.000 description 1
- AGIJRRREJXSQJR-UHFFFAOYSA-N 2h-thiazine Chemical group N1SC=CC=C1 AGIJRRREJXSQJR-UHFFFAOYSA-N 0.000 description 1
- ONJRTQUWKRDCTA-UHFFFAOYSA-N 2h-thiochromene Chemical compound C1=CC=C2C=CCSC2=C1 ONJRTQUWKRDCTA-UHFFFAOYSA-N 0.000 description 1
- QMDFJHAAWUGVKQ-UHFFFAOYSA-N 2h-thiopyran Chemical group C1SC=CC=C1 QMDFJHAAWUGVKQ-UHFFFAOYSA-N 0.000 description 1
- ZZQUQFZVCJWSER-UHFFFAOYSA-N 3,4-dihydro-1h-isothiochromene Chemical compound C1=CC=C2CSCCC2=C1 ZZQUQFZVCJWSER-UHFFFAOYSA-N 0.000 description 1
- HYTIPJFUWHYQON-UHFFFAOYSA-N 3,4-dihydro-1h-quinoxalin-2-one Chemical compound C1=CC=C2NC(=O)CNC2=C1 HYTIPJFUWHYQON-UHFFFAOYSA-N 0.000 description 1
- IDUSJBBWEKNWAK-UHFFFAOYSA-N 3,4-dihydro-2h-1,2-benzothiazine Chemical compound C1=CC=C2SNCCC2=C1 IDUSJBBWEKNWAK-UHFFFAOYSA-N 0.000 description 1
- BGDOLELXXPTPFX-UHFFFAOYSA-N 3,4-dihydro-2h-1,2-benzoxazine Chemical compound C1=CC=C2ONCCC2=C1 BGDOLELXXPTPFX-UHFFFAOYSA-N 0.000 description 1
- BOLMDIXLULGTBD-UHFFFAOYSA-N 3,4-dihydro-2h-oxazine Chemical compound C1CC=CON1 BOLMDIXLULGTBD-UHFFFAOYSA-N 0.000 description 1
- NWWJFMCCTZLKNT-UHFFFAOYSA-N 3,4-dihydro-2h-thiazine Chemical compound C1CC=CSN1 NWWJFMCCTZLKNT-UHFFFAOYSA-N 0.000 description 1
- WPWNEKFMGCWNPR-UHFFFAOYSA-N 3,4-dihydro-2h-thiochromene Chemical compound C1=CC=C2CCCSC2=C1 WPWNEKFMGCWNPR-UHFFFAOYSA-N 0.000 description 1
- ATVJJNGVPSKBGO-UHFFFAOYSA-N 3,4-dihydro-2h-thiopyran Chemical compound C1CSC=CC1 ATVJJNGVPSKBGO-UHFFFAOYSA-N 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-M 3-Methylbutanoic acid Natural products CC(C)CC([O-])=O GWYFCOCPABKNJV-UHFFFAOYSA-M 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- UOQHWNPVNXSDDO-UHFFFAOYSA-N 3-bromoimidazo[1,2-a]pyridine-6-carbonitrile Chemical compound C1=CC(C#N)=CN2C(Br)=CN=C21 UOQHWNPVNXSDDO-UHFFFAOYSA-N 0.000 description 1
- NMESVFJGKMPJPM-UHFFFAOYSA-N 3-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile Chemical compound COC1=CC(C#N)=CC=C1B1OC(C)(C)C(C)(C)O1 NMESVFJGKMPJPM-UHFFFAOYSA-N 0.000 description 1
- WMZNGTSLFSJHMZ-UHFFFAOYSA-N 3-methoxycarbonylbenzoic acid Chemical compound COC(=O)C1=CC=CC(C(O)=O)=C1 WMZNGTSLFSJHMZ-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- UYDZUCNMZXCLJI-UHFFFAOYSA-N 4-bromo-3-methoxyphenol Chemical compound COC1=CC(O)=CC=C1Br UYDZUCNMZXCLJI-UHFFFAOYSA-N 0.000 description 1
- IMPPGHMHELILKG-UHFFFAOYSA-N 4-ethoxyaniline Chemical compound CCOC1=CC=C(N)C=C1 IMPPGHMHELILKG-UHFFFAOYSA-N 0.000 description 1
- JFUAWXPBHXKZGA-IBGZPJMESA-N 4-fluoro-2-[(4r)-5,5,5-trifluoro-4-hydroxy-2-methyl-4-(1h-pyrrolo[2,3-c]pyridin-2-ylmethyl)pentan-2-yl]phenol Chemical compound C([C@@](O)(CC=1NC2=CN=CC=C2C=1)C(F)(F)F)C(C)(C)C1=CC(F)=CC=C1O JFUAWXPBHXKZGA-IBGZPJMESA-N 0.000 description 1
- QJRWLNLUIAJTAD-UHFFFAOYSA-N 4-hydroxy-3-methoxybenzonitrile Chemical compound COC1=CC(C#N)=CC=C1O QJRWLNLUIAJTAD-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- UZOFELREXGAFOI-UHFFFAOYSA-N 4-methylpiperidine Chemical compound CC1CCNCC1 UZOFELREXGAFOI-UHFFFAOYSA-N 0.000 description 1
- COWZPSUDTMGBAT-UHFFFAOYSA-N 5-bromothiophene-2-carboxylic acid Chemical compound OC(=O)C1=CC=C(Br)S1 COWZPSUDTMGBAT-UHFFFAOYSA-N 0.000 description 1
- CKJOSIHYVLHIER-UHFFFAOYSA-N 5-fluoro-2-methylphenol Chemical compound CC1=CC=C(F)C=C1O CKJOSIHYVLHIER-UHFFFAOYSA-N 0.000 description 1
- IFLKEBSJTZGCJG-UHFFFAOYSA-N 5-methyl-2-thiophenecarboxylic acid Natural products CC=1C=CSC=1C(O)=O IFLKEBSJTZGCJG-UHFFFAOYSA-N 0.000 description 1
- VCNGNQLPFHVODE-UHFFFAOYSA-N 5-methylthiophene-2-carboxylic acid Chemical compound CC1=CC=C(C(O)=O)S1 VCNGNQLPFHVODE-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- WZMQTPPXOLWHOP-UHFFFAOYSA-N 8-[(2-methoxyanilino)methyl]-7-[2-methoxy-4-(methoxymethoxy)phenyl]-1,3,3-trimethyl-4h-quinoxalin-2-one Chemical compound COC1=CC(OCOC)=CC=C1C1=CC=C(NC(C)(C)C(=O)N2C)C2=C1CNC1=CC=CC=C1OC WZMQTPPXOLWHOP-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 1
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 1
- 229910015900 BF3 Inorganic materials 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- HIFHJIUNBJJRFW-UHFFFAOYSA-N C=C(C)C(=O)OCCNC(=O)OC1=CC=C(C2=CC=C3NC(C)(C)C(=O)N(C)C3=C2COC2=C(C)C=CC(F)=C2)C(OC)=C1 Chemical compound C=C(C)C(=O)OCCNC(=O)OC1=CC=C(C2=CC=C3NC(C)(C)C(=O)N(C)C3=C2COC2=C(C)C=CC(F)=C2)C(OC)=C1 HIFHJIUNBJJRFW-UHFFFAOYSA-N 0.000 description 1
- ZRGMBFNOBRTOFG-UHFFFAOYSA-N C=CCC1=C(OCC2=C3C(=CC=C2C2=CC=C(F)C=C2OC)NC(C)(C)C(=O)N3C)C=CC=C1 Chemical compound C=CCC1=C(OCC2=C3C(=CC=C2C2=CC=C(F)C=C2OC)NC(C)(C)C(=O)N3C)C=CC=C1 ZRGMBFNOBRTOFG-UHFFFAOYSA-N 0.000 description 1
- RBFLYTWYFUQVTK-UHFFFAOYSA-N CC1=C(NCC2=C3C(=CC=C2Br)NC(C)(C)C(=O)N3C)C=C(F)C=C1 Chemical compound CC1=C(NCC2=C3C(=CC=C2Br)NC(C)(C)C(=O)N3C)C=C(F)C=C1 RBFLYTWYFUQVTK-UHFFFAOYSA-N 0.000 description 1
- JMENCLMQGFOSKO-UHFFFAOYSA-N CC1=C(OCC2=C3C(=CC=C2Br)NC(C)(C)C(=O)N3C)C=CC=C1 Chemical compound CC1=C(OCC2=C3C(=CC=C2Br)NC(C)(C)C(=O)N3C)C=CC=C1 JMENCLMQGFOSKO-UHFFFAOYSA-N 0.000 description 1
- WICWSULYEVDMQD-UHFFFAOYSA-N CC1=C(OCC2=C3C(=CC=C2C2=CC(F)=C(F)C=C2)NC(C)(C)C(=O)N3C)C=C(F)C=C1 Chemical compound CC1=C(OCC2=C3C(=CC=C2C2=CC(F)=C(F)C=C2)NC(C)(C)C(=O)N3C)C=C(F)C=C1 WICWSULYEVDMQD-UHFFFAOYSA-N 0.000 description 1
- QTBQIWIIJRIODP-UHFFFAOYSA-N CC1=C(OCC2=C3C(=CC=C2C2=CC=CC=C2C#N)NC(C)(C)C(=O)N3C)C=C(F)C=C1 Chemical compound CC1=C(OCC2=C3C(=CC=C2C2=CC=CC=C2C#N)NC(C)(C)C(=O)N3C)C=C(F)C=C1 QTBQIWIIJRIODP-UHFFFAOYSA-N 0.000 description 1
- JDJCAADMMIRVSH-UHFFFAOYSA-N CC1=C(OCC2=C3C(=CC=C2C2=CC=CC=C2C(F)(F)F)NC(C)(C)C(=O)N3C)C=C(F)C=C1 Chemical compound CC1=C(OCC2=C3C(=CC=C2C2=CC=CC=C2C(F)(F)F)NC(C)(C)C(=O)N3C)C=C(F)C=C1 JDJCAADMMIRVSH-UHFFFAOYSA-N 0.000 description 1
- VJKOWXUKZXOLQZ-UHFFFAOYSA-N CC1=C(OCC2=C3C(=CC=C2C2=CC=CC=C2F)NC(C)(C)C(=O)N3C)C=C(F)C=C1 Chemical compound CC1=C(OCC2=C3C(=CC=C2C2=CC=CC=C2F)NC(C)(C)C(=O)N3C)C=C(F)C=C1 VJKOWXUKZXOLQZ-UHFFFAOYSA-N 0.000 description 1
- LVXNHCJHMAMUMN-UHFFFAOYSA-N CC1=C(OCC2=C3C(=CC=C2C2=CC=CC=C2OC(F)(F)F)NC(C)(C)C(=O)N3C)C=C(F)C=C1 Chemical compound CC1=C(OCC2=C3C(=CC=C2C2=CC=CC=C2OC(F)(F)F)NC(C)(C)C(=O)N3C)C=C(F)C=C1 LVXNHCJHMAMUMN-UHFFFAOYSA-N 0.000 description 1
- RQBGNHCKXKNFHE-UHFFFAOYSA-N CCC(=O)OC1=CC=C(C2=CC=C3NC(C)(C)C(=O)N(C)C3=C2COC2=C(C)C=CC(F)=C2)C(OC)=C1 Chemical compound CCC(=O)OC1=CC=C(C2=CC=C3NC(C)(C)C(=O)N(C)C3=C2COC2=C(C)C=CC(F)=C2)C(OC)=C1 RQBGNHCKXKNFHE-UHFFFAOYSA-N 0.000 description 1
- DSOMKMMCXNYOQQ-UHFFFAOYSA-N CCC1=CC=C(C(=O)OCC2=C3C(=CC=C2C2=CC(Cl)=CC=C2OC)NC(C)(C)C(=O)N3C)S1 Chemical compound CCC1=CC=C(C(=O)OCC2=C3C(=CC=C2C2=CC(Cl)=CC=C2OC)NC(C)(C)C(=O)N3C)S1 DSOMKMMCXNYOQQ-UHFFFAOYSA-N 0.000 description 1
- YRKAMHOJJMGVNG-UHFFFAOYSA-N CCC1=CC=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound CCC1=CC=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 YRKAMHOJJMGVNG-UHFFFAOYSA-N 0.000 description 1
- ONWMTQXZOKYVML-UHFFFAOYSA-N CCCC(=O)OC1=CC=C(C2=CC=C3NC(C)(C)C(=O)N(C)C3=C2COC(=O)C2=CC=C(C)S2)C(OC)=C1 Chemical compound CCCC(=O)OC1=CC=C(C2=CC=C3NC(C)(C)C(=O)N(C)C3=C2COC(=O)C2=CC=C(C)S2)C(OC)=C1 ONWMTQXZOKYVML-UHFFFAOYSA-N 0.000 description 1
- CVDIVMCEPFGVPE-UHFFFAOYSA-N CCCNC(=O)NC1=CC=C(C2=CC=C3NC(C)(C)C(=O)N(C)C3=C2COC2=C(C)C=CC(F)=C2)C(OC)=C1 Chemical compound CCCNC(=O)NC1=CC=C(C2=CC=C3NC(C)(C)C(=O)N(C)C3=C2COC2=C(C)C=CC(F)=C2)C(OC)=C1 CVDIVMCEPFGVPE-UHFFFAOYSA-N 0.000 description 1
- JGLMVXWAHNTPRF-CMDGGOBGSA-N CCN1N=C(C)C=C1C(=O)NC1=NC2=CC(=CC(OC)=C2N1C\C=C\CN1C(NC(=O)C2=CC(C)=NN2CC)=NC2=CC(=CC(OCCCN3CCOCC3)=C12)C(N)=O)C(N)=O Chemical compound CCN1N=C(C)C=C1C(=O)NC1=NC2=CC(=CC(OC)=C2N1C\C=C\CN1C(NC(=O)C2=CC(C)=NN2CC)=NC2=CC(=CC(OCCCN3CCOCC3)=C12)C(N)=O)C(N)=O JGLMVXWAHNTPRF-CMDGGOBGSA-N 0.000 description 1
- KFMJSAQQMLLBER-UHFFFAOYSA-N CCOC(=O)C(C)(C)NC1=CC=C(Br)C(C(=O)OC)=C1[N+](=O)[O-] Chemical compound CCOC(=O)C(C)(C)NC1=CC=C(Br)C(C(=O)OC)=C1[N+](=O)[O-] KFMJSAQQMLLBER-UHFFFAOYSA-N 0.000 description 1
- MERNCTFRYDVDJY-UHFFFAOYSA-N CCOC(=O)CNC(=O)OC1=CC=C(C2=CC=C3NC(C)(C)C(=O)N(C)C3=C2COC2=C(C)C=CC(F)=C2)C(OC)=C1 Chemical compound CCOC(=O)CNC(=O)OC1=CC=C(C2=CC=C3NC(C)(C)C(=O)N(C)C3=C2COC2=C(C)C=CC(F)=C2)C(OC)=C1 MERNCTFRYDVDJY-UHFFFAOYSA-N 0.000 description 1
- SZEWJMUJJJUSOC-UHFFFAOYSA-N CN1C(=O)C(C)(C)NC2=CC=C3C(=C21)C(=O)OC1=C3/C=C\C(F)=C\1 Chemical compound CN1C(=O)C(C)(C)NC2=CC=C3C(=C21)C(=O)OC1=C3/C=C\C(F)=C\1 SZEWJMUJJJUSOC-UHFFFAOYSA-N 0.000 description 1
- IGGJJYDFDKNRLN-UHFFFAOYSA-N COC(=O)C1=C2C(=CC=C1C1=CC=C(F)C=C1OC)NC(C)(C)C(=O)N2C Chemical compound COC(=O)C1=C2C(=CC=C1C1=CC=C(F)C=C1OC)NC(C)(C)C(=O)N2C IGGJJYDFDKNRLN-UHFFFAOYSA-N 0.000 description 1
- WZYSRDSRRQBNBM-UHFFFAOYSA-N COC(=O)C1=C2NC(=O)C(C)(C)NC2=CC=C1C1=CC(F)=CC=C1OC Chemical compound COC(=O)C1=C2NC(=O)C(C)(C)NC2=CC=C1C1=CC(F)=CC=C1OC WZYSRDSRRQBNBM-UHFFFAOYSA-N 0.000 description 1
- RHTXCOQIKOYRNT-UHFFFAOYSA-N COC(=O)C1=C2NC(=O)C(C)(C)NC2=CC=C1C1=CC=C(F)C=C1OC Chemical compound COC(=O)C1=C2NC(=O)C(C)(C)NC2=CC=C1C1=CC=C(F)C=C1OC RHTXCOQIKOYRNT-UHFFFAOYSA-N 0.000 description 1
- PGMFZZNDUPHHBG-UHFFFAOYSA-N COC(=O)C1=C2NC(=O)C(C)(C)NC2=CC=C1C1=CC=C(OC(=O)C2=CC=CC=C2)C=C1OC Chemical compound COC(=O)C1=C2NC(=O)C(C)(C)NC2=CC=C1C1=CC=C(OC(=O)C2=CC=CC=C2)C=C1OC PGMFZZNDUPHHBG-UHFFFAOYSA-N 0.000 description 1
- BFNCIPMAUSEQIE-UHFFFAOYSA-N COC(=O)C1=CC=C(OC)C(B2OC(C)(C)C(C)(C)O2)=C1 Chemical compound COC(=O)C1=CC=C(OC)C(B2OC(C)(C)C(C)(C)O2)=C1 BFNCIPMAUSEQIE-UHFFFAOYSA-N 0.000 description 1
- ZUZOAMUWKKKOKI-UHFFFAOYSA-N COC(=O)C1=CC=C(OC)C(C2=CC=C3NC(C)(C)C(=O)N4CN(C5=C(OC)C=CC=C5)CC2=C34)=C1 Chemical compound COC(=O)C1=CC=C(OC)C(C2=CC=C3NC(C)(C)C(=O)N4CN(C5=C(OC)C=CC=C5)CC2=C34)=C1 ZUZOAMUWKKKOKI-UHFFFAOYSA-N 0.000 description 1
- JOUKULSXVHNYQV-UHFFFAOYSA-N COC(=O)C1=CC=CC(C(=O)OC2=CC=C(C3=CC=C4NC(C)(C)C(=O)N(C)C4=C3CNC3=C(OC)C=CC=C3)C(OC)=C2)=C1 Chemical compound COC(=O)C1=CC=CC(C(=O)OC2=CC=C(C3=CC=C4NC(C)(C)C(=O)N(C)C4=C3CNC3=C(OC)C=CC=C3)C(OC)=C2)=C1 JOUKULSXVHNYQV-UHFFFAOYSA-N 0.000 description 1
- UFPINQHLXGMVTM-UHFFFAOYSA-N COC(=O)C1=CC=CC(OCC2=C3C(=CC=C2C2=CC(Cl)=CC=C2OC)NC(C)(C)C(=O)N3C)=C1 Chemical compound COC(=O)C1=CC=CC(OCC2=C3C(=CC=C2C2=CC(Cl)=CC=C2OC)NC(C)(C)C(=O)N3C)=C1 UFPINQHLXGMVTM-UHFFFAOYSA-N 0.000 description 1
- ZCJCDHCTZBPHNT-UHFFFAOYSA-N COC(=O)OC1=CC=C(C2=CC=C3NC(C)(C)C(=O)N(C)C3=C2CNC2=C(OC)C=CC=C2)C(OC)=C1 Chemical compound COC(=O)OC1=CC=C(C2=CC=C3NC(C)(C)C(=O)N(C)C3=C2CNC2=C(OC)C=CC=C2)C(OC)=C1 ZCJCDHCTZBPHNT-UHFFFAOYSA-N 0.000 description 1
- CCKCSFVTRYBXAW-UHFFFAOYSA-N COC1=C(B(O)O)C=C([N+](=O)[O-])C=C1 Chemical compound COC1=C(B(O)O)C=C([N+](=O)[O-])C=C1 CCKCSFVTRYBXAW-UHFFFAOYSA-N 0.000 description 1
- NFHJOFJUJTZCDI-UHFFFAOYSA-N COC1=C(F)C=C(F)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=C(F)C=C(F)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 NFHJOFJUJTZCDI-UHFFFAOYSA-N 0.000 description 1
- WGOIHUAWOWGDSK-UHFFFAOYSA-N COC1=C(F)C=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=C(F)C=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 WGOIHUAWOWGDSK-UHFFFAOYSA-N 0.000 description 1
- HLZRBKYQMPUYRP-UHFFFAOYSA-N COC1=C(NCC2=C3C(=CC=C2Br)NC(C)(C)C(=O)N3C)C=CC=C1 Chemical compound COC1=C(NCC2=C3C(=CC=C2Br)NC(C)(C)C(=O)N3C)C=CC=C1 HLZRBKYQMPUYRP-UHFFFAOYSA-N 0.000 description 1
- RMEBZWJEUGUYLN-UHFFFAOYSA-N COC1=CC(C(C)=O)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(C(C)=O)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 RMEBZWJEUGUYLN-UHFFFAOYSA-N 0.000 description 1
- DWCUSAJDQBICEQ-UHFFFAOYSA-N COC1=CC(C)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(C)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 DWCUSAJDQBICEQ-UHFFFAOYSA-N 0.000 description 1
- SVFCPAWGGIPPRU-UHFFFAOYSA-N COC1=CC(Cl)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(Cl)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 SVFCPAWGGIPPRU-UHFFFAOYSA-N 0.000 description 1
- OKDVLPYJKWIXOB-UHFFFAOYSA-N COC1=CC(F)=C(Cl)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(F)=C(Cl)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 OKDVLPYJKWIXOB-UHFFFAOYSA-N 0.000 description 1
- CKCPRACNXYIBCA-UHFFFAOYSA-N COC1=CC(F)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC=CS1 Chemical compound COC1=CC(F)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC=CS1 CKCPRACNXYIBCA-UHFFFAOYSA-N 0.000 description 1
- SPFQEAQMWRFOPY-UHFFFAOYSA-N COC1=CC(F)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC=C1 Chemical compound COC1=CC(F)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC=C1 SPFQEAQMWRFOPY-UHFFFAOYSA-N 0.000 description 1
- WBLIUWDFVOSJHC-UHFFFAOYSA-N COC1=CC(F)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=CC(C#N)=CC=C1 Chemical compound COC1=CC(F)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=CC(C#N)=CC=C1 WBLIUWDFVOSJHC-UHFFFAOYSA-N 0.000 description 1
- CRMGSHHDFUCMPI-UHFFFAOYSA-N COC1=CC(F)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=CC(C(C)=O)=CC=C1 Chemical compound COC1=CC(F)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=CC(C(C)=O)=CC=C1 CRMGSHHDFUCMPI-UHFFFAOYSA-N 0.000 description 1
- BFNNIVDFPCNNHB-UHFFFAOYSA-N COC1=CC(F)=CC=C1C1=CC=C2NC(C)(C)C(=O)NC2=C1COC(=O)C1=CC=C(C)S1 Chemical compound COC1=CC(F)=CC=C1C1=CC=C2NC(C)(C)C(=O)NC2=C1COC(=O)C1=CC=C(C)S1 BFNNIVDFPCNNHB-UHFFFAOYSA-N 0.000 description 1
- IGQBDVLDJXAMCB-UHFFFAOYSA-N COC1=CC(F)=CC=C1C1=CC=C2NC(C)(C)C(=O)NC2=C1COC(=O)C1=CC=CC=C1 Chemical compound COC1=CC(F)=CC=C1C1=CC=C2NC(C)(C)C(=O)NC2=C1COC(=O)C1=CC=CC=C1 IGQBDVLDJXAMCB-UHFFFAOYSA-N 0.000 description 1
- WKQXCOCNVCUNKS-UHFFFAOYSA-N COC1=CC(N(C)C(=O)C2=CC=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(N(C)C(=O)C2=CC=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 WKQXCOCNVCUNKS-UHFFFAOYSA-N 0.000 description 1
- XJWBJSUMOZUQRA-UHFFFAOYSA-N COC1=CC(N(C)C(=O)C2=CN=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(N(C)C(=O)C2=CN=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 XJWBJSUMOZUQRA-UHFFFAOYSA-N 0.000 description 1
- YFNWNSDDMONDAV-UHFFFAOYSA-N COC1=CC(N(C)C(=O)C2=NC=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(N(C)C(=O)C2=NC=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 YFNWNSDDMONDAV-UHFFFAOYSA-N 0.000 description 1
- OMHJJTFGOCILDR-UHFFFAOYSA-N COC1=CC(NC(=O)C2=C(C)C=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(NC(=O)C2=C(C)C=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 OMHJJTFGOCILDR-UHFFFAOYSA-N 0.000 description 1
- AJURFIBADKJTFE-UHFFFAOYSA-N COC1=CC(NC(=O)C2=C(F)C=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(NC(=O)C2=C(F)C=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 AJURFIBADKJTFE-UHFFFAOYSA-N 0.000 description 1
- ZTKXUYLSQXVEHB-UHFFFAOYSA-N COC1=CC(NC(=O)C2=C(OC)C=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(NC(=O)C2=C(OC)C=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 ZTKXUYLSQXVEHB-UHFFFAOYSA-N 0.000 description 1
- KIVKIJDWHAWSDF-UHFFFAOYSA-N COC1=CC(NC(=O)C2=C(SC)C=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(NC(=O)C2=C(SC)C=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 KIVKIJDWHAWSDF-UHFFFAOYSA-N 0.000 description 1
- PEKPAIYWUMPEDF-UHFFFAOYSA-N COC1=CC(NC(=O)C2=CC=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(NC(=O)C2=CC=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 PEKPAIYWUMPEDF-UHFFFAOYSA-N 0.000 description 1
- GSLULOLFCMVVPW-UHFFFAOYSA-N COC1=CC(NC(=O)C2=CC=CC=C2C(F)(F)F)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(NC(=O)C2=CC=CC=C2C(F)(F)F)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 GSLULOLFCMVVPW-UHFFFAOYSA-N 0.000 description 1
- BKWAWLVMEISHDJ-UHFFFAOYSA-N COC1=CC(NC(=O)C2=CC=CC=C2[N+](=O)=O)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(NC(=O)C2=CC=CC=C2[N+](=O)=O)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 BKWAWLVMEISHDJ-UHFFFAOYSA-N 0.000 description 1
- ZHLHKFVKOJUPRX-UHFFFAOYSA-N COC1=CC(NC(=O)C2=CC=CO2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(NC(=O)C2=CC=CO2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 ZHLHKFVKOJUPRX-UHFFFAOYSA-N 0.000 description 1
- NHGMTTDNFRZEGU-UHFFFAOYSA-N COC1=CC(NC(=O)C2=CN=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(NC(=O)C2=CN=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 NHGMTTDNFRZEGU-UHFFFAOYSA-N 0.000 description 1
- FSHKJSKHHQXUGN-UHFFFAOYSA-N COC1=CC(NC(=O)CN)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1.Cl Chemical compound COC1=CC(NC(=O)CN)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1.Cl FSHKJSKHHQXUGN-UHFFFAOYSA-N 0.000 description 1
- GDFXHTWOAYKIBV-UHFFFAOYSA-N COC1=CC(NC(C)=O)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(NC(C)=O)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 GDFXHTWOAYKIBV-UHFFFAOYSA-N 0.000 description 1
- SDADQJAZGIAYHL-UHFFFAOYSA-N COC1=CC(O)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1C[N-](C(=O)OCC1C2=C(C=CC=C2)C2=C1C=CC=C2)C1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(O)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1C[N-](C(=O)OCC1C2=C(C=CC=C2)C2=C1C=CC=C2)C1=C(C)C=CC(F)=C1 SDADQJAZGIAYHL-UHFFFAOYSA-N 0.000 description 1
- JZCANZPOSKROOU-UHFFFAOYSA-N COC1=CC(O)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1C[N-](C(=O)OCC1C2=C(C=CC=C2)C2=C1C=CC=C2)C1=C(OC)C=CC=C1 Chemical compound COC1=CC(O)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1C[N-](C(=O)OCC1C2=C(C=CC=C2)C2=C1C=CC=C2)C1=C(OC)C=CC=C1 JZCANZPOSKROOU-UHFFFAOYSA-N 0.000 description 1
- WZXKMXSMHGMWOZ-UHFFFAOYSA-N COC1=CC(OC(=O)C(C)(C)C)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(OC(=O)C(C)(C)C)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 WZXKMXSMHGMWOZ-UHFFFAOYSA-N 0.000 description 1
- PDANHCALFDUMGO-UHFFFAOYSA-N COC1=CC(OC(=O)C(C)C)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC=C(C)S1 Chemical compound COC1=CC(OC(=O)C(C)C)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC=C(C)S1 PDANHCALFDUMGO-UHFFFAOYSA-N 0.000 description 1
- HBAKVNXMFHNJPH-UHFFFAOYSA-N COC1=CC(OC(=O)C(C)C)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(OC(=O)C(C)C)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 HBAKVNXMFHNJPH-UHFFFAOYSA-N 0.000 description 1
- GNHAXHROWFMONG-UHFFFAOYSA-N COC1=CC(OC(=O)C2=C(C(F)(F)F)C=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(OC(=O)C2=C(C(F)(F)F)C=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 GNHAXHROWFMONG-UHFFFAOYSA-N 0.000 description 1
- CPVVLNLQOHOLEN-UHFFFAOYSA-N COC1=CC(OC(=O)C2=C(C)C=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1CNC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(OC(=O)C2=C(C)C=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1CNC1=C(C)C=CC(F)=C1 CPVVLNLQOHOLEN-UHFFFAOYSA-N 0.000 description 1
- PVHZRPUCUWCQDD-UHFFFAOYSA-N COC1=CC(OC(=O)C2=C(C)C=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC=C(Br)S1 Chemical compound COC1=CC(OC(=O)C2=C(C)C=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC=C(Br)S1 PVHZRPUCUWCQDD-UHFFFAOYSA-N 0.000 description 1
- DAFCEHSWVQRRJJ-UHFFFAOYSA-N COC1=CC(OC(=O)C2=C(C)C=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC=C(C)C=C1 Chemical compound COC1=CC(OC(=O)C2=C(C)C=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC=C(C)C=C1 DAFCEHSWVQRRJJ-UHFFFAOYSA-N 0.000 description 1
- PVBIBWBHPGJDCL-UHFFFAOYSA-N COC1=CC(OC(=O)C2=C(C)C=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC=C(C)S1 Chemical compound COC1=CC(OC(=O)C2=C(C)C=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC=C(C)S1 PVBIBWBHPGJDCL-UHFFFAOYSA-N 0.000 description 1
- BCEHFYLDBTWSCG-UHFFFAOYSA-N COC1=CC(OC(=O)C2=C(C)C=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)NC2=C1COC(=O)C1=CC(F)=CC=C1 Chemical compound COC1=CC(OC(=O)C2=C(C)C=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)NC2=C1COC(=O)C1=CC(F)=CC=C1 BCEHFYLDBTWSCG-UHFFFAOYSA-N 0.000 description 1
- LWQZAYQMUNSECH-UHFFFAOYSA-N COC1=CC(OC(=O)C2=C(C)C=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)NC2=C1COC(=O)C1=CC=C(Br)S1 Chemical compound COC1=CC(OC(=O)C2=C(C)C=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)NC2=C1COC(=O)C1=CC=C(Br)S1 LWQZAYQMUNSECH-UHFFFAOYSA-N 0.000 description 1
- DVXVHPNSHFMHKQ-UHFFFAOYSA-N COC1=CC(OC(=O)C2=C(C)C=CO2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1CNC1=C(OC)C=CC=C1 Chemical compound COC1=CC(OC(=O)C2=C(C)C=CO2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1CNC1=C(OC)C=CC=C1 DVXVHPNSHFMHKQ-UHFFFAOYSA-N 0.000 description 1
- GAENGLJXOGAVMI-UHFFFAOYSA-N COC1=CC(OC(=O)C2=C(C)C=CO2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(OC(=O)C2=C(C)C=CO2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 GAENGLJXOGAVMI-UHFFFAOYSA-N 0.000 description 1
- PPYXLTQUMOUZRS-UHFFFAOYSA-N COC1=CC(OC(=O)C2=C(Cl)C(C)=CS2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(OC(=O)C2=C(Cl)C(C)=CS2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 PPYXLTQUMOUZRS-UHFFFAOYSA-N 0.000 description 1
- LRSNGZAESKDMEN-UHFFFAOYSA-N COC1=CC(OC(=O)C2=C(Cl)C=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1CNC1=C(OC)C=CC=C1 Chemical compound COC1=CC(OC(=O)C2=C(Cl)C=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1CNC1=C(OC)C=CC=C1 LRSNGZAESKDMEN-UHFFFAOYSA-N 0.000 description 1
- AWHLMVNRLLBUCL-UHFFFAOYSA-N COC1=CC(OC(=O)C2=C(Cl)C=CS2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1CNC1=C(OC)C=CC=C1 Chemical compound COC1=CC(OC(=O)C2=C(Cl)C=CS2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1CNC1=C(OC)C=CC=C1 AWHLMVNRLLBUCL-UHFFFAOYSA-N 0.000 description 1
- SGLYVQIZVAUUHQ-UHFFFAOYSA-N COC1=CC(OC(=O)C2=C(Cl)C=CS2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC=C(C)S1 Chemical compound COC1=CC(OC(=O)C2=C(Cl)C=CS2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC=C(C)S1 SGLYVQIZVAUUHQ-UHFFFAOYSA-N 0.000 description 1
- PUGPGZNWSUPWKH-UHFFFAOYSA-N COC1=CC(OC(=O)C2=C(F)C=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(OC(=O)C2=C(F)C=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 PUGPGZNWSUPWKH-UHFFFAOYSA-N 0.000 description 1
- CJDXOQBMOYJGAZ-UHFFFAOYSA-N COC1=CC(OC(=O)C2=C(SC)C=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC=C(C)S1 Chemical compound COC1=CC(OC(=O)C2=C(SC)C=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC=C(C)S1 CJDXOQBMOYJGAZ-UHFFFAOYSA-N 0.000 description 1
- WWLFHWRVLCMTJL-UHFFFAOYSA-N COC1=CC(OC(=O)C2=C(SC)C=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(OC(=O)C2=C(SC)C=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 WWLFHWRVLCMTJL-UHFFFAOYSA-N 0.000 description 1
- QQSWZLVUCRBUPJ-UHFFFAOYSA-N COC1=CC(OC(=O)C2=CC(C(C)=O)=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1CNC1=C(OC)C=CC=C1 Chemical compound COC1=CC(OC(=O)C2=CC(C(C)=O)=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1CNC1=C(OC)C=CC=C1 QQSWZLVUCRBUPJ-UHFFFAOYSA-N 0.000 description 1
- RPGZZRGXMGMPTD-UHFFFAOYSA-N COC1=CC(OC(=O)C2=CC(C(C)=O)=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC=C(C)S1 Chemical compound COC1=CC(OC(=O)C2=CC(C(C)=O)=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC=C(C)S1 RPGZZRGXMGMPTD-UHFFFAOYSA-N 0.000 description 1
- HZJKMCNSAZCNLE-UHFFFAOYSA-N COC1=CC(OC(=O)C2=CC(Cl)=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(OC(=O)C2=CC(Cl)=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 HZJKMCNSAZCNLE-UHFFFAOYSA-N 0.000 description 1
- SWNPFBUEQOUJEV-UHFFFAOYSA-N COC1=CC(OC(=O)C2=CC(Cl)=NC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(OC(=O)C2=CC(Cl)=NC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 SWNPFBUEQOUJEV-UHFFFAOYSA-N 0.000 description 1
- QFJPZMYPESMYID-UHFFFAOYSA-N COC1=CC(OC(=O)C2=CC(F)=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(OC(=O)C2=CC(F)=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 QFJPZMYPESMYID-UHFFFAOYSA-N 0.000 description 1
- UBEGTGXNPXNVHC-UHFFFAOYSA-N COC1=CC(OC(=O)C2=CC=C(Br)O2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(OC(=O)C2=CC=C(Br)O2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 UBEGTGXNPXNVHC-UHFFFAOYSA-N 0.000 description 1
- ISFULGNRRUVMHP-UHFFFAOYSA-N COC1=CC(OC(=O)C2=CC=C(C(C)=O)C=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(OC(=O)C2=CC=C(C(C)=O)C=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 ISFULGNRRUVMHP-UHFFFAOYSA-N 0.000 description 1
- JHWAOVWFQTYEOO-UHFFFAOYSA-N COC1=CC(OC(=O)C2=CC=C(C)O2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(OC(=O)C2=CC=C(C)O2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 JHWAOVWFQTYEOO-UHFFFAOYSA-N 0.000 description 1
- BTKBUUPAMVDVQD-UHFFFAOYSA-N COC1=CC(OC(=O)C2=CC=C(C)S2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(OC(=O)C2=CC=C(C)S2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 BTKBUUPAMVDVQD-UHFFFAOYSA-N 0.000 description 1
- IPWPXWBSTIHZQK-UHFFFAOYSA-N COC1=CC(OC(=O)C2=CC=C(Cl)C=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC=C(C)S1 Chemical compound COC1=CC(OC(=O)C2=CC=C(Cl)C=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC=C(C)S1 IPWPXWBSTIHZQK-UHFFFAOYSA-N 0.000 description 1
- LRTHXGZTQCLAIQ-UHFFFAOYSA-N COC1=CC(OC(=O)C2=CC=C(Cl)C=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(OC(=O)C2=CC=C(Cl)C=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 LRTHXGZTQCLAIQ-UHFFFAOYSA-N 0.000 description 1
- KSEZGNWQKQCFEN-UHFFFAOYSA-N COC1=CC(OC(=O)C2=CC=C(Cl)S2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(OC(=O)C2=CC=C(Cl)S2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 KSEZGNWQKQCFEN-UHFFFAOYSA-N 0.000 description 1
- RVQJYRAFKZMBQB-UHFFFAOYSA-N COC1=CC(OC(=O)C2=CC=C([N+](=O)[O-])C=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(OC(=O)C2=CC=C([N+](=O)[O-])C=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 RVQJYRAFKZMBQB-UHFFFAOYSA-N 0.000 description 1
- BVFDLUHMIVWZHW-UHFFFAOYSA-N COC1=CC(OC(=O)C2=CC=CO2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1CNC1=C(OC)C=CC=C1 Chemical compound COC1=CC(OC(=O)C2=CC=CO2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1CNC1=C(OC)C=CC=C1 BVFDLUHMIVWZHW-UHFFFAOYSA-N 0.000 description 1
- RSWRDDBMCGMNQH-UHFFFAOYSA-N COC1=CC(OC(=O)C2=CC=CO2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(OC(=O)C2=CC=CO2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 RSWRDDBMCGMNQH-UHFFFAOYSA-N 0.000 description 1
- YBWSSTGWLFZJOU-UHFFFAOYSA-N COC1=CC(OC(=O)C2=CC=CS2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1CNC1=C(OC)C=CC=C1 Chemical compound COC1=CC(OC(=O)C2=CC=CS2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1CNC1=C(OC)C=CC=C1 YBWSSTGWLFZJOU-UHFFFAOYSA-N 0.000 description 1
- KWESZHHAWNXVKT-UHFFFAOYSA-N COC1=CC(OC(=O)C2=CC=CS2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC=C(C)S1 Chemical compound COC1=CC(OC(=O)C2=CC=CS2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC=C(C)S1 KWESZHHAWNXVKT-UHFFFAOYSA-N 0.000 description 1
- TXQIKATZKJZJNJ-UHFFFAOYSA-N COC1=CC(OC(=O)C2=CC=CS2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(OC(=O)C2=CC=CS2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 TXQIKATZKJZJNJ-UHFFFAOYSA-N 0.000 description 1
- OZFMWJXIEGEUOJ-UHFFFAOYSA-N COC1=CC(OC(=O)C2=CC=NC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC=C(C)S1 Chemical compound COC1=CC(OC(=O)C2=CC=NC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC=C(C)S1 OZFMWJXIEGEUOJ-UHFFFAOYSA-N 0.000 description 1
- YURDJQGNSDUBKS-UHFFFAOYSA-N COC1=CC(OC(=O)C2=CC=NC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(OC(=O)C2=CC=NC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 YURDJQGNSDUBKS-UHFFFAOYSA-N 0.000 description 1
- ZLZSWNRFZAZGED-UHFFFAOYSA-N COC1=CC(OC(=O)C2=CN=C(Cl)C=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(OC(=O)C2=CN=C(Cl)C=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 ZLZSWNRFZAZGED-UHFFFAOYSA-N 0.000 description 1
- RKTJXXKHDIAKDU-UHFFFAOYSA-N COC1=CC(OC(=O)C2=CN=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC=C(C)S1 Chemical compound COC1=CC(OC(=O)C2=CN=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC=C(C)S1 RKTJXXKHDIAKDU-UHFFFAOYSA-N 0.000 description 1
- MQDBLQNWSLMSEK-UHFFFAOYSA-N COC1=CC(OC(=O)C2=CN=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(OC(=O)C2=CN=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 MQDBLQNWSLMSEK-UHFFFAOYSA-N 0.000 description 1
- YAPIWGREACOFQR-UHFFFAOYSA-N COC1=CC(OC(=O)C2=CN=CC=C2C)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(OC(=O)C2=CN=CC=C2C)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 YAPIWGREACOFQR-UHFFFAOYSA-N 0.000 description 1
- AJKDGIHTXQTLOW-UHFFFAOYSA-N COC1=CC(OC(=O)C2=CN=CN=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(OC(=O)C2=CN=CN=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 AJKDGIHTXQTLOW-UHFFFAOYSA-N 0.000 description 1
- OYWXSDBEIKBACH-UHFFFAOYSA-N COC1=CC(OC(=O)C2=CN=CS2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC=C(C)S1 Chemical compound COC1=CC(OC(=O)C2=CN=CS2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC=C(C)S1 OYWXSDBEIKBACH-UHFFFAOYSA-N 0.000 description 1
- OQUUPFPZOQRPDT-UHFFFAOYSA-N COC1=CC(OC(=O)C2=CN=CS2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(OC(=O)C2=CN=CS2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 OQUUPFPZOQRPDT-UHFFFAOYSA-N 0.000 description 1
- ZWZLETWVLFZXIA-UHFFFAOYSA-N COC1=CC(OC(=O)C2=COC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC=C(C)S1 Chemical compound COC1=CC(OC(=O)C2=COC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC=C(C)S1 ZWZLETWVLFZXIA-UHFFFAOYSA-N 0.000 description 1
- DTRLLEHXQMXOCO-UHFFFAOYSA-N COC1=CC(OC(=O)C2=CSC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC=C(C)S1 Chemical compound COC1=CC(OC(=O)C2=CSC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC=C(C)S1 DTRLLEHXQMXOCO-UHFFFAOYSA-N 0.000 description 1
- RIRFONYHZDAXSX-UHFFFAOYSA-N COC1=CC(OC(=O)C2=CSC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(OC(=O)C2=CSC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 RIRFONYHZDAXSX-UHFFFAOYSA-N 0.000 description 1
- YPTVSUUMNZJGSO-UHFFFAOYSA-N COC1=CC(OC(=O)C2=CSC=N2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC=C(C)S1 Chemical compound COC1=CC(OC(=O)C2=CSC=N2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC=C(C)S1 YPTVSUUMNZJGSO-UHFFFAOYSA-N 0.000 description 1
- YFZSWDBRECEEJF-UHFFFAOYSA-N COC1=CC(OC(=O)C2=CSC=N2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(OC(=O)C2=CSC=N2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 YFZSWDBRECEEJF-UHFFFAOYSA-N 0.000 description 1
- XVEMSNYDMYTBDO-UHFFFAOYSA-N COC1=CC(OC(=O)C2=NC=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(OC(=O)C2=NC=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 XVEMSNYDMYTBDO-UHFFFAOYSA-N 0.000 description 1
- WEHIIIIULJHVCG-UHFFFAOYSA-N COC1=CC(OC(=O)C2CCCCC2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1CNC1=C(OC)C=CC=C1 Chemical compound COC1=CC(OC(=O)C2CCCCC2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1CNC1=C(OC)C=CC=C1 WEHIIIIULJHVCG-UHFFFAOYSA-N 0.000 description 1
- AHOCEBHWNSNZSO-UHFFFAOYSA-N COC1=CC(OC(=O)C2CCCCC2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC=C(C)S1 Chemical compound COC1=CC(OC(=O)C2CCCCC2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC=C(C)S1 AHOCEBHWNSNZSO-UHFFFAOYSA-N 0.000 description 1
- ZORMWVHBMDCBOD-UHFFFAOYSA-N COC1=CC(OC(=O)C2CCCCC2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(OC(=O)C2CCCCC2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 ZORMWVHBMDCBOD-UHFFFAOYSA-N 0.000 description 1
- QEOVZHZKWAYHHK-UHFFFAOYSA-N COC1=CC(OC(=O)CC2=CC=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1CNC1=C(OC)C=CC=C1 Chemical compound COC1=CC(OC(=O)CC2=CC=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1CNC1=C(OC)C=CC=C1 QEOVZHZKWAYHHK-UHFFFAOYSA-N 0.000 description 1
- CHRDZXPKZDNYQH-UHFFFAOYSA-N COC1=CC(OC(=O)CC2=CC=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC=C(C)S1 Chemical compound COC1=CC(OC(=O)CC2=CC=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC=C(C)S1 CHRDZXPKZDNYQH-UHFFFAOYSA-N 0.000 description 1
- WJDFRMMREGPYFF-UHFFFAOYSA-N COC1=CC(OC(=O)CC2=CC=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(OC(=O)CC2=CC=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 WJDFRMMREGPYFF-UHFFFAOYSA-N 0.000 description 1
- FJRWOFYDYOLXFK-UHFFFAOYSA-N COC1=CC(OC(=O)CCC2=CC=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(OC(=O)CCC2=CC=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 FJRWOFYDYOLXFK-UHFFFAOYSA-N 0.000 description 1
- FKIOYBOEDBPNQA-UHFFFAOYSA-N COC1=CC(OC(=O)N2CCC(O)CC2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(OC(=O)N2CCC(O)CC2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 FKIOYBOEDBPNQA-UHFFFAOYSA-N 0.000 description 1
- UDULFCBXJZVNQJ-UHFFFAOYSA-N COC1=CC(OC(=O)N2CCOCC2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1CNC1=C(OC)C=CC=C1 Chemical compound COC1=CC(OC(=O)N2CCOCC2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1CNC1=C(OC)C=CC=C1 UDULFCBXJZVNQJ-UHFFFAOYSA-N 0.000 description 1
- AGMJVDSFBKPVJJ-UHFFFAOYSA-N COC1=CC(OC(=O)NC(C)C)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1CNC1=C(OC)C=CC=C1 Chemical compound COC1=CC(OC(=O)NC(C)C)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1CNC1=C(OC)C=CC=C1 AGMJVDSFBKPVJJ-UHFFFAOYSA-N 0.000 description 1
- JBFBBOFJXRXUCI-UHFFFAOYSA-N COC1=CC(OC(=O)NC(C)C)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC=C(C)S1 Chemical compound COC1=CC(OC(=O)NC(C)C)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC=C(C)S1 JBFBBOFJXRXUCI-UHFFFAOYSA-N 0.000 description 1
- UHAAMDAXCQBMFS-UHFFFAOYSA-N COC1=CC(OC(=O)NC(C)C)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(OC(=O)NC(C)C)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 UHAAMDAXCQBMFS-UHFFFAOYSA-N 0.000 description 1
- IKJSHGYVRBMGIA-UHFFFAOYSA-N COC1=CC(OC(=O)NC2=C(OC)C=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(OC(=O)NC2=C(OC)C=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 IKJSHGYVRBMGIA-UHFFFAOYSA-N 0.000 description 1
- NZPVGGWRAROOPN-UHFFFAOYSA-N COC1=CC(OC(=O)NC2=CC=C(C)C=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(OC(=O)NC2=CC=C(C)C=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 NZPVGGWRAROOPN-UHFFFAOYSA-N 0.000 description 1
- HZAPSQSCBWZNKI-UHFFFAOYSA-N COC1=CC(OC(=O)NC2=CC=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(OC(=O)NC2=CC=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 HZAPSQSCBWZNKI-UHFFFAOYSA-N 0.000 description 1
- KBYGGBOJZZKVFL-UHFFFAOYSA-N COC1=CC(OC(=O)NC2=CN=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1CNC1=C(OC)C=CC=C1 Chemical compound COC1=CC(OC(=O)NC2=CN=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1CNC1=C(OC)C=CC=C1 KBYGGBOJZZKVFL-UHFFFAOYSA-N 0.000 description 1
- OELHEZMSVVVTEV-UHFFFAOYSA-N COC1=CC(OC(=O)NC2CCCCC2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(OC(=O)NC2CCCCC2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 OELHEZMSVVVTEV-UHFFFAOYSA-N 0.000 description 1
- ZBMNDVHIJDYGBH-UHFFFAOYSA-N COC1=CC(OC(=O)NCC2=CC=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(OC(=O)NCC2=CC=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 ZBMNDVHIJDYGBH-UHFFFAOYSA-N 0.000 description 1
- ARPCAVMRUCLXPD-UHFFFAOYSA-N COC1=CC(OC(=O)NCC2=CC=CO2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(OC(=O)NCC2=CC=CO2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 ARPCAVMRUCLXPD-UHFFFAOYSA-N 0.000 description 1
- NJPVRXJAYWJNBA-UHFFFAOYSA-N COC1=CC(OC(=O)OC2=CC=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC=C(C)S1 Chemical compound COC1=CC(OC(=O)OC2=CC=CC=C2)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC=C(C)S1 NJPVRXJAYWJNBA-UHFFFAOYSA-N 0.000 description 1
- DDLFRCKOOBDXIM-UHFFFAOYSA-N COC1=CC(OC(C)=O)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC(OC(C)=O)=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 DDLFRCKOOBDXIM-UHFFFAOYSA-N 0.000 description 1
- YGIKKCVIOHDVBM-UHFFFAOYSA-N COC1=CC([N+](=O)[O-])=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC([N+](=O)[O-])=CC=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 YGIKKCVIOHDVBM-UHFFFAOYSA-N 0.000 description 1
- RBSKMRUTBHCAPC-UHFFFAOYSA-N COC1=CC=C(C#N)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC=C(C#N)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 RBSKMRUTBHCAPC-UHFFFAOYSA-N 0.000 description 1
- JWEAFZFSUIAHMM-UHFFFAOYSA-N COC1=CC=C(C(=O)NC2=CC=C(C3=CC=C4NC(C)(C)C(=O)N(C)C4=C3COC3=C(C)C=CC(F)=C3)C(OC)=C2)C=C1 Chemical compound COC1=CC=C(C(=O)NC2=CC=C(C3=CC=C4NC(C)(C)C(=O)N(C)C4=C3COC3=C(C)C=CC(F)=C3)C(OC)=C2)C=C1 JWEAFZFSUIAHMM-UHFFFAOYSA-N 0.000 description 1
- BWEYUIDCZORMFY-UHFFFAOYSA-N COC1=CC=C(C(=O)O)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1CNC1=C(OC)C=CC=C1 Chemical compound COC1=CC=C(C(=O)O)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1CNC1=C(OC)C=CC=C1 BWEYUIDCZORMFY-UHFFFAOYSA-N 0.000 description 1
- BCAYNMYNAOGXQJ-UHFFFAOYSA-N COC1=CC=C(C(=O)OC2=CC=C(C3=CC=C4NC(C)(C)C(=O)N(C)C4=C3CNC3=C(OC)C=CC=C3)C(OC)=C2)C=C1 Chemical compound COC1=CC=C(C(=O)OC2=CC=C(C3=CC=C4NC(C)(C)C(=O)N(C)C4=C3CNC3=C(OC)C=CC=C3)C(OC)=C2)C=C1 BCAYNMYNAOGXQJ-UHFFFAOYSA-N 0.000 description 1
- XJITXIWYVPRTBJ-UHFFFAOYSA-N COC1=CC=C(C(=O)OC2=CC=C(C3=CC=C4NC(C)(C)C(=O)N(C)C4=C3COC(=O)C3=CC=C(C)S3)C(OC)=C2)C=C1 Chemical compound COC1=CC=C(C(=O)OC2=CC=C(C3=CC=C4NC(C)(C)C(=O)N(C)C4=C3COC(=O)C3=CC=C(C)S3)C(OC)=C2)C=C1 XJITXIWYVPRTBJ-UHFFFAOYSA-N 0.000 description 1
- YYQVGGLXMHFPPD-UHFFFAOYSA-N COC1=CC=C(C(=O)OCC2=C3C(=CC=C2C2=CC(Cl)=CC=C2OC)NC(C)(C)C(=O)N3C)C=C1 Chemical compound COC1=CC=C(C(=O)OCC2=C3C(=CC=C2C2=CC(Cl)=CC=C2OC)NC(C)(C)C(=O)N3C)C=C1 YYQVGGLXMHFPPD-UHFFFAOYSA-N 0.000 description 1
- RRMOUEYQIGZOHK-UHFFFAOYSA-N COC1=CC=C(C(=O)OCC2=C3C(=CC=C2C2=CC(Cl)=CC=C2OC)NC(C)(C)C(=O)N3C)O1 Chemical compound COC1=CC=C(C(=O)OCC2=C3C(=CC=C2C2=CC(Cl)=CC=C2OC)NC(C)(C)C(=O)N3C)O1 RRMOUEYQIGZOHK-UHFFFAOYSA-N 0.000 description 1
- JKHCQJFGJYEOAR-UHFFFAOYSA-N COC1=CC=C(C(=O)OCC2=C3C(=CC=C2C2=CC(F)=CC=C2OC)NC(C)(C)C(=O)N3C)C=C1 Chemical compound COC1=CC=C(C(=O)OCC2=C3C(=CC=C2C2=CC(F)=CC=C2OC)NC(C)(C)C(=O)N3C)C=C1 JKHCQJFGJYEOAR-UHFFFAOYSA-N 0.000 description 1
- KGLNLFMRKWAPMH-UHFFFAOYSA-N COC1=CC=C(C(=O)OCC2=C3C(=CC=C2C2=CC=C(F)C=C2OC)NC(C)(C)C(=O)N3C)C=C1 Chemical compound COC1=CC=C(C(=O)OCC2=C3C(=CC=C2C2=CC=C(F)C=C2OC)NC(C)(C)C(=O)N3C)C=C1 KGLNLFMRKWAPMH-UHFFFAOYSA-N 0.000 description 1
- SYZIQOIDGHYORD-UHFFFAOYSA-N COC1=CC=C(C(=O)OCC2=C3CC(=O)C(C)(C)NC3=CC=C2C2=CC=C(OC(=O)C3=C(C)C=CC=C3)C=C2OC)C=C1 Chemical compound COC1=CC=C(C(=O)OCC2=C3CC(=O)C(C)(C)NC3=CC=C2C2=CC=C(OC(=O)C3=C(C)C=CC=C3)C=C2OC)C=C1 SYZIQOIDGHYORD-UHFFFAOYSA-N 0.000 description 1
- VBMDUANBLPRHPR-UHFFFAOYSA-N COC1=CC=C(C(=O)OCC2=C3NC(=O)C(C)(C)NC3=CC=C2C2=CC(F)=CC=C2OC)C=C1 Chemical compound COC1=CC=C(C(=O)OCC2=C3NC(=O)C(C)(C)NC3=CC=C2C2=CC(F)=CC=C2OC)C=C1 VBMDUANBLPRHPR-UHFFFAOYSA-N 0.000 description 1
- QJFOUVAZBWPFTG-UHFFFAOYSA-N COC1=CC=C(C(C)(C)C)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC=C(C(C)(C)C)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 QJFOUVAZBWPFTG-UHFFFAOYSA-N 0.000 description 1
- GSUUZMNMCMERLO-UHFFFAOYSA-N COC1=CC=C(C(C)=O)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC=C(C(C)=O)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 GSUUZMNMCMERLO-UHFFFAOYSA-N 0.000 description 1
- TUFIPGYDFPWOSX-UHFFFAOYSA-N COC1=CC=C(C(C)C)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC=C(C(C)C)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 TUFIPGYDFPWOSX-UHFFFAOYSA-N 0.000 description 1
- STRLUDQVXYHKDH-UHFFFAOYSA-N COC1=CC=C(C(F)(F)F)C=C1C1=CC=C2NC(C)(C)C(=O)N3CN(C4=C(OC)C=CC=C4)CC1=C23 Chemical compound COC1=CC=C(C(F)(F)F)C=C1C1=CC=C2NC(C)(C)C(=O)N3CN(C4=C(OC)C=CC=C4)CC1=C23 STRLUDQVXYHKDH-UHFFFAOYSA-N 0.000 description 1
- RQWXBFZJOIKWTE-UHFFFAOYSA-N COC1=CC=C(C)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC=C(C)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 RQWXBFZJOIKWTE-UHFFFAOYSA-N 0.000 description 1
- JCJFKHSNQFUZCC-UHFFFAOYSA-N COC1=CC=C(C)C=C1C1=CC=C2NC(C)(C)C(=O)N3CN(C4=C(OC)C=CC=C4)CC1=C23 Chemical compound COC1=CC=C(C)C=C1C1=CC=C2NC(C)(C)C(=O)N3CN(C4=C(OC)C=CC=C4)CC1=C23 JCJFKHSNQFUZCC-UHFFFAOYSA-N 0.000 description 1
- ATGKHUWMCBUVMS-UHFFFAOYSA-N COC1=CC=C(C2=CC=C3NC(C)(C)C(=O)N(C)C3=C2COC2=C(C)C=CC(F)=C2)C(OC)=C1 Chemical compound COC1=CC=C(C2=CC=C3NC(C)(C)C(=O)N(C)C3=C2COC2=C(C)C=CC(F)=C2)C(OC)=C1 ATGKHUWMCBUVMS-UHFFFAOYSA-N 0.000 description 1
- DFKSDFRQZSRINM-UHFFFAOYSA-N COC1=CC=C(CO)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1CNC1=C(OC)C=CC=C1 Chemical compound COC1=CC=C(CO)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1CNC1=C(OC)C=CC=C1 DFKSDFRQZSRINM-UHFFFAOYSA-N 0.000 description 1
- XJWYMXDHBPYYRV-UHFFFAOYSA-N COC1=CC=C(Cl)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1CNC1=C(C)C=CC(C)=C1 Chemical compound COC1=CC=C(Cl)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1CNC1=C(C)C=CC(C)=C1 XJWYMXDHBPYYRV-UHFFFAOYSA-N 0.000 description 1
- YSNWAWDDJZYWRG-UHFFFAOYSA-N COC1=CC=C(Cl)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1CNC1=C(OC)C=CC(C)=C1 Chemical compound COC1=CC=C(Cl)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1CNC1=C(OC)C=CC(C)=C1 YSNWAWDDJZYWRG-UHFFFAOYSA-N 0.000 description 1
- MKPQZKSGMURWOT-UHFFFAOYSA-N COC1=CC=C(Cl)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1CNC1=C(OC)C=CC=C1 Chemical compound COC1=CC=C(Cl)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1CNC1=C(OC)C=CC=C1 MKPQZKSGMURWOT-UHFFFAOYSA-N 0.000 description 1
- SCZCKOUUOHSULE-UHFFFAOYSA-N COC1=CC=C(Cl)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC=C(C)S1 Chemical compound COC1=CC=C(Cl)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC=C(C)S1 SCZCKOUUOHSULE-UHFFFAOYSA-N 0.000 description 1
- JASFYXAWYWZRPW-UHFFFAOYSA-N COC1=CC=C(Cl)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC=C(Cl)C=C1 Chemical compound COC1=CC=C(Cl)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC=C(Cl)C=C1 JASFYXAWYWZRPW-UHFFFAOYSA-N 0.000 description 1
- OZVUTOLVQMXQNF-UHFFFAOYSA-N COC1=CC=C(Cl)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(C)=C1 Chemical compound COC1=CC=C(Cl)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(C)=C1 OZVUTOLVQMXQNF-UHFFFAOYSA-N 0.000 description 1
- MDYUHMQGQWMORV-UHFFFAOYSA-N COC1=CC=C(Cl)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC([N+](=O)[O-])=C1 Chemical compound COC1=CC=C(Cl)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC([N+](=O)[O-])=C1 MDYUHMQGQWMORV-UHFFFAOYSA-N 0.000 description 1
- FOALTISNOFBLJD-UHFFFAOYSA-N COC1=CC=C(Cl)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(OC)C=CC=C1 Chemical compound COC1=CC=C(Cl)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(OC)C=CC=C1 FOALTISNOFBLJD-UHFFFAOYSA-N 0.000 description 1
- YELHUWLETXNKON-UHFFFAOYSA-N COC1=CC=C(Cl)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=CC(C(F)(F)F)=CC=C1 Chemical compound COC1=CC=C(Cl)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=CC(C(F)(F)F)=CC=C1 YELHUWLETXNKON-UHFFFAOYSA-N 0.000 description 1
- YAWLVOJLFJZURW-UHFFFAOYSA-N COC1=CC=C(Cl)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=CC=C(C2=CC=CC=C2)C=C1 Chemical compound COC1=CC=C(Cl)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=CC=C(C2=CC=CC=C2)C=C1 YAWLVOJLFJZURW-UHFFFAOYSA-N 0.000 description 1
- XSFAQYHEBOPWMZ-UHFFFAOYSA-N COC1=CC=C(F)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1CNC1=C(C)C=CC=C1 Chemical compound COC1=CC=C(F)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1CNC1=C(C)C=CC=C1 XSFAQYHEBOPWMZ-UHFFFAOYSA-N 0.000 description 1
- KUMQLUNZHAMBBE-UHFFFAOYSA-N COC1=CC=C(F)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1CNC1=CC(C)=CC=C1 Chemical compound COC1=CC=C(F)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1CNC1=CC(C)=CC=C1 KUMQLUNZHAMBBE-UHFFFAOYSA-N 0.000 description 1
- MXWBFHKDKLPRFC-UHFFFAOYSA-N COC1=CC=C(F)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1CNC1=CC=C(C)C=C1 Chemical compound COC1=CC=C(F)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1CNC1=CC=C(C)C=C1 MXWBFHKDKLPRFC-UHFFFAOYSA-N 0.000 description 1
- DJIKIMKVRUOTED-UHFFFAOYSA-N COC1=CC=C(F)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=C(C)C=CC=C1 Chemical compound COC1=CC=C(F)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=C(C)C=CC=C1 DJIKIMKVRUOTED-UHFFFAOYSA-N 0.000 description 1
- BPINVNNPXDQSKZ-UHFFFAOYSA-N COC1=CC=C(F)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC(C)=CC=C1 Chemical compound COC1=CC=C(F)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC(C)=CC=C1 BPINVNNPXDQSKZ-UHFFFAOYSA-N 0.000 description 1
- AQNPFUAOLOKSPU-UHFFFAOYSA-N COC1=CC=C(F)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC=C(C)C=C1 Chemical compound COC1=CC=C(F)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC=C(C)C=C1 AQNPFUAOLOKSPU-UHFFFAOYSA-N 0.000 description 1
- MSEQQUOCXQPSAA-UHFFFAOYSA-N COC1=CC=C(F)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC=C(C)S1 Chemical compound COC1=CC=C(F)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC=C(C)S1 MSEQQUOCXQPSAA-UHFFFAOYSA-N 0.000 description 1
- IAIDFQKODMUVNS-UHFFFAOYSA-N COC1=CC=C(F)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC=CS1 Chemical compound COC1=CC=C(F)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC(=O)C1=CC=CS1 IAIDFQKODMUVNS-UHFFFAOYSA-N 0.000 description 1
- YSYNEFJCHGIGRE-UHFFFAOYSA-N COC1=CC=C(F)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC=C(F)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 YSYNEFJCHGIGRE-UHFFFAOYSA-N 0.000 description 1
- QHAADWVLXUPNSE-UHFFFAOYSA-N COC1=CC=C(F)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC=C1 Chemical compound COC1=CC=C(F)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC=C1 QHAADWVLXUPNSE-UHFFFAOYSA-N 0.000 description 1
- PJLCNCICKLOOHJ-UHFFFAOYSA-N COC1=CC=C(F)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=CC(C)=CC=C1 Chemical compound COC1=CC=C(F)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=CC(C)=CC=C1 PJLCNCICKLOOHJ-UHFFFAOYSA-N 0.000 description 1
- KPIKLFRUHGXKTB-UHFFFAOYSA-N COC1=CC=C(F)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=CC(F)=CC=C1 Chemical compound COC1=CC=C(F)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=CC(F)=CC=C1 KPIKLFRUHGXKTB-UHFFFAOYSA-N 0.000 description 1
- SWOBUZUSVZHMNL-UHFFFAOYSA-N COC1=CC=C(F)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=CC=C(C)C=C1 Chemical compound COC1=CC=C(F)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=CC=C(C)C=C1 SWOBUZUSVZHMNL-UHFFFAOYSA-N 0.000 description 1
- SGTJTDDQOZLGQJ-UHFFFAOYSA-N COC1=CC=C(F)C=C1C1=CC=C2NC(C)(C)C(=O)NC2=C1CNC1=C(C)C=CC=C1 Chemical compound COC1=CC=C(F)C=C1C1=CC=C2NC(C)(C)C(=O)NC2=C1CNC1=C(C)C=CC=C1 SGTJTDDQOZLGQJ-UHFFFAOYSA-N 0.000 description 1
- HKAPOGIKHVNQOQ-UHFFFAOYSA-N COC1=CC=C(F)C=C1C1=CC=C2NC(C)(C)C(=O)NC2=C1CNC1=CC(C)=CC=C1 Chemical compound COC1=CC=C(F)C=C1C1=CC=C2NC(C)(C)C(=O)NC2=C1CNC1=CC(C)=CC=C1 HKAPOGIKHVNQOQ-UHFFFAOYSA-N 0.000 description 1
- PWLOADWNNASWRT-UHFFFAOYSA-N COC1=CC=C(F)C=C1C1=CC=C2NC(C)(C)C(=O)NC2=C1CNC1=CC=CC=C1 Chemical compound COC1=CC=C(F)C=C1C1=CC=C2NC(C)(C)C(=O)NC2=C1CNC1=CC=CC=C1 PWLOADWNNASWRT-UHFFFAOYSA-N 0.000 description 1
- OHOCYAYGUIUMAX-UHFFFAOYSA-N COC1=CC=C(F)C=C1C1=CC=C2NC(C)(C)C(=O)NC2=C1CO Chemical compound COC1=CC=C(F)C=C1C1=CC=C2NC(C)(C)C(=O)NC2=C1CO OHOCYAYGUIUMAX-UHFFFAOYSA-N 0.000 description 1
- IVWNMHAUSJOPMZ-UHFFFAOYSA-N COC1=CC=C(F)C=C1C1=CC=C2NC(C)(C)C(=O)NC2=C1COC(=O)C1=C(C)C=CC=C1 Chemical compound COC1=CC=C(F)C=C1C1=CC=C2NC(C)(C)C(=O)NC2=C1COC(=O)C1=C(C)C=CC=C1 IVWNMHAUSJOPMZ-UHFFFAOYSA-N 0.000 description 1
- WONPJWAINPFZOK-UHFFFAOYSA-N COC1=CC=C(F)C=C1C1=CC=C2NC(C)(C)C(=O)NC2=C1COC(=O)C1=CC(C)=CC=C1 Chemical compound COC1=CC=C(F)C=C1C1=CC=C2NC(C)(C)C(=O)NC2=C1COC(=O)C1=CC(C)=CC=C1 WONPJWAINPFZOK-UHFFFAOYSA-N 0.000 description 1
- TZETYEBAWNHCHO-UHFFFAOYSA-N COC1=CC=C(F)C=C1C1=CC=C2NC(C)(C)C(=O)NC2=C1COC(=O)C1=CC=CS1 Chemical compound COC1=CC=C(F)C=C1C1=CC=C2NC(C)(C)C(=O)NC2=C1COC(=O)C1=CC=CS1 TZETYEBAWNHCHO-UHFFFAOYSA-N 0.000 description 1
- PJGPHDBOPCSVFF-UHFFFAOYSA-N COC1=CC=C(F)C=C1C1=CC=C2NC(C)(C)C(=O)NC2=C1COC1=C(C)C=CC=C1 Chemical compound COC1=CC=C(F)C=C1C1=CC=C2NC(C)(C)C(=O)NC2=C1COC1=C(C)C=CC=C1 PJGPHDBOPCSVFF-UHFFFAOYSA-N 0.000 description 1
- ZIYHMRKCUMVBTD-UHFFFAOYSA-N COC1=CC=C(F)C=C1C1=CC=C2NC(C)(C)C(=O)NC2=C1COC1=CC(C)=CC=C1 Chemical compound COC1=CC=C(F)C=C1C1=CC=C2NC(C)(C)C(=O)NC2=C1COC1=CC(C)=CC=C1 ZIYHMRKCUMVBTD-UHFFFAOYSA-N 0.000 description 1
- NNQZNVFMQKBLHQ-UHFFFAOYSA-N COC1=CC=C(F)C=C1C1=CC=C2NC(C)(C)C(=O)NC2=C1COC1=CC(F)=CC=C1 Chemical compound COC1=CC=C(F)C=C1C1=CC=C2NC(C)(C)C(=O)NC2=C1COC1=CC(F)=CC=C1 NNQZNVFMQKBLHQ-UHFFFAOYSA-N 0.000 description 1
- BKENSSDTYHZWBJ-UHFFFAOYSA-N COC1=CC=C(F)C=C1C1=CC=C2NC(C)(C)C(=O)NC2=C1COC1=CC=C(C)C=C1 Chemical compound COC1=CC=C(F)C=C1C1=CC=C2NC(C)(C)C(=O)NC2=C1COC1=CC=C(C)C=C1 BKENSSDTYHZWBJ-UHFFFAOYSA-N 0.000 description 1
- JRYSGLWCZVFRCL-UHFFFAOYSA-N COC1=CC=C(F)C=C1C1=CC=C2NC(C)(C)C(=O)NC2=C1COC1=CC=CC=C1 Chemical compound COC1=CC=C(F)C=C1C1=CC=C2NC(C)(C)C(=O)NC2=C1COC1=CC=CC=C1 JRYSGLWCZVFRCL-UHFFFAOYSA-N 0.000 description 1
- GWQJPMGTLGAOBA-UHFFFAOYSA-N COC1=CC=C(O)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 Chemical compound COC1=CC=C(O)C=C1C1=CC=C2NC(C)(C)C(=O)N(C)C2=C1COC1=C(C)C=CC(F)=C1 GWQJPMGTLGAOBA-UHFFFAOYSA-N 0.000 description 1
- IXDWYPZUEONKAO-UHFFFAOYSA-N COC1=CC=C(OC)C(C2=CC=C3NC(C)(C)C(=O)N(C)C3=C2COC2=C(C)C=CC(F)=C2)=C1 Chemical compound COC1=CC=C(OC)C(C2=CC=C3NC(C)(C)C(=O)N(C)C3=C2COC2=C(C)C=CC(F)=C2)=C1 IXDWYPZUEONKAO-UHFFFAOYSA-N 0.000 description 1
- WSNRUJZHXYALAJ-UHFFFAOYSA-N COC1=CC=C([N+](=O)[O-])C=C1C1=CC=C2NC(C)(C)C(=O)N3CN(C4=C(OC)C=CC=C4)CC1=C23 Chemical compound COC1=CC=C([N+](=O)[O-])C=C1C1=CC=C2NC(C)(C)C(=O)N3CN(C4=C(OC)C=CC=C4)CC1=C23 WSNRUJZHXYALAJ-UHFFFAOYSA-N 0.000 description 1
- GSQXFFZBRMDSGY-UHFFFAOYSA-N COC1=CC=CC(C(=O)OC2=CC=C(C3=CC=C4NC(C)(C)C(=O)N(C)C4=C3COC3=C(C)C=CC(F)=C3)C(OC)=C2)=C1 Chemical compound COC1=CC=CC(C(=O)OC2=CC=C(C3=CC=C4NC(C)(C)C(=O)N(C)C4=C3COC3=C(C)C=CC(F)=C3)C(OC)=C2)=C1 GSQXFFZBRMDSGY-UHFFFAOYSA-N 0.000 description 1
- UVLCCOBFUUANNQ-UHFFFAOYSA-N COCOC1=CC=C(C2=CC=C3NC(C)(C)C(=O)N(C)C3=C2COC(=O)C2=CC=C(C)S2)C(OC)=C1 Chemical compound COCOC1=CC=C(C2=CC=C3NC(C)(C)C(=O)N(C)C3=C2COC(=O)C2=CC=C(C)S2)C(OC)=C1 UVLCCOBFUUANNQ-UHFFFAOYSA-N 0.000 description 1
- IQGYAOZUYVDCKT-UHFFFAOYSA-N COCOC1=CC=C(C2=CC=C3NC(C)(C)C(=O)N(C)C3=C2C[N-](C(=O)OCC2C3=C(C=CC=C3)C3=C2C=CC=C3)C2=C(C)C=CC(F)=C2)C(OC)=C1 Chemical compound COCOC1=CC=C(C2=CC=C3NC(C)(C)C(=O)N(C)C3=C2C[N-](C(=O)OCC2C3=C(C=CC=C3)C3=C2C=CC=C3)C2=C(C)C=CC(F)=C2)C(OC)=C1 IQGYAOZUYVDCKT-UHFFFAOYSA-N 0.000 description 1
- JIKOZMXGBZYFFA-UHFFFAOYSA-N COCOC1=CC=C(C2=CC=C3NC(C)(C)C(=O)N(C)C3=C2C[N-](C(=O)OCC2C3=C(C=CC=C3)C3=C2C=CC=C3)C2=C(OC)C=CC=C2)C(OC)=C1 Chemical compound COCOC1=CC=C(C2=CC=C3NC(C)(C)C(=O)N(C)C3=C2C[N-](C(=O)OCC2C3=C(C=CC=C3)C3=C2C=CC=C3)C2=C(OC)C=CC=C2)C(OC)=C1 JIKOZMXGBZYFFA-UHFFFAOYSA-N 0.000 description 1
- HOHZNKCKXWXCFO-UHFFFAOYSA-N COCOC1=CC=C(C2=CC=C3NC(C)(C)C(=O)N4CN(C5=C(C)C=CC(F)=C5)CC2=C34)C(OC)=C1 Chemical compound COCOC1=CC=C(C2=CC=C3NC(C)(C)C(=O)N4CN(C5=C(C)C=CC(F)=C5)CC2=C34)C(OC)=C1 HOHZNKCKXWXCFO-UHFFFAOYSA-N 0.000 description 1
- ZGZGMVXZGKFDNU-UHFFFAOYSA-N COCOC1=CC=C(C2=CC=C3NC(C)(C)C(=O)N4CN(C5=C(OC)C=CC=C5)CC2=C34)C(OC)=C1 Chemical compound COCOC1=CC=C(C2=CC=C3NC(C)(C)C(=O)N4CN(C5=C(OC)C=CC=C5)CC2=C34)C(OC)=C1 ZGZGMVXZGKFDNU-UHFFFAOYSA-N 0.000 description 1
- LNCMUSCPSJHXCS-UHFFFAOYSA-N COCOC1=CC=C(C2=CC=C3NC(C)(C)C(=O)NC3=C2C(=O)OC)C(OC)=C1 Chemical compound COCOC1=CC=C(C2=CC=C3NC(C)(C)C(=O)NC3=C2C(=O)OC)C(OC)=C1 LNCMUSCPSJHXCS-UHFFFAOYSA-N 0.000 description 1
- AMWAWSIHEUAKDD-UHFFFAOYSA-N COCOC1=CC=C(C2=CC=C3NC(C)(C)C(=O)NC3=C2CCl)C(OC)=C1 Chemical compound COCOC1=CC=C(C2=CC=C3NC(C)(C)C(=O)NC3=C2CCl)C(OC)=C1 AMWAWSIHEUAKDD-UHFFFAOYSA-N 0.000 description 1
- DZMKSHHTAXYRFQ-UHFFFAOYSA-N COCOC1=CC=C(C2=CC=C3NC(C)(C)C(=O)NC3=C2CO)C(OC)=C1 Chemical compound COCOC1=CC=C(C2=CC=C3NC(C)(C)C(=O)NC3=C2CO)C(OC)=C1 DZMKSHHTAXYRFQ-UHFFFAOYSA-N 0.000 description 1
- FVBJWNPPGUPTOW-UHFFFAOYSA-N COCOC1=CC=C(C2=CC=C3NC(C)(C)C(=O)NC3=C2COC(=O)C2=CC=C(C)S2)C(OC)=C1 Chemical compound COCOC1=CC=C(C2=CC=C3NC(C)(C)C(=O)NC3=C2COC(=O)C2=CC=C(C)S2)C(OC)=C1 FVBJWNPPGUPTOW-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- XJUZRXYOEPSWMB-UHFFFAOYSA-N Chloromethyl methyl ether Chemical compound COCCl XJUZRXYOEPSWMB-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- OMFXVFTZEKFJBZ-UHFFFAOYSA-N Corticosterone Natural products O=C1CCC2(C)C3C(O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 OMFXVFTZEKFJBZ-UHFFFAOYSA-N 0.000 description 1
- PMPVIKIVABFJJI-UHFFFAOYSA-N Cyclobutane Chemical compound C1CCC1 PMPVIKIVABFJJI-UHFFFAOYSA-N 0.000 description 1
- NMEZJSDUZQOPFE-UHFFFAOYSA-N Cyclohex-1-enecarboxylic acid Chemical compound OC(=O)C1=CCCCC1 NMEZJSDUZQOPFE-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- LVZWSLJZHVFIQJ-UHFFFAOYSA-N Cyclopropane Chemical compound C1CC1 LVZWSLJZHVFIQJ-UHFFFAOYSA-N 0.000 description 1
- HTJDQJBWANPRPF-UHFFFAOYSA-N Cyclopropylamine Chemical compound NC1CC1 HTJDQJBWANPRPF-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- BUDQDWGNQVEFAC-UHFFFAOYSA-N Dihydropyran Chemical compound C1COC=CC1 BUDQDWGNQVEFAC-UHFFFAOYSA-N 0.000 description 1
- NTURVSFTOYPGON-UHFFFAOYSA-N Dihydroquinazoline Chemical compound C1=CC=C2C=NCNC2=C1 NTURVSFTOYPGON-UHFFFAOYSA-N 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical compound OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 239000007821 HATU Substances 0.000 description 1
- 101000926939 Homo sapiens Glucocorticoid receptor Proteins 0.000 description 1
- 101001071608 Homo sapiens Glutathione reductase, mitochondrial Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- OJGMBLNIHDZDGS-UHFFFAOYSA-N N-Ethylaniline Chemical compound CCNC1=CC=CC=C1 OJGMBLNIHDZDGS-UHFFFAOYSA-N 0.000 description 1
- AFBPFSWMIHJQDM-UHFFFAOYSA-N N-methylaniline Chemical compound CNC1=CC=CC=C1 AFBPFSWMIHJQDM-UHFFFAOYSA-N 0.000 description 1
- OPFJDXRVMFKJJO-ZHHKINOHSA-N N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl}-G-dR-G-dD-dD-dD-NH2 Chemical compound S1C(C=2NN=C(C=2)C(=O)NCC(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(N)=O)=C(C)N=C1NC(=O)C1=CC=CC=C1 OPFJDXRVMFKJJO-ZHHKINOHSA-N 0.000 description 1
- 229910004619 Na2MoO4 Inorganic materials 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 1
- WYNCHZVNFNFDNH-UHFFFAOYSA-N Oxazolidine Chemical compound C1COCN1 WYNCHZVNFNFDNH-UHFFFAOYSA-N 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- YPWFISCTZQNZAU-UHFFFAOYSA-N Thiane Chemical group C1CCSCC1 YPWFISCTZQNZAU-UHFFFAOYSA-N 0.000 description 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 1
- AJCQJELUJDPGEY-UHFFFAOYSA-N [2-methoxy-4-(trifluoromethoxy)phenyl]boronic acid Chemical compound COC1=CC(OC(F)(F)F)=CC=C1B(O)O AJCQJELUJDPGEY-UHFFFAOYSA-N 0.000 description 1
- UBOHQMVXDJJMFD-UHFFFAOYSA-N [C-]#[N+]C1=CC=C(B2OC(C)(C)C(C)(C)O2)C(OC)=C1 Chemical compound [C-]#[N+]C1=CC=C(B2OC(C)(C)C(C)(C)O2)C(OC)=C1 UBOHQMVXDJJMFD-UHFFFAOYSA-N 0.000 description 1
- QTDJYNYIUPHKAP-UHFFFAOYSA-N [C-]#[N+]C1=CC=C(C2=CC=C3NC(C)(C)C(=O)N(C)C3=C2COC2=C(C)C=CC(F)=C2)C(OC)=C1 Chemical compound [C-]#[N+]C1=CC=C(C2=CC=C3NC(C)(C)C(=O)N(C)C3=C2COC2=C(C)C=CC(F)=C2)C(OC)=C1 QTDJYNYIUPHKAP-UHFFFAOYSA-N 0.000 description 1
- UHSJMUNGTKGLOQ-UHFFFAOYSA-N [C-]#[N+]C1=CC=C(OS(=O)(=O)C(F)(F)F)C(OC)=C1 Chemical compound [C-]#[N+]C1=CC=C(OS(=O)(=O)C(F)(F)F)C(OC)=C1 UHSJMUNGTKGLOQ-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 125000006323 alkenyl amino group Chemical group 0.000 description 1
- 125000005195 alkyl amino carbonyloxy group Chemical group 0.000 description 1
- 125000005278 alkyl sulfonyloxy group Chemical group 0.000 description 1
- 125000006319 alkynyl amino group Chemical group 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical compound [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 229910000091 aluminium hydride Inorganic materials 0.000 description 1
- 125000005428 anthryl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C3C(*)=C([H])C([H])=C([H])C3=C([H])C2=C1[H] 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 239000012300 argon atmosphere Substances 0.000 description 1
- 125000002029 aromatic hydrocarbon group Chemical group 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- ZSIQJIWKELUFRJ-UHFFFAOYSA-N azepane Chemical compound C1CCCNCC1 ZSIQJIWKELUFRJ-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- RFRXIWQYSOIBDI-UHFFFAOYSA-N benzarone Chemical compound CCC=1OC2=CC=CC=C2C=1C(=O)C1=CC=C(O)C=C1 RFRXIWQYSOIBDI-UHFFFAOYSA-N 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- MXMZCLLIUQEKSN-UHFFFAOYSA-N benzimidazoline Chemical compound C1=CC=C2NCNC2=C1 MXMZCLLIUQEKSN-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 1
- 239000012964 benzotriazole Substances 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N beta-methyl-butyric acid Natural products CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 229910000085 borane Inorganic materials 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000004369 butenyl group Chemical group C(=CCC)* 0.000 description 1
- 125000000480 butynyl group Chemical group [*]C#CC([H])([H])C([H])([H])[H] 0.000 description 1
- DVECBJCOGJRVPX-UHFFFAOYSA-N butyryl chloride Chemical compound CCCC(Cl)=O DVECBJCOGJRVPX-UHFFFAOYSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical class [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 1
- 239000001354 calcium citrate Chemical class 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 125000005708 carbonyloxy group Chemical group [*:2]OC([*:1])=O 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 230000009084 cardiovascular function Effects 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- JYFJNCCRKBBRKZ-UHFFFAOYSA-N chembl194764 Chemical compound C=1C=CC=C(F)C=1CCN1C(=O)C(CC)=C(C)N=C1C1=CC=CC=C1O JYFJNCCRKBBRKZ-UHFFFAOYSA-N 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 229960004926 chlorobutanol Drugs 0.000 description 1
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
- VZWXIQHBIQLMPN-UHFFFAOYSA-N chromane Chemical compound C1=CC=C2CCCOC2=C1 VZWXIQHBIQLMPN-UHFFFAOYSA-N 0.000 description 1
- QZHPTGXQGDFGEN-UHFFFAOYSA-N chromene Chemical compound C1=CC=C2C=C[CH]OC2=C1 QZHPTGXQGDFGEN-UHFFFAOYSA-N 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- WCZVZNOTHYJIEI-UHFFFAOYSA-N cinnoline Chemical compound N1=NC=CC2=CC=CC=C21 WCZVZNOTHYJIEI-UHFFFAOYSA-N 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 229940126086 compound 21 Drugs 0.000 description 1
- 229940125898 compound 5 Drugs 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- OMFXVFTZEKFJBZ-HJTSIMOOSA-N corticosterone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@H](CC4)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OMFXVFTZEKFJBZ-HJTSIMOOSA-N 0.000 description 1
- LDHQCZJRKDOVOX-NSCUHMNNSA-N crotonic acid Chemical compound C\C=C\C(O)=O LDHQCZJRKDOVOX-NSCUHMNNSA-N 0.000 description 1
- KZZKOVLJUKWSKX-UHFFFAOYSA-N cyclobutanamine Chemical compound NC1CCC1 KZZKOVLJUKWSKX-UHFFFAOYSA-N 0.000 description 1
- TXWOGHSRPAYOML-UHFFFAOYSA-N cyclobutanecarboxylic acid Chemical compound OC(=O)C1CCC1 TXWOGHSRPAYOML-UHFFFAOYSA-N 0.000 description 1
- KTHXBEHDVMTNOH-UHFFFAOYSA-N cyclobutanol Chemical compound OC1CCC1 KTHXBEHDVMTNOH-UHFFFAOYSA-N 0.000 description 1
- 125000006637 cyclobutyl carbonyl group Chemical group 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- VZFUCHSFHOYXIS-UHFFFAOYSA-N cycloheptane carboxylic acid Natural products OC(=O)C1CCCCCC1 VZFUCHSFHOYXIS-UHFFFAOYSA-N 0.000 description 1
- 125000006640 cycloheptyl carbonyl group Chemical group 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 1
- PQANGXXSEABURG-UHFFFAOYSA-N cyclohexenol Natural products OC1CCCC=C1 PQANGXXSEABURG-UHFFFAOYSA-N 0.000 description 1
- 125000006639 cyclohexyl carbonyl group Chemical group 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000006641 cyclooctyl carbonyl group Chemical group 0.000 description 1
- 125000004410 cyclooctyloxy group Chemical group C1(CCCCCCC1)O* 0.000 description 1
- NISGSNTVMOOSJQ-UHFFFAOYSA-N cyclopentanamine Chemical compound NC1CCCC1 NISGSNTVMOOSJQ-UHFFFAOYSA-N 0.000 description 1
- XCIXKGXIYUWCLL-UHFFFAOYSA-N cyclopentanol Chemical compound OC1CCCC1 XCIXKGXIYUWCLL-UHFFFAOYSA-N 0.000 description 1
- NWZXFAYYQNFDCA-UHFFFAOYSA-N cyclopenten-1-ol Chemical compound OC1=CCCC1 NWZXFAYYQNFDCA-UHFFFAOYSA-N 0.000 description 1
- PYRZPBDTPRQYKG-UHFFFAOYSA-N cyclopentene-1-carboxylic acid Chemical compound OC(=O)C1=CCCC1 PYRZPBDTPRQYKG-UHFFFAOYSA-N 0.000 description 1
- 125000006638 cyclopentyl carbonyl group Chemical group 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- YMGUBTXCNDTFJI-UHFFFAOYSA-N cyclopropanecarboxylic acid Chemical compound OC(=O)C1CC1 YMGUBTXCNDTFJI-UHFFFAOYSA-N 0.000 description 1
- YOXHCYXIAVIFCZ-UHFFFAOYSA-N cyclopropanol Chemical compound OC1CC1 YOXHCYXIAVIFCZ-UHFFFAOYSA-N 0.000 description 1
- 125000006255 cyclopropyl carbonyl group Chemical group [H]C1([H])C([H])([H])C1([H])C(*)=O 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- HTFFABIIOAKIBH-UHFFFAOYSA-N diazinane Chemical compound C1CCNNC1 HTFFABIIOAKIBH-UHFFFAOYSA-N 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- SIYLLGKDQZGJHK-UHFFFAOYSA-N dimethyl-(phenylmethyl)-[2-[2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy]ethyl]ammonium Chemical compound C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 SIYLLGKDQZGJHK-UHFFFAOYSA-N 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 229940043264 dodecyl sulfate Drugs 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- AFAXGSQYZLGZPG-UHFFFAOYSA-N ethanedisulfonic acid Chemical compound OS(=O)(=O)CCS(O)(=O)=O AFAXGSQYZLGZPG-UHFFFAOYSA-N 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- IOLQWGVDEFWYNP-UHFFFAOYSA-N ethyl 2-bromo-2-methylpropanoate Chemical compound CCOC(=O)C(C)(C)Br IOLQWGVDEFWYNP-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229940043351 ethyl-p-hydroxybenzoate Drugs 0.000 description 1
- 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 description 1
- 125000006260 ethylaminocarbonyl group Chemical group [H]N(C(*)=O)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004672 ethylcarbonyl group Chemical group [H]C([H])([H])C([H])([H])C(*)=O 0.000 description 1
- LIWAQLJGPBVORC-UHFFFAOYSA-N ethylmethylamine Chemical compound CCNC LIWAQLJGPBVORC-UHFFFAOYSA-N 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 125000006125 ethylsulfonyl group Chemical group 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 125000005290 ethynyloxy group Chemical group C(#C)O* 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- ICGWWCLWBPLPDF-UHFFFAOYSA-N furan-2-ol Chemical compound OC1=CC=CO1 ICGWWCLWBPLPDF-UHFFFAOYSA-N 0.000 description 1
- LRBQNJMCXXYXIU-QWKBTXIPSA-N gallotannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@H]2[C@@H]([C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-QWKBTXIPSA-N 0.000 description 1
- 229940126013 glucocorticoid receptor antagonist Drugs 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 125000006038 hexenyl group Chemical group 0.000 description 1
- 125000005980 hexynyl group Chemical group 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 229940071870 hydroiodic acid Drugs 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- LPAGFVYQRIESJQ-UHFFFAOYSA-N indoline Chemical compound C1=CC=C2NCCC2=C1 LPAGFVYQRIESJQ-UHFFFAOYSA-N 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229940045996 isethionic acid Drugs 0.000 description 1
- 125000006328 iso-butylcarbonyl group Chemical group [H]C([H])([H])C([H])(C(*)=O)C([H])([H])[H] 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000005929 isobutyloxycarbonyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])OC(*)=O 0.000 description 1
- HEBMCVBCEDMUOF-UHFFFAOYSA-N isochromane Chemical compound C1=CC=C2COCCC2=C1 HEBMCVBCEDMUOF-UHFFFAOYSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 125000005921 isopentoxy group Chemical group 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000005932 isopentyloxycarbonyl group Chemical group 0.000 description 1
- 125000000555 isopropenyl group Chemical group [H]\C([H])=C(\*)C([H])([H])[H] 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000005928 isopropyloxycarbonyl group Chemical group [H]C([H])([H])C([H])(OC(*)=O)C([H])([H])[H] 0.000 description 1
- ZLTPDFXIESTBQG-UHFFFAOYSA-N isothiazole Chemical compound C=1C=NSC=1 ZLTPDFXIESTBQG-UHFFFAOYSA-N 0.000 description 1
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940099563 lactobionic acid Drugs 0.000 description 1
- 229940041476 lactose 100 mg Drugs 0.000 description 1
- QDLAGTHXVHQKRE-UHFFFAOYSA-N lichenxanthone Natural products COC1=CC(O)=C2C(=O)C3=C(C)C=C(OC)C=C3OC2=C1 QDLAGTHXVHQKRE-UHFFFAOYSA-N 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
- VSEYYEKRZNRECT-UHFFFAOYSA-N methyl 2-bromo-5-nitrobenzoate Chemical compound COC(=O)C1=CC([N+]([O-])=O)=CC=C1Br VSEYYEKRZNRECT-UHFFFAOYSA-N 0.000 description 1
- 229940102396 methyl bromide Drugs 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- JZMJDSHXVKJFKW-UHFFFAOYSA-M methyl sulfate(1-) Chemical compound COS([O-])(=O)=O JZMJDSHXVKJFKW-UHFFFAOYSA-M 0.000 description 1
- 125000004458 methylaminocarbonyl group Chemical group [H]N(C(*)=O)C([H])([H])[H] 0.000 description 1
- 125000004674 methylcarbonyl group Chemical group CC(=O)* 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- ACTNHJDHMQSOGL-UHFFFAOYSA-N n',n'-dibenzylethane-1,2-diamine Chemical compound C=1C=CC=CC=1CN(CCN)CC1=CC=CC=C1 ACTNHJDHMQSOGL-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000006126 n-butyl sulfonyl group Chemical group 0.000 description 1
- 125000003136 n-heptyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000006137 n-hexyl sulfonyl group Chemical group 0.000 description 1
- LKPFBGKZCCBZDK-UHFFFAOYSA-N n-hydroxypiperidine Chemical compound ON1CCCCC1 LKPFBGKZCCBZDK-UHFFFAOYSA-N 0.000 description 1
- CPGWSLFYXMRNDV-UHFFFAOYSA-N n-methyl-n-phenylcarbamoyl chloride Chemical compound ClC(=O)N(C)C1=CC=CC=C1 CPGWSLFYXMRNDV-UHFFFAOYSA-N 0.000 description 1
- SVEUVITYHIHZQE-UHFFFAOYSA-N n-methylpyridin-2-amine Chemical compound CNC1=CC=CC=N1 SVEUVITYHIHZQE-UHFFFAOYSA-N 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000006129 n-pentyl sulfonyl group Chemical group 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000006124 n-propyl sulfonyl group Chemical group 0.000 description 1
- 125000006252 n-propylcarbonyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C(*)=O 0.000 description 1
- PSZYNBSKGUBXEH-UHFFFAOYSA-N naphthalene-1-sulfonic acid Chemical compound C1=CC=C2C(S(=O)(=O)O)=CC=CC2=C1 PSZYNBSKGUBXEH-UHFFFAOYSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 125000005185 naphthylcarbonyl group Chemical group C1(=CC=CC2=CC=CC=C12)C(=O)* 0.000 description 1
- 125000005146 naphthylsulfonyl group Chemical group C1(=CC=CC2=CC=CC=C12)S(=O)(=O)* 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 102000006255 nuclear receptors Human genes 0.000 description 1
- 108020004017 nuclear receptors Proteins 0.000 description 1
- ZWLPBLYKEWSWPD-UHFFFAOYSA-N o-toluic acid Chemical compound CC1=CC=CC=C1C(O)=O ZWLPBLYKEWSWPD-UHFFFAOYSA-N 0.000 description 1
- 125000004365 octenyl group Chemical group C(=CCCCCCC)* 0.000 description 1
- 125000005069 octynyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C#C* 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229960002969 oleic acid Drugs 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- CELWCAITJAEQNL-UHFFFAOYSA-N oxan-2-ol Chemical compound OC1CCCCO1 CELWCAITJAEQNL-UHFFFAOYSA-N 0.000 description 1
- NWVVVBRKAWDGAB-UHFFFAOYSA-N p-methoxyphenol Chemical compound COC1=CC=C(O)C=C1 NWVVVBRKAWDGAB-UHFFFAOYSA-N 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- WLJNZVDCPSBLRP-UHFFFAOYSA-N pamoic acid Chemical compound C1=CC=C2C(CC=3C4=CC=CC=C4C=C(C=3O)C(=O)O)=C(O)C(C(O)=O)=CC2=C1 WLJNZVDCPSBLRP-UHFFFAOYSA-N 0.000 description 1
- 125000002255 pentenyl group Chemical group C(=CCCC)* 0.000 description 1
- 229940100684 pentylamine Drugs 0.000 description 1
- 125000005981 pentynyl group Chemical group 0.000 description 1
- 125000005327 perimidinyl group Chemical group N1C(=NC2=CC=CC3=CC=CC1=C23)* 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 125000005561 phenanthryl group Chemical group 0.000 description 1
- 229950000688 phenothiazine Drugs 0.000 description 1
- 125000001644 phenoxazinyl group Chemical group C1(=CC=CC=2OC3=CC=CC=C3NC12)* 0.000 description 1
- 125000006678 phenoxycarbonyl group Chemical group 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 description 1
- SFLGSKRGOWRGBR-UHFFFAOYSA-N phthalane Chemical compound C1=CC=C2COCC2=C1 SFLGSKRGOWRGBR-UHFFFAOYSA-N 0.000 description 1
- LFSXCDWNBUNEEM-UHFFFAOYSA-N phthalazine Chemical compound C1=NN=CC2=CC=CC=C21 LFSXCDWNBUNEEM-UHFFFAOYSA-N 0.000 description 1
- IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 description 1
- 125000005575 polycyclic aromatic hydrocarbon group Chemical group 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- WSHYKIAQCMIPTB-UHFFFAOYSA-M potassium;2-oxo-3-(3-oxo-1-phenylbutyl)chromen-4-olate Chemical compound [K+].[O-]C=1C2=CC=CC=C2OC(=O)C=1C(CC(=O)C)C1=CC=CC=C1 WSHYKIAQCMIPTB-UHFFFAOYSA-M 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 229960004618 prednisone Drugs 0.000 description 1
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- 229960004919 procaine Drugs 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- UKCYZZJQSYCZQQ-UHFFFAOYSA-N propan-2-yl-di(propan-2-yloxy)borane Chemical compound CC(C)OB(C(C)C)OC(C)C UKCYZZJQSYCZQQ-UHFFFAOYSA-N 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- 125000002568 propynyl group Chemical group [*]C#CC([H])([H])[H] 0.000 description 1
- 125000004309 pyranyl group Chemical group O1C(C=CC=C1)* 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical compound C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 description 1
- UBQKCCHYAOITMY-UHFFFAOYSA-N pyridin-2-ol Chemical compound OC1=CC=CC=N1 UBQKCCHYAOITMY-UHFFFAOYSA-N 0.000 description 1
- SBMSLRMNBSMKQC-UHFFFAOYSA-N pyrrolidin-1-amine Chemical compound NN1CCCC1 SBMSLRMNBSMKQC-UHFFFAOYSA-N 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- JWVCLYRUEFBMGU-UHFFFAOYSA-N quinazoline Chemical compound N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 229910052701 rubidium Inorganic materials 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000005930 sec-butyloxycarbonyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(OC(*)=O)C([H])([H])[H] 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 229960004249 sodium acetate Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229940037001 sodium edetate Drugs 0.000 description 1
- 235000015393 sodium molybdate Nutrition 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 235000011008 sodium phosphates Nutrition 0.000 description 1
- 239000012453 solvate Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 125000006253 t-butylcarbonyl group Chemical group [H]C([H])([H])C(C(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 238000003419 tautomerization reaction Methods 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 150000003527 tetrahydropyrans Chemical group 0.000 description 1
- RAOIDOHSFRTOEL-UHFFFAOYSA-N tetrahydrothiophene Chemical compound C1CCSC1 RAOIDOHSFRTOEL-UHFFFAOYSA-N 0.000 description 1
- 150000007970 thio esters Chemical class 0.000 description 1
- BRNULMACUQOKMR-UHFFFAOYSA-N thiomorpholine Chemical group C1CSCCN1 BRNULMACUQOKMR-UHFFFAOYSA-N 0.000 description 1
- GLQWRXYOTXRDNH-UHFFFAOYSA-N thiophen-2-amine Chemical compound NC1=CC=CS1 GLQWRXYOTXRDNH-UHFFFAOYSA-N 0.000 description 1
- WZMPOCLULGAHJR-UHFFFAOYSA-N thiophen-2-ol Chemical compound OC1=CC=CS1 WZMPOCLULGAHJR-UHFFFAOYSA-N 0.000 description 1
- 229930192474 thiophene Natural products 0.000 description 1
- QERYCTSHXKAMIS-UHFFFAOYSA-N thiophene-2-carboxylic acid Chemical compound OC(=O)C1=CC=CS1 QERYCTSHXKAMIS-UHFFFAOYSA-N 0.000 description 1
- HPGGPRDJHPYFRM-UHFFFAOYSA-J tin(iv) chloride Chemical compound Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 description 1
- 239000012929 tonicity agent Substances 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- LDHQCZJRKDOVOX-UHFFFAOYSA-N trans-crotonic acid Natural products CC=CC(O)=O LDHQCZJRKDOVOX-UHFFFAOYSA-N 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 150000003852 triazoles Chemical class 0.000 description 1
- 235000013337 tricalcium citrate Nutrition 0.000 description 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-N triflic acid Chemical compound OS(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-N 0.000 description 1
- GRGCWBWNLSTIEN-UHFFFAOYSA-N trifluoromethanesulfonyl chloride Chemical compound FC(F)(F)S(Cl)(=O)=O GRGCWBWNLSTIEN-UHFFFAOYSA-N 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 229960000281 trometamol Drugs 0.000 description 1
- 229940005605 valeric acid Drugs 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/46—Phenazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Definitions
- the present invention relates to a novel 1,2,3,4-tetrahydroquinoxaline derivative or a salt thereof, which is useful as a pharmaceutical.
- the derivative has a glucocorticoid receptor binding activity and is useful as a glucocorticoid receptor modulator having a nonsteroidal structure (a glucocorticoid receptor agonist and/or a glucocorticoid receptor antagonist).
- a glucocorticoid receptor is a 94 kDa ligand-activated intracellular transcriptional factor that is a member of the nuclear receptor superfamily. This receptor is a mediator of glucocorticoid action which effects the metabolism of carbohydrates, proteins, fats and the like, the suppression of the immune or inflammatory responses, the activation of the central nervous system, the regulation of the cardiovascular function and the basal and stress-related homeostasis and the like.
- glucocorticoid action-related diseases metabolic disorders such as diabetes and obesity, inflammatory diseases such as arthritis, enteritis and chronic obstructive pulmonary diseases, autoimmune diseases such as connective tissue diseases, allergic diseases such as asthma, atopic dermatitis, allergic rhinitis and conjunctivitis, central nervous system diseases such as psychiatric disorders, Alzheimer's disease and drug use disorders, cardiovascular diseases such as hypertension, hypercalcemia, hyperinsulinemia and hyperlipidemia, homeostasis-related diseases causing an abnormality of neuro-immune-endocrine balance, glaucoma and the like are known. (SOUGOU RINSYOU, 54(7), 1951-2076 (2005), JP-A-2002-193955.)
- a compound having a glucocorticoid receptor binding activity is considered to be useful as a preventive and/or therapeutic agent for these diseases.
- glucocorticoid receptor agonists synthesized in the living body such as cortisol and corticosterone, synthetic glucocorticoid receptor agonists such as dexamethasone, prednisone and prednisilone, non-selective glucocorticoid receptor antagonists such as RU486 and the like are known. (JP-A-2002-193955)
- compounds having a 1,2,3,4-tetrahydroquinoxaline structure are disclosed in WO 04/099192 and JP-A-5-148243 and the like.
- the compounds disclosed in WO 04/099192 are protein thyrosine phosphatase inhibitors essentially having a carboxylic group.
- a large number of compounds having 1,2,3,4-tetrahydroquinoxaline structure are disclosed as anti-virus agents in JP-A-5-148243.
- the present compound has not been specifically disclosed in any of patents.
- the present inventors conducted studies about the synthesis of 1,2,3,4-tetrahydroquinoxaline derivatives having a novel chemical structure, and succeeded in producing a large number of novel compounds. Further, the present inventors studied the pharmacological actions of the derivatives and as a result, they found that the derivatives have a glucocorticoid receptor binding activity and are useful as a pharmaceutical, and thus the present invention has been completed.
- the present invention relates to a compound represented by the following general formula (1) or a salt thereof (hereinafter referred to as “the present compound”) and a pharmaceutical composition containing the same.
- a preferred invention in its pharmaceutical use relates to a glucocorticoid receptor modulator, and its target diseases are glucocorticoid receptor-related diseases, that is, metabolic disorders such as diabetes and obesity, inflammatory diseases such as arthritis, enteritis and chronic obstructive pulmonary diseases, autoimmune diseases such as connective tissue diseases, allergic diseases such as asthma, atopic dermatitis, allergic rhinitis and conjunctivitis, central nervous system diseases such as psychiatric disorders, Alzheimer's disease and drug use disorders, cardiovascular diseases such as hypertension, hypercalcemia, hyperinsulinemia and hyperlipidemia, homeostasis-related diseases causing an abnormality of neuro-immune-endocrine balance, glaucoma and the like.
- a particularly preferred invention is an invention relating to a preventive or a
- R 1 represents a halogen atom, a lower alkyl group which may have at least a substituent, a lower cycloalkyl group which may have at least a substituent, an aryl group which may have at least a substituent, a heterocyclic group which may have at least a substituent, a hydroxy group, an ester of a hydroxy group, a lower alkoxy group which may have at least a substituent, a lower cycloalkyloxy group which may have at least a substituent, an aryloxy group which may have at least a substituent, a heterocyclic oxy group which may have at least a substituent, a mercapto group, an ester of a mercapto group, a lower alkylthio group which may have at least a substituent, a lower cycloalkylthio group which may have at least a substituent, an arylthio group which may have at least a substituent, a heterocyclic thi
- p represents an integer of 0 to 5;
- each R 1 may be the same or different;
- R 2 represents a halogen atom, a lower alkyl group which may have at least a substituent, a hydroxy group, an ester of a hydroxy group or a lower alkoxy group which may have at least a substituent;
- q represents an integer of 0 to 2;
- each R 2 may be the same or different;
- R 3 represents a hydrogen atom, a lower alkyl group which may have at least a substituent, a lower alkenyl group which may have at least a substituent, a lower alkylcarbonyl group which may have at least a substituent, a lower alkenylcarbonyl group which may have at least a substituent or an arylcarbonyl group which may have at least a substituent;
- R 4 and R 5 may be the same or different and represent a hydrogen atom, a halogen atom, a lower alkyl group which may have at least a substituent, a lower alkenyl group which may have at least a substituent, a lower alkynyl group which may have at least a substituent, a lower cycloalkyl group which may have at least a substituent, an aryl group which may have at least a substituent or a heterocyclic group which may have at least a substituent;
- R 4 and R 5 may be combined together to form a 3- to 8-membered lower cycloalkane ring which may have at least a substituent;
- R 6 represents a hydrogen atom, a lower alkyl group which may have at least a substituent, a lower alkenyl group which may have at least a substituent, a lower alkynyl group which may have at least a substituent, a lower cycloalkyl group which may have at least a substituent, an aryl group which may have at least a substituent or a heterocyclic group which may have at least a substituent;
- A represents a lower alkylene group which may have at least a substituent
- R 7 represents OR 8 , NR 8 R 9 , SR 8 , S(O)R 8 or S(O) 2 R 8 ;
- R 8 and R 9 may be the same or different and represent a hydrogen atom, a lower alkyl group which may have at least a substituent, a lower alkenyl group which may have at least a substituent, a lower alkynyl group which may have at least a substituent, a lower cycloalkyl group which may have at least a substituent, an aryl group which may have at least a substituent, a heterocyclic group which may have at least a substituent, a formyl group, a lower alkylcarbonyl group which may have at least a substituent, a lower alkenylcarbonyl group which may have at least a substituent, a lower alkynylcarbonyl group which may have at least a substituent, a lower cycloalkylcarbonyl group which may have at least a substituent, an arylcarbonyl group which may have at least a substituent, a heterocyclic carbonyl group which may have at least a substituent,
- R 7 is NR 8 R 9
- R 8 and R 9 may be combined together to form a 3- to 8-membered nitrogen-containing heterocyclic ring which may have at least a substituent
- the present invention provides a 1,2,3,4-tetrahydroquinoxaline derivative or a salt thereof, which is useful as a pharmaceutical.
- the present compound has an excellent glucocorticoid receptor binding activity and is useful as a glucocorticoid receptor modulator.
- the present compound is useful as a preventive or therapeutic agent for glucocorticoid action related diseases, that is, metabolic disorders such as diabetes and obesity, inflammatory diseases such as arthritis, enteritis and chronic obstructive pulmonary diseases, autoimmune diseases such as connective tissue diseases, allergic diseases such as asthma, atopic dermatitis, allergic rhinitis and conjunctivitis, central nervous system diseases such as psychiatric disorders, Alzheimer's disease and drug use disorders, cardiovascular diseases such as hypertension, hypercalcemia, hyperinsulinemia and hyperlipidemia, homeostasis-related diseases causing an abnormality of neuro-immune-endocrine balance, glaucoma and the like.
- metabolic disorders such as diabetes and obesity
- inflammatory diseases such as arthritis, enteritis and chronic obstructive pulmonary diseases
- autoimmune diseases such as connective tissue diseases
- allergic diseases such as asthma, atopic dermatitis, allergic rhinitis and conjunctivitis
- central nervous system diseases such as psychi
- halogen atom refers to a fluorine, chlorine, bromine or iodine atom.
- the “lower alkyl group” refers to a straight chain or branched alkyl group having 1 to 8 carbon atoms. Specific examples thereof include methyl, ethyl, n-propyl, n-butyl, n-pentyl, n-hexyl, n-heptyl, n-octyl, isopropyl, isobutyl, sec-butyl, tert-butyl and isopentyl groups and the like.
- lower alkenyl group refers to a straight chain or branched alkenyl group having 2 to 8 carbon atoms. Specific examples thereof include vinyl, propenyl, butenyl, pentenyl, hexenyl, heptenyl, octenyl, isopropenyl, 2-methyl-1-propenyl and 2-methyl-2-butenyl groups and the like.
- lower alkynyl group refers to a straight chain or branched alkynyl group having 2 to 8 carbon atoms. Specific examples thereof include ethynyl, propynyl, butynyl, pentynyl, hexynyl, heptynyl, octynyl, isobutynyl and isopentynyl groups and the like.
- the “lower cycloalkyl group” refers to a cycloalkyl group having 3 to 8 carbon atoms. Specific examples thereof include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl and cyclooctyl groups.
- the “lower cycloalkane ring” refers to a cycloalkane ring having 3 to 8 carbon atoms. Specific examples thereof include cyclopropane, cyclobutane, cyclopentane, cyclohexane, cycloheptane and cyclooctane rings.
- the “aryl group” refers to a residue formed by removing one hydrogen atom from a monocyclic aromatic hydrocarbon group, or bicyclic or tricyclic condensed polycyclic aromatic hydrocarbon having 6 to 14 carbon atoms. Further, A residue formed by removing one hydrogen atom from bicyclic or tricyclic condensed polycyclic hydrocarbon having 6 to 14 carbon atoms is also included in the scope of the “aryl group”. Specific examples thereof include phenyl, naphthyl, anthryl, phenanthryl and fluorenyl groups and the like.
- heterocyclic group refers to a residue formed by removing one hydrogen atom from a saturated or unsaturated monocyclic heterocyclic ring, or a bicyclic or tricyclic condensed polycyclic heterocyclic ring having one or a plurality of heteroatoms selected from a nitrogen atom, an oxygen atom and a sulfur atom in the ring.
- saturated monocyclic heterocyclic ring examples include pyrrolidine, pyrazolidine, imidazolidine, triazolidine, piperidine, hexahydropyridazine, hexahydropyrimidine, piperazine, homopiperidine and homopiperazine rings and the like having a nitrogen atom in the ring, tetrahydrofuran and tetrahydropyran rings and the like having an oxygen atom in the ring, tetrahydrothiophene and tetrahydrothiopyran rings and the like having a sulfur atom in the ring, oxazolidine, isoxazolidine and morpholine rings and the like having a nitrogen atom and an oxygen atom in the ring, and thiazolidine, isothiazolidine and thiomorpholine rings and the like having a nitrogen atom and a sulfur atom in the ring.
- such a saturated monocyclic heterocyclic ring can be condensed with a benzene ring or the like to form a bicyclic or tricyclic condensed polycyclic heterocyclic ring such as a dihydroindole, dihydroindazole, dihydrobenzimidazole, tetrahydroquinoline, tetrahydroisoquinoline, tetrahydrocinnoline, tetrahydrophthalazine, tetrahydroquinazoline, tetrahydroquinoxaline, dihydrobenzofuran, dihydroisobenzofuran, chromane, isochromane, dihydrobenzothiophene, dihydroisobenzothiophene, thiochromane, isothiochromane, dihydrobenzoxazole, dihydrobenzisoxazole, dihydrobenzoxazine, dihydrobenzothiazole, dihydrobenzimi
- the unsaturated monocyclic heterocyclic ring include dihydropyrrole, pyrrole, dihydropyrazole, pyrazole, dihydroimidazole, imidazole, dihydrotriazole, triazole, tetrahydropyridine, dihydropyridine, pyridine, tetrahydropyridazine, dihydropyridazine, pyridazine, tetrahydropyrimidine, dihydropyrimidine, pyrimidine, tetrahydropyrazine, dihydropyrazine and pyrazine rings and the like having a nitrogen atom in the ring, dihydrofuran, furan, dihydropyran and pyran rings and the like having an oxygen atom in the ring, dihydrothiophene, thiophene, dihydrothiopyran and thiopyran rings and the like having a sulfur atom in the ring, dihydrooxazo
- an unsaturated monocyclic heterocyclic ring can be condensed with a benzene ring or the like to form a bicyclic or tricyclic condensed polycyclic heterocyclic ring such as an indole, indazole, benzimidazole, benzotriazole, dihydroquinoline, quinoline, dihydroisoquinoline, isoquinoline, phenanthridine, dihydrocinnoline, cinnoline, dihydrophthalazine, phthalazine, dihydroquinazoline, quinazoline, dihydroquinoxaline, quinoxaline, benzofuran, isobenzofuran, chromene, isochromene, benzothiophene, isobenzothiophene, thiochromene, isothiochromene, benzoxazole, benzisoxazole, benzoxazine, benzothiazole, benzisothiazole, be
- the “lower alkoxy group” refers to a group formed by replacing the hydrogen atom of a hydroxy group with a lower alkyl group. Specific examples thereof include methoxy, ethoxy, n-propoxy, n-butoxy, n-pentoxy, n-hexyloxy, n-heptyloxy, n-octyloxy, isopropoxy, isobutoxy, sec-butoxy, tert-butoxy and isopentoxy groups and the like.
- lower alkenyloxy group refers to a group formed by replacing the hydrogen atom of a hydroxy group with a lower alkenyl group. Specific examples thereof include vinyloxy, propenyloxy, butenyloxy, pentenyloxy, hexenyloxy, heptenyloxy, octenyloxy, isopropenyloxy, 2-methyl-1-propenyloxy and 2-methyl-2-butenyloxy groups and the like.
- lower alkynyloxy group refers to a group formed by replacing the hydrogen atom of a hydroxy group with a lower alkynyl group. Specific examples thereof include ethynyloxy, propynyloxy, butynyloxy, pentynyloxy, hexynyloxy, heptynyloxy, octynyloxy, isobutynyloxy and isopentynyloxy groups and the like.
- lower cycloalkyloxy group refers to a group formed by replacing the hydrogen atom of a hydroxy group with a lower cycloalkyl group. Specific examples thereof include cyclopropyloxy, cyclobutyloxy, cyclopentyloxy, cyclohexyloxy, cycloheptyloxy and cyclooctyloxy groups.
- aryloxy group refers to a group formed by replacing the hydrogen atom of a hydroxy group with an aryl group. Specific examples thereof include phenoxy, naphthoxy, anthryloxy and phenanthryloxy groups and the like.
- heterocyclic oxy group refers to a group formed by replacing the hydrogen atom of a hydroxy group with a heterocyclic group.
- the “lower alkylthio group” refers to a group formed by replacing the hydrogen atom of a mercapto group with a lower alkyl group. Specific examples thereof include methylthio, ethylthio, n-propylthio, n-butylthio, n-pentylthio, n-hexylthio, n-heptylthio, n-octylthio, isopropylthio, isobutylthio, sec-butylthio, tert-butylthio and isopentylthio groups and the like.
- lower cycloalkylthio group refers to a group formed by replacing the hydrogen atom of a mercapto group with a lower cycloalkyl group. Specific examples thereof include cyclopropylthio, cyclobutylthio, cyclopentylthio, cyclohexylthio, cycloheptylthio and cyclooctylthio groups.
- arylthio group refers to a group formed by replacing the hydrogen atom of a mercapto group with an aryl group. Specific examples thereof include phenylthio, naphthylthio, anthrylthio and phenanthrylthio groups and the like.
- heterocyclic thio group refers to a group formed by replacing the hydrogen atom of a mercapto group with a heterocyclic group.
- lower alkylamino group refers to a group formed by replacing one or both of the hydrogen atoms of an amino group with a lower alkyl group. Specific examples thereof include methylamino, ethylamino, propylamino, dimethylamino, diethylamino and ethyl(methyl)amino groups and the like.
- lower cycloalkylamino group refers to a group formed by replacing one or both of the hydrogen atoms of an amino group with a lower cycloalkyl group, or a group formed by replacing one of the hydrogen atoms of an amino group with a lower cycloalkyl group and the other hydrogen atom with a lower alkyl group, a lower alkenyl group or a lower alkynyl group.
- cyclopropylamino cyclobutylamino, cyclopentylamino, cyclohexylamino, cycloheptylamino, cyclooctylamino, dicyclohexylamino, cyclohexyl(methyl)amino, cyclohexyl(vinyl)amino and cyclohexyl(ethynyl)amino groups and the like.
- arylamino group refers to a group formed by replacing one or both of the hydrogen atoms of an amino group with an aryl group, or a group formed by replacing one of the hydrogen atoms of an amino group with an aryl group and the other hydrogen atom with a lower alkyl group, a lower alkenyl group, a lower alkynyl group or a lower cycloalkyl group.
- phenylamino examples thereof include phenylamino, naphthylamino, anthrylamino, phenanthrylamino, diphenylamino, methyl(phenyl)amino, ethyl(phenyl)amino, phenyl(vinyl)amino, ethynyl(phenyl)amino and cyclohexyl(phenyl)amino groups and the like.
- heterocyclic amino group refers to a group formed by replacing one or both of the hydrogen atoms of an amino group with a heterocyclic group, or a group formed by replacing one of the hydrogen atoms of an amino group with a heterocyclic group and the other hydrogen atom with a lower alkyl group, a lower alkenyl group, a lower alkynyl group, a lower cycloalkyl group or an aryl group.
- the “lower alkylcarbonyl group” refers to a group formed by replacing the hydrogen atom of a formyl group with a lower alkyl group. Specific examples thereof include methylcarbonyl, ethylcarbonyl, n-propylcarbonyl, n-butylcarbonyl, n-pentylcarbonyl, n-hexylcarbonyl, n-heptylcarbonyl, n-octylcarbonyl, isopropylcarbonyl, isobutylcarbonyl, sec-butylcarbonyl, tert-butylcarbonyl and isopentylcarbonyl groups and the like.
- lower alkenylcarbonyl group refers to a group formed by replacing the hydrogen atom of a formyl group with a lower alkenyl group.
- Specific examples thereof include vinylcarbonyl, propenylcarbonyl, butenylcarbonyl, pentenylcarbonyl, hexenylcarbonyl, heptenylcarbonyl, octenylcarbonyl, isopropenylcarbonyl, 2-methyl-1-propenylcarbonyl and 2-methyl-2-butenylcarbonyl groups and the like.
- lower alkynylcarbonyl group refers to a group formed by replacing the hydrogen atom of a formyl group with a lower alkynyl group. Specific examples thereof include ethynylcarbonyl, propynylcarbonyl, butynylcarbonyl, pentynylcarbonyl, hexynylcarbonyl, heptynylcarbonyl, octynylcarbonyl, isobutynylcarbonyl and isopentynylcarbonyl groups and the like.
- lower cycloalkylcarbonyl group refers to a group formed by replacing the hydrogen atom of a formyl group with a lower cycloalkyl group. Specific examples thereof include cyclopropylcarbonyl, cyclobutylcarbonyl, cyclopentylcarbonyl, cyclohexylcarbonyl, cycloheptylcarbonyl and cyclooctylcarbonyl groups.
- arylcarbonyl group refers to a group formed by replacing the hydrogen atom of a formyl group with an aryl group. Specific examples thereof include phenylcarbonyl, naphthylcarbonyl, anthrylcarbonyl and phenanthrylcarbonyl groups and the like.
- heterocyclic carbonyl group refers to a group formed by replacing the hydrogen atom of a formyl group with a heterocyclic group.
- the “lower alkoxycarbonyl group” refers to a group formed by replacing the hydrogen atom of a formyl group with a lower alkoxy group. Specific examples thereof include methoxycarbonyl, ethoxycarbonyl, n-propoxycarbonyl, n-butoxycarbonyl, n-pentoxycarbonyl, n-hexyloxycarbonyl, n-heptyloxycarbonyl, n-octyloxycarbonyl, isopropoxycarbonyl, isobutoxycarbonyl, sec-butoxycarbonyl, tert-butoxycarbonyl and isopentoxycarbonyl groups and the like.
- lower alkenyloxycarbonyl group refers to a group formed by replacing the hydrogen atom of a formyl group with a lower alkenyloxy group. Specific examples thereof include vinyloxycarbonyl, propenyloxycarbonyl, butenyloxycarbonyl, pentenyloxycarbonyl, hexenyloxycarbonyl, heptenyloxycarbonyl, octenyloxycarbonyl, isopropenyloxycarbonyl, 2-methyl-1-propenyloxycarbonyl and 2-methyl-2-butenyloxycarbonyl groups and the like.
- lower alkynyloxycarbonyl group refers to a group formed by replacing the hydrogen atom of a formyl group with a lower alkynyloxy group. Specific examples thereof include ethynyloxycarbonyl, propynyloxycarbonyl, butynyloxycarbonyl, pentynyloxycarbonyl, hexynyloxycarbonyl, heptynyloxycarbonyl, octynyloxycarbonyl, isobutynyloxycarbonyl and isopentynyloxycarbonyl groups and the like.
- lower cycloalkyloxycarbonyl group refers to a group formed by replacing the hydrogen atom of a formyl group with a lower cycloalkyloxy group. Specific examples thereof include cyclopropyloxycarbonyl, cyclobutyloxycarbonyl, cyclopentyloxycarbonyl, cyclohexyloxycarbonyl, cycloheptyloxycarbonyl and cyclooctyloxycarbonyl groups.
- aryloxycarbonyl group refers to a group formed by replacing the hydrogen atom of a formyl group with an aryloxy group. Specific examples thereof include phenoxycarbonyl, naphthoxycarbonyl, anthryloxycarbonyl and phenanthryloxycarbonyl groups and the like.
- heterocyclic oxycarbonyl group refers to a group formed by replacing the hydrogen atom of a formyl group with a heterocyclic oxy group.
- lower alkylaminocarbonyl group refers to a group formed by replacing the hydrogen atom of a formyl group with a lower alkylamino group. Specific examples thereof include methylaminocarbonyl, ethylaminocarbonyl, propylaminocarbonyl, dimethylaminocarbonyl, diethylaminocarbonyl and ethylmethylaminocarbonyl groups and the like.
- the “lower alkenylaminocarbonyl group” refers to a group formed by replacing the hydrogen atom of a formyl group with a lower alkenylamino group. Specific examples thereof include vinylaminocarbonyl, propenylaminocarbonyl, butenylaminocarbonyl, pentenylaminocarbonyl, hexenylaminocarbonyl, heptenylaminocarbonyl, octenylaminocarbonyl, isopropenylaminocarbonyl, 2-methyl-1-propenylaminocarbonyl, 2-methyl-2-butenylaminocarbonyl, divinylaminocarbonyl and methyl(vinyl)aminocarbonyl groups and the like.
- the “lower alkynylaminocarbonyl group” refers to a group formed by replacing the hydrogen atom of a formyl group with a lower alkynylamino group. Specific examples thereof include ethynylaminocarbonyl, propynylaminocarbonyl, butynylaminocarbonyl, pentynylaminocarbonyl, hexynylaminocarbonyl, heptynylaminocarbonyl, octynylaminocarbonyl, isobutynylaminocarbonyl, isopentynylaminocarbonyl, diethynylaminocarbonyl, ethynyl(methyl)aminocarbonyl and ethynyl(vinyl)aminocarbonyl groups and the like.
- the “lower cycloalkylaminocarbonyl group” refers to a group formed by replacing the hydrogen atom of a formyl group with a lower cycloalkylamino group. Specific examples thereof include cyclopropylaminocarbonyl, cyclobutylaminocarbonyl, cyclopentylaminocarbonyl, cyclohexylaminocarbonyl, cycloheptylaminocarbonyl, cyclooctylaminocarbonyl, dicyclohexylaminocarbonyl, cyclohexyl(methyl)aminocarbonyl, cyclohexyl(vinyl)aminocarbonyl and cyclohexyl(ethynyl)aminocarbonyl groups and the like.
- arylaminocarbonyl group refers to a group formed by replacing the hydrogen atom of a formyl group with an arylamino group. Specific examples thereof include phenylaminocarbonyl, naphthylaminocarbonyl, anthrylaminocarbonyl, phenanthrylaminocarbonyl, diphenylaminocarbonyl, methylphenylaminocarbonyl ethylphenylaminocarbonyl, phenyl(vinyl)aminocarbonyl, ethynyl(phenyl)aminocarbonyl and cyclohexyl(phenyl)aminocarbonyl groups and the like.
- heterocyclic aminocarbonyl group refers to a group formed by replacing the hydrogen atom of a formyl group with a heterocyclic amino group.
- lower alkylsulfonyl group refers to a group formed by replacing the hydroxy group of a sulfonic acid group with a lower alkyl group. Specific examples thereof include methylsulfonyl, ethylsulfonyl, n-propylsulfonyl, n-butylsulfonyl, n-pentylsulfonyl, n-hexylsulfonyl, n-heptylsulfonyl, n-octylsulfonyl, isopropylsulfonyl, isobutylsulfonyl, sec-butylsulfonyl, tert-butylsulfonyl and isopentylsulfonyl groups and the like.
- lower alkenylsulfonyl group refers to a group formed by replacing the hydroxy group of a sulfonic acid group with a lower alkenyl group.
- Specific examples thereof include vinylsulfonyl, propenylsulfonyl, butenylsulfonyl, pentenylsulfonyl, hexenylsulfonyl, heptenylsulfonyl, octenylsulfonyl, isopropenylsulfonyl, 2-methyl-1-propenylsulfonyl and 2-methyl-2-butenylsulfonyl groups and the like.
- lower alkynylsulfonyl group refers to a group formed by replacing the hydroxy group of a sulfonic acid group with a lower alkynyl group. Specific examples thereof include ethynylsulfonyl, propynylsulfonyl, butynylsulfonyl, pentynylsulfonyl, hexynylsulfonyl, heptynylsulfonyl, octynylsulfonyl, isobutynylsulfonyl and isopentynylsulfonyl groups and the like.
- lower cycloalkylsulfonyl group refers to a group formed by replacing the hydroxy group of a sulfonic acid group with a lower cycloalkyl group. Specific examples thereof include cyclopropylsulfonyl, cyclobutylsulfonyl, cyclopentylsulfonyl, cyclohexylsulfonyl, cycloheptylsulfonyl and cyclooctylsulfonyl groups.
- arylsulfonyl group refers to a group formed by replacing the hydroxy group of a sulfonic acid group with an aryl group. Specific examples thereof include phenylsulfonyl, naphthylsulfonyl, anthrylsulfonyl and phenanthrylsulfonyl groups and the like.
- heterocyclic sulfonyl group refers to a group formed by replacing the hydroxy group of a sulfonic acid group with a heterocyclic group.
- the “3- to 8-membered nitrogen-containing heterocyclic ring” refers to a saturated monocyclic heterocyclic ring containing one or two nitrogen atoms in the ring. Specific examples thereof include aziridine, azetidine, pyrrolidine, piperidine, imidazolidine, pyrazolidine, piperazine and morpholine rings and the like.
- lower alkylene group refers to a straight chain or branched alkylene group having 1 to 8 carbon atoms. Specific examples thereof include methylene, ethylene, trimethylene, tetramethylene, pentamethylene, hexamethylene, heptamethylene, octamethylene, methylmethylene and ethylmethylene groups and the like.
- ester of a hydroxy group refers to an ester formed from a hydroxy group and a carboxylic acid and/or a group represented by —OCO—R.
- R represents a hydrogen atom, a lower alkyl group which may have at least a substituent, a lower alkenyl group which may have at least a substituent, a lower alkynyl group which may have at least a substituent, a lower cycloalkyl group which may have at least a substituent, an aryl group which may have at least a substituent, a heterocyclic group which may have at least a substituent, a lower alkoxy group which may have at least a substituent, a lower alkenyloxy group which may have at least a substituent, a lower alkynyloxy group which may have at least a substituent, a lower cycloalkyloxy group which may have at least a substituent, an aryloxy group which may have at least a substituent, a heterocyclic oxy group which may have at least a substituent, an amino group, a lower alkylamino group which may have at least a substituent, a lower cycloal
- ester of a mercapto group refers to a thioester formed from a mercapto group and a carboxylic acid and/or a group represented by —SCO—R.
- R is the same as the above.
- amide of an amino group refers to an amide formed from an amino group and a carboxylic acid and/or a group represented by —NHCO—R.
- R is the same as the above.
- amide of a lower alkylamino group refers to an amide formed from a lower alkylamino group and a carboxylic acid and/or a group represented by —NR′CO—R.
- R′ represents a lower alkyl group which may have at least a substituent, and R is the same as the above.
- amide of a lower cycloalkylamino group refers to an amide formed from a lower cycloalkylamino group and a carboxylic acid and/or a group represented by —NR′′CO—R.
- R′′ represents a lower cycloalkyl group which may have at least a substituent, and R is the same as the above.
- amide of an arylamino group refers to an amide formed from an arylamino group and a carboxylic acid and/or a group represented by —NR′′′CO—R.
- R′′′ represents an aryl group which may have at least a substituent, and R is the same as the above.
- amide of a heterocyclic amino group refers to an amide formed from a heterocyclic amino group and a carboxylic acid and/or a group represented by —NR′′′′CO—R.
- R′′′′ represents a heterocyclic group which may have at least a substituent, and R is the same for the above.
- the “carboxylic acid” refers to a saturated aliphatic carboxylic acid, an unsaturated aliphatic carboxylic acid, an aryl carboxylic acid, a heterocyclic carboxylic acid or the like represented by R a COOH (R a represents a hydrogen atom, a lower alkyl group which may have at least a substituent, a lower alkenyl group which may have at least a substituent, a lower alkynyl group which may have at least a substituent, a lower cycloalkyl group which may have at least a substituent, an aryl group which may have at least a substituent, a heterocyclic group which may have at least a substituent and the like).
- saturated aliphatic carboxylic acids such as formic acid, acetic acid, propionic acid, butyric acid, isobutyric acid, valeric acid, isovaleric acid, pivalic acid, cyclopropanecarboxylic acid, cyclobutanecarboxylic acid, cyclopentanecarboxylic acid and cyclohexanecarboxylic acid; unsaturated aliphatic carboxylic acids such as acrylic acid, propionic acid, crotonic acid, cinnamic acid, cyclopentenecarboxylic acid and cyclohexenecarboxylic acid; aryl carboxylic acids such as benzoic acid, phthalic acid, isophthalic acid, terephthalic acid, naphthoic acid and toluic acid; heterocyclic carboxylic acids such as furancarboxylic acid, thiophenecarboxylic acid, nicotinic acid and isonicotinic acid; and the saturated ali
- esters of a carboxy group refers to an ester formed from a carboxy group and an alcohol or a phenol.
- ester of a sulfonic acid group refers to an ester formed from a sulfonic acid group and an alcohol or a phenol.
- the “alcohol” refers to a saturated aliphatic hydroxy compound, an unsaturated aliphatic hydroxy compound, a heterocyclic hydroxyl compound or the like represented by R b OH (R b represents a lower alkyl group which may have at least a substituent, a lower alkenyl group which may have at least a substituent, a lower alkynyl group which may have at least a substituent, a lower cycloalkyl group which may have at least a substituent, a heterocyclic group which may have at least a substituent or the like).
- saturated aliphatic hydroxy compounds such as methanol, ethanol, propanol, butanol, isopropanol, cyclopropanol, cyclobutanol, cyclopentanol, cyclohexanol, benzylalcohol and phenethylalcohol
- unsaturated aliphatic hydroxy compounds such as vinyl alcohol, allylalcohol, propagylalcohol, cyclopentenol and cyclohexenol
- heterocyclic hydroxy compounds such as hydroxypiperidine and hydroxytetrahydropyran.
- the “phenol” refers to an aryl hydroxy compound, a heterocyclic hydroxyl compound or the like represented by R c OH (R c represents an aryl group which may have at least a substituent, a heterocyclic group which may have at least a substituent or the like). Specific examples thereof include aryl hydroxyl compounds such as phenol, naphthol, anthrol and phenanthrol; heterocyclic hydroxyl compounds such as hydroxypyridine, hydroxyfuran and hydroxythiophen.
- amide of a carboxy group refers to an acid amide formed from a carboxy group and an amine.
- amide of a sulfonic acid group refers to an acid amide formed from a sulfonic acid group and an amine.
- the “amine” refers to ammonia, a saturated aliphatic amine compound, an unsaturated aliphatic amine compound, an aryl amine compound, a heterocyclic amine compound, a saturated cyclic amine compound or the like represented by HNR d R e (R d and R e may be the same or different and represent a hydrogen atom, a lower alkyl group which may have at least a substituent, a lower alkenyl group which may have at least a substituent, a lower alkynyl group which may have at least a substituent, a lower cycloalkyl group which may have at least a substituent, an aryl group which may have at least a substituent, a heterocyclic group or the like, or R d and R e may be combined together to form a saturated cyclic amine).
- saturated aliphatic amine compounds such as methylamine, ethylamine, propylamine, pentylamine, dimethylamine, diethylamine, ethylmethylamine, cyclopropylamine, cyclobutylamine, cyclopentylamine, cyclohexylamine, benzylamine and phenetylamine; unsaturated aliphatic amine compounds such as allylamine and propagylamine; aryl amine compounds such as phenylamine, naphthylamine, anthrylamine, phenanthrylamine, diphenylamine, methylphenylamine and ethylphenylamine; heterocyclic amine compounds such as furylamine, thienylamine, pyrrolidylamine, pyridylamine, quinolylamine and methylpyridylamine; saturated cyclic amine compounds such as aziridine, azetidine, pyr
- lower alkyl group which may have at least a substituent “lower alkenyl group which may have at least a substituent”, “lower alkynyl group which may have at least a substituent”, “lower alkoxy group which may have at least a substituent”, “lower alkylthio group which may have at least a substituent”, “lower alkylamino group which may have at least a substituent”, “lower alkylcarbonyl group which may have at least a substituent”, “lower alkenylcarbonyl group which may have at least a substituent”, “lower alkynylcarbonyl group which may have at least a substituent”, “lower alkoxycarbonyl group which may have at least a substituent”, “lower alkenyloxycarbonyl group which may have at least a substituent”, “lower alkynyloxycarbonyl group which may have at least a substituent”, “lower alkylaminocarbonyl group which may have at least a substitu
- lower cycloalkyl group which may have at least a substituent “aryl group which may have at least a substituent”, “heterocyclic group which may have at least a substituent”, “lower cycloalkyloxy group which may have at least a substituent”, “aryloxy group which may have at least a substituent”, “heterocyclic oxy group which may have at least a substituent”, “lower cycloalkylthio group which may have at least a substituent”, “arylthio group which may have at least a substituent”, “heterocyclic thio group which may have at least a substituent”, “lower cycloalkylamino group which may have at least a substituent”, “arylamino group which may have at least a substituent”, “heterocyclic amino group which may have at least a substituent”, “lower cycloalkylcarbonyl group which may have at least a substituent”, “arylcarbonyl group which may have at least a
- a plurality of groups means that each group may be the same or different and the number of groups is preferably 2. Further, a hydrogen atom and a halogen atom are also included in the concept of the “group”.
- glucocorticoid receptor modulator refers to a modulator that exhibits a pharmaceutical action by binding to glucocorticoid receptor. Examples thereof include glucocorticoid receptor agonists, glucocorticoid receptor antagonists and the like.
- the “salt” of the present compound is not particularly limited as long as it is a pharmaceutically acceptable salt, and examples thereof include salts with an inorganic acid such as hydrochloric acid, hydrobromic acid, hydroiodic acid, nitric acid, sulfuric acid or phosphoric acid; salts with an organic acid such as acetic acid, fumalic acid, maleic acid, succinic acid, citric acid, tartaric acid, adipic acid, gluconic acid, glucoheptonic acid, glucuronic acid, terephthalic acid, methanesulfonic acid, lactic acid, hippuric acid, 1,2-ethanedisulfonic acid, isethionic acid, lactobionic acid, oleic acid, pamoic acid, polygalacturonic acid, stearic acid, tannic acid, trifluoromethanesulfonic acid, benzenesulfonic acid, p-toluenesulfonic acid, lauryl sul
- the present compound may be in the form of a hydrate or a solvate.
- the crystalline polymorphisms thereof are also included in the present invention.
- Preferred examples of the present compound include compounds in which the respective groups are groups as defined below and salts thereof in the compounds represented by the general formula (1) and salts thereof.
- R 1 represents a halogen atom, a lower alkyl group, a lower cycloalkyl group, an aryl group, a heterocyclic group, a hydroxy group, an ester of a hydroxy group, a lower alkoxy group, a lower cycloalkyloxy group, an aryloxy group, a heterocyclic oxy group, a mercapto group, an ester of a mercapto group, a lower alkylthio group, a lower cycloalkylthio group, an arylthio group, a heterocyclic thio group, an amino group, a lower alkylamino group, a lower cycloalkylamino group, an arylamino group, a heterocyclic amino group, an amide of an amino group, an amide of a lower alkylamino group, an amide of a lower cycloalkylamino group, an arylamino group, a heterocyclic amino group,
- R 1 is a lower alkyl group, a lower alkoxy group, a lower alkylthio group, a lower alkylamino group, an amide of a lower alkylamino group, a lower alkylcarbonyl group or a lower alkylsulfonyl group
- the lower alkyl group, lower alkoxy group, lower alkylthio group, lower alkylamino group, amide of a lower alkylamino group, lower alkylcarbonyl group or lower alkylsulfonyl group may have one or a plurality of groups selected from a halogen atom, a lower cycloalkyl group, an aryl group, a heterocyclic group, a hydroxy group, an ester of a hydroxy group, a lower alkoxy group, a lower alkoxy group substituted with a halogen atom, a lower cycloalkyloxy group, an aryloxy group, a heterocyclic
- R 1 is a lower cycloalkyl group, an aryl group, a heterocyclic group, a lower cycloalkyloxy group, an aryloxy group, a heterocyclic oxy group, a lower cycloalkylthio group, an arylthio group, a heterocyclic thio group, a lower cycloalkylamino group, an arylamino group, a heterocyclic amino group, an amide of a lower cycloalkylamino group, an amide of an arylamino group, an amide of a heterocyclic amino group, a lower cycloalkylcarbonyl group, an arylcarbonyl group, a heterocyclic carbonyl group, a lower cycloalkylsulfonyl group, an arylsulfonyl group or a heterocyclic sulfonyl group, the lower cycloalkyl group, aryl group, heterocyclic group
- (a2) p represents an integer of 0 to 3;
- each R 1 may be the same or different;
- R 2 represents a halogen atom, a lower alkyl group, a hydroxy group or a lower alkoxy group
- (a4) q represents an integer of 0 to 2;
- each R 2 may be the same or different;
- R 3 represents a hydrogen atom, a lower alkyl group, a lower alkenyl group, a lower alkylcarbonyl group, a lower alkenylcarbonyl group or an arylcarbonyl group;
- R 3 is a lower alkyl group or a lower alkylcarbonyl group
- the lower alkyl group or lower alkylcarbonyl group may have one or a plurality of groups selected from a halogen atom and an aryl group as substituents;
- the arylcarbonyl group may have one or a plurality of groups selected from a halogen atom, a lower alkyl group, a lower alkyl group substituted with a halogen atom, a lower alkoxy group and a lower alkoxy group substituted with a halogen atom as substituents; and/or
- R 4 and R 5 may be the same or different and represent a hydrogen atom, a halogen atom, a lower alkyl group, a lower cycloalkyl group, aryl or a heterocyclic group;
- the lower alkyl group may have one or a plurality of groups selected from a halogen atom, a lower cycloalkyl group, an aryl group, a heterocyclic group, a hydroxy group, an ester of a hydroxy group, a lower alkoxy group, a lower alkoxy group substituted with a halogen atom, a lower cycloalkyloxy group, an aryloxy group, a heterocyclic oxy group, a lower alkylthio group, a lower cycloalkylthio group, an arylthio group, a heterocyclic thio group, an amino group, a lower alkylamino group, a lower cycloalkylamino group, an arylamino group, a heterocyclic amino group, an amide of an amino group, an amide of a lower alkylamino group, an amide of a lower cycloalkylamino group, an arylamino group, a hetero
- R 4 or R 5 is a lower cycloalkyl group, aryl or a heterocyclic group
- the lower cycloalkyl group, aryl or heterocyclic group may have one or a plurality of groups selected from a halogen atom, a lower alkyl group, a lower alkyl group substituted with a halogen atom, a hydroxy group, an ester of a hydroxy group, a lower alkoxy group, a lower alkoxy group substituted with a halogen atom, a lower alkylthio group, an amino group, a lower alkylamino group, an amide of an amino group, an amide of a lower alkylamino group, a lower alkylcarbonyl group, a carboxy group, an ester of a carboxy group, an amide of a carboxy group, a lower alkylsulfonyl group, a sulfonic acid group, an ester of a sulf
- R 4 and R 5 may be combined together to form a 3- to 8-membered lower cycloalkane ring;
- R 6 represents a hydrogen atom, a lower alkyl group, a lower alkenyl group, a lower alkynyl group or a lower cycloalkyl group;
- R 6 is a lower alkyl group, a lower alkenyl group, a lower alkynyl group or a lower cycloalkyl group
- the lower alkyl group, lower alkenyl group, lower alkynyl group or lower cycloalkyl group may have one or a plurality of groups selected from a halogen atom and an aryl group as substituents; and/or
- A represents a lower alkylene group which may be substituted with a hydroxy group or a halogen atom;
- R 7 represents OR 8 , NR 8 R 9 or SR 8 ;
- R 8 and R 9 may be the same or different and represent a hydrogen atom, a lower alkyl group, a lower alkenyl group, a lower alkynyl group, a lower cycloalkyl group, an aryl group, a heterocyclic group, a formyl group, a lower alkylcarbonyl group, a lower alkenylcarbonyl group, a lower alkynylcarbonyl group, a lower cycloalkylcarbonyl group, an arylcarbonyl group, a heterocyclic carbonyl group, a carboxy group, a lower alkoxycarbonyl group, a lower alkenyloxycarbonyl group, a lower alkynyloxycarbonyl group, a lower cycloalkyloxycarbonyl group, an aryloxycarbonyl group, a heterocyclic oxycarbonyl group, a lower alkylsulfonyl group, a lower alkenylsulfonyl
- R 8 or R 9 is a lower alkyl group, a lower alkenyl group, a lower alkynyl group, a lower alkylcarbonyl group, a lower alkenylcarbonyl group, a lower alkynylcarbonyl group, a lower alkoxycarbonyl group, a lower alkenyloxycarbonyl group, a lower alkynyloxycarbonyl group, a lower alkylsulfonyl group, a lower alkenylsulfonyl group, a lower alkynylsulfonyl group, a lower alkylaminocarbonyl group, a lower alkenylaminocarbonyl group or a lower alkynylaminocarbonyl group, the lower alkyl group, lower alkenyl group, lower alkynyl group, lower alkylcarbonyl group, lower alkenylcarbonyl group, lower alkynylcarbonyl group, lower alkoxycarbonyl group
- R 8 or R 9 is a lower cycloalkyl group, an aryl group, a heterocyclic group, a lower cycloalkylcarbonyl group, an arylcarbonyl group, a heterocyclic carbonyl group, a lower cycloalkyloxycarbonyl group, an aryloxycarbonyl group, a heterocyclic oxycarbonyl group, a lower cycloalkylsulfonyl group, an arylsulfonyl group, a heterocyclic sulfonyl group, a lower cycloalkylaminocarbonyl group, an arylaminocarbonyl group or a heterocyclic aminocarbonyl group, the lower cycloalkyl group, aryl group, heterocyclic group, lower cycloalkylcarbonyl group, arylcarbonyl group, heterocyclic carbonyl group, lower cycloalkyloxycarbonyl group, aryloxycarbonyl group, aryl
- R 7 is NR 8 R 9
- R 8 and R 9 may be combined together to form a 5- or 6-membered nitrogen-containing heterocyclic ring;
- preferred examples include compounds that comprises one or a combination of two or more selected from the above (a1), (a2), (a3), (a4), (a5), (a6), (a7), (a8), (a9) and (a10), and salts thereof.
- More preferred examples of the present compound include compounds in which the respective groups are groups as defined below and salts thereof in the compounds represented by the general formula (1) and salts thereof.
- R 1 represents a halogen atom, a lower alkyl group, a hydroxy group, an ester of a hydroxy group, a lower alkoxy group, a lower alkylthio group, an amino group, a lower alkylamino group, an amide of an amino group, an amide of a lower alkylamino group, a lower alkylcarbonyl group, a carboxy group, an ester of a carboxy group, an amide of a carboxy group, a lower alkylsulfonyl group, a nitro group or a cyano group;
- R 1 is a lower alkyl group, a lower alkoxy group, a lower alkylthio group, a lower alkylamino group, an amide of a lower alkylamino group, a lower alkylcarbonyl group or a lower alkylsulfonyl group
- the lower alkyl group, lower alkoxy group, lower alkylthio group, lower alkylamino group, amide of a lower alkylamino group, lower alkylcarbonyl group or lower alkylsulfonyl group may have one or a plurality of groups selected from a halogen atom, a lower cycloalkyl group, an aryl group, a heterocyclic group, a hydroxy group, an ester of a hydroxy group, a lower alkoxy group, a lower alkoxy group substituted with a halogen atom, a lower cycloalkyloxy group, an aryloxy group, a heterocyclic
- (b2) p represents an integer of 0 to 3;
- each R 1 may be the same or different;
- R 3 represents a hydrogen atom, a lower alkyl group, a lower alkenyl group, a lower alkylcarbonyl group, a lower alkenylcarbonyl group or an arylcarbonyl group;
- R 3 is a lower alkyl group
- the lower alkyl group may have one or a plurality of aryl groups as substituents
- R 3 is an arylcarbonyl group
- the arylcarbonyl group may have one or a plurality of groups selected from a halogen atom and a lower alkyl group as substituents; and/or
- R 4 and R 5 may be the same or different and represent a hydrogen atom, a halogen atom, a lower alkyl group, a lower cycloalkyl group, aryl or a heterocyclic group;
- the lower alkyl group may have one or a plurality of groups selected from a halogen atom, a hydroxy group, an ester of a hydroxy group, a lower alkoxy group, a lower alkoxy group substituted with a halogen atom, a lower alkylthio group, an amino group, a lower alkylamino group, an amide of an amino group, an amide of a lower alkylamino group, a lower alkylcarbonyl group, a carboxy group, an ester of a carboxy group, an amide of a carboxy group, a nitro group and a cyano group as substituents;
- R 4 or R 5 is a lower cycloalkyl group, aryl or a heterocyclic group
- the lower cycloalkyl group, aryl or heterocyclic group may have one or a plurality of groups selected from a halogen atom, a lower alkyl group, a lower alkyl group substituted with a halogen atom, a hydroxy group, an ester of a hydroxy group, a lower alkoxy group, a lower alkoxy group substituted with a halogen atom, a lower alkylthio group, an amino group, a lower alkylamino group, an amide of an amino group, an amide of a lower alkylamino group, a lower alkylcarbonyl group, a carboxy group, an ester of a carboxy group, an amide of a carboxy group, a lower alkylsulfonyl group, a nitro group and a cyano group as substituents;
- R 4 and R 5 may be combined together to form a 3- to 8-membered lower cycloalkane ring;
- R 6 represents a hydrogen atom, a lower alkyl group, a lower alkenyl group, a lower alkynyl group or a lower cycloalkyl group;
- R 6 is a lower alkyl group, a lower alkenyl group, a lower alkynyl group or a lower cycloalkyl group
- the lower alkyl group, lower alkenyl group, lower alkynyl group or lower cycloalkyl group may have one or a plurality of groups selected from a halogen atom and an aryl group as substituents; and/or
- (b7) A represents a lower alkylene group
- R 7 represents OR 8 , NR 8 R 9 or SR 8 ;
- R 8 and R 9 may be the same or different and represent a hydrogen atom, a lower alkyl group, a lower alkenyl group, a lower alkynyl group, a lower cycloalkyl group, an aryl group, a heterocyclic group, a formyl group, a lower alkylcarbonyl group, a lower alkenylcarbonyl group, a lower alkynylcarbonyl group, a lower cycloalkylcarbonyl group, an arylcarbonyl group, a heterocyclic carbonyl group, a carboxy group, a lower alkoxycarbonyl group, a lower alkenyloxycarbonyl group, a lower alkynyloxycarbonyl group, a lower cycloalkyloxycarbonyl group, an aryloxycarbonyl group, a heterocyclic oxycarbonyl group, a lower alkylsulfonyl group, a lower alkenylsulfonyl
- R 8 or R 9 is a lower alkyl group, a lower alkenyl group, a lower alkynyl group, a lower alkylcarbonyl group, a lower alkenylcarbonyl group, a lower alkynylcarbonyl group, a lower alkoxycarbonyl group, a lower alkenyloxycarbonyl group, a lower alkynyloxycarbonyl group, a lower alkylsulfonyl group, a lower alkenylsulfonyl group, a lower alkynylsulfonyl group, a lower alkylaminocarbonyl group, a lower alkenylaminocarbonyl group or a lower alkynylaminocarbonyl group, the lower alkyl group, lower alkenyl group, lower alkynyl group, lower alkylcarbonyl group, lower alkenylcarbonyl group, lower alkynylcarbonyl group, lower alkoxycarbonyl group
- R 8 or R 9 is a lower cycloalkyl group, an aryl group, a heterocyclic group, a lower cycloalkylcarbonyl group, an arylcarbonyl group, a heterocyclic carbonyl group, a lower cycloalkyloxycarbonyl group, an aryloxycarbonyl group, a heterocyclic oxycarbonyl group, a lower cycloalkylsulfonyl group, an arylsulfonyl group, a heterocyclic sulfonyl group, a lower cycloalkylaminocarbonyl group, an arylaminocarbonyl group or a heterocyclic aminocarbonyl group, the lower cycloalkyl group, aryl group, heterocyclic group, lower cycloalkylcarbonyl group, arylcarbonyl group, heterocyclic carbonyl group, lower cycloalkyloxycarbonyl group, aryloxycarbonyl group, aryl
- R 7 is NR 8 R 9
- R 8 and R 9 may be combined together to form a 5- or 6-membered nitrogen-containing heterocyclic ring;
- more preferred examples include compounds that comprises one or a combination of two or more selected from the above (b1), (b2), (b3), (b4), (b5), (b6), (b7), (b8) and (b9), and salts thereof.
- R 1 represents a halogen atom, a lower alkyl group, a hydroxy group, an ester of a hydroxy group, a lower alkoxy group, a lower alkylthio group, an amino group, an amide of an amino group, an amide of a lower alkylamino group, a lower alkylcarbonyl group, a carboxy group, an ester of a carboxy group, a nitro group or a cyano group;
- R 1 is a lower alkyl group or a lower alkoxy group
- the lower alkyl group or lower alkoxy group may have one or a plurality of groups selected from a halogen atom, a hydroxy group and a lower alkoxy group as substituents; and/or
- (c2) p represents 1, 2 or 3;
- each R 1 may be the same or different;
- R 3 represents a hydrogen atom
- R 4 and R 5 may be the same or different and represent a lower alkyl group
- R 6 represents a hydrogen atom, a lower alkyl group or a lower alkenyl group
- (c7) A represents a lower alkylene group
- R 7 represents OR 8 or NR 8 R 9 ;
- R 8 and R 9 may be the same or different and represent a hydrogen atom, an aryl group, an arylcarbonyl group or a heterocyclic carbonyl group;
- R 8 or R 9 is an aryl group, an arylcarbonyl group or a heterocyclic carbonyl group
- the aryl group, arylcarbonyl group or heterocyclic carbonyl group may have one or a plurality of groups selected from a halogen atom, a lower alkyl group, a lower alkyl group substituted with at least a halogen atom, a lower alkyl group substituted with at least a hydroxy group, a lower alkenyl group, an aryl group, a lower alkoxy group, a lower alkylcarbonyl group, an ester of a carboxy group, a nitro group and a cyano group as substituents; and/or
- further more preferred examples include compounds that comprises one or a combination of two or more selected from the above (c1), (c2), (c3), (c4), (c5), (c6), (c7), (c8) and (c9), and salts thereof.
- R 1 represents a halogen atom, a hydroxy group, an ester of a hydroxy group, a lower alkoxy group, an amide of an amino group or an amide of a lower alkylamino group;
- each R 1 may be the same or different;
- R 3 represents a hydrogen atom
- R 4 and R 5 may be the same or different and represent a lower alkyl group
- R 6 represents a lower alkyl group
- (d7) A represents a lower alkylene group
- R 7 represents OR 8 or NR 8 R 9 ;
- R 8 represents an aryl group, an arylcarbonyl group or a heterocyclic carbonyl group, in this case, the aryl group, arylcarbonyl group or heterocyclic carbonyl group may have one or a plurality of groups selected from a halogen atom, a lower alkyl group, a lower alkyl group substituted with at least a halogen atom, a lower alkyl group substituted with at least a hydroxy group, a lower alkenyl group, an aryl group, a lower alkoxy group, a lower alkylcarbonyl group, an ester of a carboxy group, a nitro group and a cyano group as substituents;
- R 9 represents a hydrogen atom
- further more preferred examples include compounds that comprises one or a combination of two or more selected from the above (d1), (d2), (d3), (d4), (d5), (d6), (d7), (d8) and (d9), and salts thereof.
- R 1 in the present compound include compounds that satisfy the following requirement and salts thereof.
- R 1 represents a halogen atom, a hydroxy group, an ester of a hydroxy group, a lower alkoxy group, an amide of an amino group or an amide of a lower alkylamino group, and satisfies the requirement of the above (a), (b) and/or (c).
- R 4 , R 5 and R 6 in the present compound include compounds that satisfy the following requirement and salts thereof.
- R 4 , R 5 and R 6 each represent a methyl group, and satisfies the requirement of the above (a), (b), (c) and/or (d).
- R 8 in the present compound include compounds that satisfy the following requirement and salts thereof.
- R 8 represents an aryl group, an arylcarbonyl group or a heterocyclic carbonyl group, and the aryl group represents a phenyl group, the arylcarbonyl group represents a phenylcarbonyl group, and/or the heterocyclic carbonyl group represents a thiophenecarbonyl group, and satisfies the requirement of the above (a), (b), (c) and/or (d).
- Preferred examples of A in the present compound include compounds that satisfy the following requirement and salts thereof.
- a compound or a salt thereof wherein in the general formula (1), A represent a methylene group, and satisfies the requirement of the above (a), (b), (c) and/or (d).
- R 1 is an ester of a hydroxyl group in the present compound
- R 1 is an ester of a hydroxyl group in the present compound
- the ester of a hydroxy group represents —OCO—R a1 , in which the R a1 represents a hydrogen atom, a lower alkyl group which may have at least a substituent, a lower alkenyl group which may have at least a substituent, a lower alkynyl group which may have at least a substituent, a lower cycloalkyl group which may have at least a substituent, an aryl group which may have at least a substituent, a heterocyclic group which may have at least a substituent, a lower alkoxy group which may have at least a substituent, a lower alkenyloxy group which may have at least a substituent, a lower alkynyloxy group which may have at least a substituent, a lower cycloalkyloxy group which may have at least a substituent, an aryloxy group which may have at least a substituent, a heterocyclic oxy group which may have at at least a substituent, a
- the R a1 represents a hydrogen atom, a lower alkyl group, a lower alkenyl group, a lower cycloalkyl group, an aryl group, a heterocyclic group, a lower alkoxy group, a lower alkenyloxy group, a lower cycloalkyloxy group, an aryloxy group, a heterocyclic oxy group, an amino group, a lower alkylamino group, a lower cycloalkylamino group, an arylamino group or a heterocyclic amino group;
- R a1 is a lower alkyl group, a lower alkenyl group, a lower alkoxy group, a lower alkenyloxy group or a lower alkylamino group
- the lower alkyl group, lower alkenyl group, lower alkoxy group, lower alkenyloxy group or lower alkylamino group may have one or a plurality of groups selected from a halogen atom, an aryl group, a heterocyclic group, a hydroxy group, an ester of a hydroxy group, an amino group, a lower alkylamino group, a carboxy group and an ester of a carboxy group as substituents; and
- R a1 is a lower cycloalkyl group, an aryl group, a heterocyclic group, a lower cycloalkyloxy group, an aryloxy group, a heterocyclic oxy group, a lower cycloalkylamino group, an arylamino group or a heterocyclic amino group
- the lower cycloalkyl group, aryl group, heterocyclic group, lower cycloalkyloxy group, aryloxy group, heterocyclic oxy group, lower cycloalkylamino group, arylamino group or heterocyclic amino group may have one or a plurality of groups selected from a halogen atom, a lower alkyl group, a lower alkyl group substituted with at least a halogen atom, a hydroxy group, an ester of a hydroxy group, a lower alkoxy group, a mercapto group, a lower alkylthio group, a formyl group, a
- the R a1 represents a lower alkyl group, a lower alkenyl group, a lower cycloalkyl group, an aryl group, a heterocyclic group, a lower alkoxy group, an aryloxy group, a lower alkylamino group, a lower cycloalkylamino group, an arylamino group or a heterocyclic amino group;
- R a1 is a lower alkyl group
- the lower alkyl group may have one or a plurality of groups selected from an aryl group and a lower alkylamino group as substituents;
- the aryl group may have one or a plurality of groups selected from a halogen atom, a lower alkyl group, a lower alkyl group substituted with at least a halogen atom, an ester of a hydroxy group, a lower alkoxy group, a lower alkylthio group, a lower alkylcarbonyl group, an ester of a carboxy group and a nitro group as substituents;
- the heterocyclic group may have one or a plurality of groups selected from a halogen atom, a lower alkyl group, a hydroxy group and a lower alkoxy group as substituents;
- R a1 is a lower alkylamino group
- the lower alkylamino group may have one or a plurality of groups selected from an aryl group, a heterocyclic group and an ester of a carboxy group as substituents;
- the arylamino group may have one or a plurality of groups selected from a halogen atom, a lower alkyl group and a lower alkoxy group as substituents, and satisfies the requirement of the above (a), (b), (c) (d) and/or (e).
- R 1 is an amide of an amino group in the present compound
- R 1 is an amide of an amino group in the present compound
- the amide of an amino group represents —NHCO—R b , in which the R b1 represents a hydrogen atom, a lower alkyl group which may have at least a substituent, a lower alkenyl group which may have at least a substituent, a lower alkynyl group which may have at least a substituent, a lower cycloalkyl group which may have at least a substituent, an aryl group which may have at least a substituent, a heterocyclic group which may have at least a substituent, a lower alkoxy group which may have at least a substituent, a lower alkenyloxy group which may have at least a substituent, a lower alkynyloxy group which may have at least a substituent, a lower cycloalkyloxy group which may have at least a substituent, an aryloxy group which may have at least a substituent, a heterocyclic oxy group which may have at least a a
- R b1 is a lower alkyl group, a lower alkenyl group, a lower alkoxy group, a lower alkenyloxy group or a lower alkylamino group
- the lower alkyl group, lower alkenyl group, lower alkoxy group, lower alkenyloxy group or lower alkylamino group may have one or a plurality of groups selected from a halogen atom, an aryl group, a heterocyclic group, a hydroxy group, an ester of a hydroxy group, an amino group, a lower alkylamino group, a carboxy group and an ester of a carboxy group as substituents; and
- R b1 is a lower cycloalkyl group, an aryl group, a heterocyclic group, a lower cycloalkyloxy group, an aryloxy group, a heterocyclic oxy group, a lower cycloalkylamino group, an arylamino group or a heterocyclic amino group
- the lower cycloalkyl group, aryl group, heterocyclic group, lower cycloalkyloxy group, aryloxy group, heterocyclic oxy group, lower cycloalkylamino group, arylamino group or heterocyclic amino group may have one or a plurality of groups selected from a halogen atom, a lower alkyl group, a lower alkyl group substituted with at least a halogen atom, a hydroxy group, an ester of a hydroxy group, a lower alkoxy group, a mercapto group, a lower alkylthio group, a formyl group, a
- the R b1 represents a lower alkyl group, an aryl group, a heterocyclic group, an aryloxy group, a lower alkylamino group or an arylamino group;
- R b1 is a lower alkyl group
- the lower alkyl group may have one or a plurality of amino groups as substituents
- the aryl group may have one or a plurality of groups selected from a halogen atom, a lower alkyl group, a lower alkyl group substituted with at least a halogen atom, an ester of a hydroxy group, a lower alkoxy group, a lower alkylthio group, a lower alkylcarbonyl group, an ester of a carboxy group and a nitro group as substituents;
- the heterocyclic group may have one or a plurality of groups selected from a halogen atom, a lower alkyl group, a hydroxy group and a lower alkoxy group as substituents;
- the lower alkylamino group may have one or a plurality of aryl groups as substituents, and satisfies the requirement of the above (a), (b), (c) (d) and/or (e).
- R 1 is an amide of a lower alkylamino group in the present compound
- R 1 is an amide of a lower alkylamino group in the present compound
- the amide of a lower alkylamino group represents —NR c1 CO—R c2 , in which the R c1 represents a lower alkyl group which may have at least a substituent, and the R c2 represents a hydrogen atom, a lower alkyl group which may have at least a substituent, a lower alkenyl group which may have at least a substituent, a lower alkynyl group which may have at least a substituent, a lower cycloalkyl group which may have at least a substituent, an aryl group which may have at least a substituent, a heterocyclic group which may have at least a substituent, a lower alkoxy group which may have at least a substituent, a lower alkenyloxy group which may have at least a substituent, a lower alkynyloxy group which may have at least a substituent, a lower cycloalkyloxy group which may have at least a
- the R c1 represents a lower alkyl group
- the R c2 represents a hydrogen atom, a lower alkyl group, a lower alkenyl group, a lower cycloalkyl group, an aryl group, a heterocyclic group, a lower alkoxy group, a lower alkenyloxy group, a lower cycloalkyloxy group, an aryloxy group, a heterocyclic oxy group, an amino group, a lower alkylamino group, a lower cycloalkylamino group, an arylamino group or a heterocyclic amino group;
- R c2 is a lower alkyl group, a lower alkenyl group, a lower alkoxy group, a lower alkenyloxy group or a lower alkylamino group
- the lower alkyl group, lower alkenyl group, lower alkoxy group, lower alkenyloxy group or lower alkylamino group may have one or a plurality of groups selected from a halogen atom, an aryl group, a heterocyclic group, a hydroxy group, an ester of a hydroxy group, an amino group, a lower alkylamino group, a carboxy group and an ester of a carboxy group as substituents; and
- R c2 is a lower cycloalkyl group, an aryl group, a heterocyclic group, a lower cycloalkyloxy group, an aryloxy group, a heterocyclic oxy group, a lower cycloalkylamino group, an arylamino group or a heterocyclic amino group
- the lower cycloalkyl group, aryl group, heterocyclic group, lower cycloalkyloxy group, aryloxy group, heterocyclic oxy group, lower cycloalkylamino group, arylamino group or heterocyclic amino group may have one or a plurality of groups selected from a halogen atom, a lower alkyl group, a lower alkyl group substituted with at least a halogen atom, a hydroxy group, an ester of a hydroxy group, a lower alkoxy group, a mercapto group, a lower alkylthio group, a formyl group, a
- the R c represents a lower alkyl group
- the R c2 represents, a lower alkyl group, an aryl group or a heterocyclic group
- R c2 is a lower alkyl group
- the lower alkyl group may have one or a plurality of amino groups as substituents
- the aryl group may have one or a plurality of groups selected from a halogen atom, a lower alkyl group, a lower alkyl group substituted with at least a halogen atom, an ester of a hydroxy group, a lower alkoxy group, a lower alkylthio group, a lower alkylcarbonyl group, an ester of a carboxy group and a nitro group as substituents;
- the heterocyclic group may have one or a plurality of groups selected from a halogen atom, a lower alkyl group, a hydroxy group and a lower alkoxy group as substituents;
- the lower alkylamino group may have one or a plurality of aryl groups as substituents, and satisfies the requirement of the above (a), (b), (c) (d) and/or (e).
- Particularly preferred specific examples of the present compound include the following compounds and salts thereof.
- the present compound can be synthesized according to the following procedures.
- the individual concrete preparation procedures are explained in details in the following examples, [preparation examples]. These examples are intended to make the present invention more clearly understandable, and do not limit the scope of the present invention.
- the Hal shown in the following synthetic routes represents a halogen atom
- MOM represents methoxymethyl group
- Fmoc represents 9-fluorenylmethoxycarbonyl group.
- the present compound (I)-(a) (the compound that A is methylene group, X is O in the general formula (1)) can be synthesized according to the synthetic route 1. Namely, the compound (I)-(a) can be given by the reaction of the present compound (I)-(b) (the compound that A is methylene group, X is O, R 6 is H in the general formula (1)) with a corresponding halide (II) in an organic solvent such as N,N-dimethylformamide (hereinafter referred to as DMF), tetrahydrofuran (hereinafter referred to as THF), 1,4-dioxane, methylene dichloride in the presence of a base such as cesium carbonate, potassium carbonate at 0° C. to 50° C. for 1 hour to 24 hours.
- a base such as cesium carbonate, potassium carbonate at 0° C. to 50° C. for 1 hour to 24 hours.
- the present compound (I)-(b) (the compound that A is methylene group, X is O, R 6 is H, R 7 is OR 8 , NR 8 R 9 or SR 8 in the general formula (1)) can be synthesized according to the synthetic route 2.
- the compound (I)-(b) can be given by the reaction of the compound (III) with a corresponding alcohol, carboxylic acid, phenol, amine, thiol, thiophenol and the like (IV) in an organic solvent such as DMF, THF, ethanol in the presence of a base such as potassium carbonate, sodium hydride at 0° C. to 100° C. for 1 hour to 48 hours.
- the present compound (I)-(c) (the compound that A is methylene group, X is O, R 7 is OR 8 in the general formula (1)) can be synthesized according to the synthetic route 3. Namely, the compound (I)-(c) can be given by the reaction of the compound (V) with a corresponding halide (VI) in an organic solvent such as DMF, THF, methylene dichloride in the presence of a base such as triethylamine, potassium carbonate at 0° C. to 50° C. for 1 hour to 48 hours.
- an organic solvent such as DMF, THF, methylene dichloride
- a base such as triethylamine
- the compound (III) and (V) can be synthesized according to the synthetic route 4.
- the compound (IX) can be given by the reaction of the compound (VII) with a corresponding boronic acid or its ester (VIII) in a solvent such as DMF, 1,4-dioxane, ethanol, toluene, water and in the presence of a base such as cesium carbonate, sodium carbonate, sodium hydrogen carbonate, tripotassium phosphate and a catalyst such as bis(triphenylphosphine)palladium (II) dichloride, tetrakis(triphenylphosphine)palladium (0) at 50° C. to 120° C. for 1 hour to 48 hours.
- the compound (V) can be given by the treatment of the compound (IX) in an organic solvent such as diethylether, THF in the presence of a reductive agent such as lithium aluminium hydride at ⁇ 30° C. to room temperature for 1 hour to 24 hours.
- the compound (III) can be given by the treatment of the compound (V) with methanesulfonyl chloride in an organic solvent such as methylene dichloride, THF in the presence of a base such as triethylamine, diisopropylethylamine (hereinafter referred to as DIEA) at 0° C. to room temperature for 30 minutes to 12 hours.
- DIEA diisopropylethylamine
- the compound (VII) can be synthesized according to the synthetic route 5.
- the compound (XI) can be given by the treatment of the compound (X) in an organic solvent such as methanol, ethanol, DMF in the presence of a reductive agent such as tin(II) chloride, ferric(II) chloride at 50° C. to 120° C. for 1 hour to 12 hours.
- the compound (XII) can be given by the treatment of the compound (XI) with an acetylation agent such as acetyl chloride, acetic anhydride in an organic solvent such as methylene dichloride, THF in the presence of a base such as triethylamine, DIEA at 0° C. to 50° C.
- the compound (XIII) can be given by the treatment of the compound (XII) with nitric acid in a solvent such as water in the presence of an acid such as sulfuric acid at ⁇ 20° C. to room temperature for 30 minutes to 12 hours.
- the compound (XIV) can be given by the treatment of the compound (XIII) in an organic solvent such as methanol in the presence of an acid such as boron trifluoride ether complex at 50° C. to the temperature under reflux for 1 hour to 12 hours.
- the compound (XVI) can be given by the reaction of the compound (XIV) with a corresponding halide (XV) in the presence of a base such as cesium carbonate, potassium carbonate at 50° C. to 120° C. for 1 hour to 120 hours.
- a base such as cesium carbonate, potassium carbonate
- the compound (VII) can be given by the treatment of the compound (XVI) in an organic solvent such as methanol, ethanol, DMF in the presence of a reductive agent such as tin(II) chloride, ferric(II) chloride at 50° C. to 120° C. for 1 hour to 12 hours.
- the present compound (I)-(a) (the compound that A is methylene group, X is O in the general formula (1)) can be also synthesized according to the synthetic route 6. Namely, the compound (I)-(a) can be given by the reaction of the compound (XVII) with a corresponding boronic acid or its ester (VIII) in a solvent such as DMF, 1,4-dioxane, ethanol, toluene, water and in the presence of a base such as cesium carbonate, sodium carbonate, sodium hydrogen carbonate, tripotassium phosphate and a catalyst such as bis(triphenylphosphine)palladium (II) dichloride, tetrakis(triphenylphosphine)palladium (0) at 50° C. to 120° C. for 1 hour to 48 hours.
- a solvent such as DMF, 1,4-dioxane, ethanol, toluene
- a base such as cesium carbonate, sodium
- the present compound (I)-(a) (the compound that A is methylene group, X is O in the general formula (1)) can be also synthesized according to the synthetic route 7.
- the compound (I)-(a) can be given by the reaction of the compound (XVIII) with a corresponding halide (XIX) in a solvent such as DMF, 1,4-dioxane, ethanol, toluene, water and in the presence of a base such as cesium carbonate, sodium carbonate, sodium hydrogen carbonate, tripotassium phosphate and a catalyst such as bis(triphenylphosphine)palladium (II) dichloride, tetrakis(triphenylphosphine)palladium (0) at 50° C. to 120° C. for 1 hour to 48 hours.
- a solvent such as DMF, 1,4-dioxane, ethanol, toluene
- a base such as cesium carbonate, sodium carbonate, sodium hydrogen
- the compound (XVII) and (XVIII) can be synthesized according to the synthetic route 8. Namely, the compound (XX) can be given by the treatment of the compound (VII) in an organic solvent such as diethylether, THF in the presence of a reductive agent such as lithium aluminium hydride at 0° C. to 50° C. for 1 hour to 24 hours.
- the compound (XXI) can be given by the reaction of the compound (XX) with a corresponding halide (II) in an organic solvent such as DMF, THF, 1,4-dioxane, methylene dichloride in the presence of a base such as cesium carbonate, potassium carbonate at 0° C. to 50° C. for 1 hour to 24 hours.
- the compound (XXII) can be given by the treatment of the compound (XXI) with methanesulfonyl chloride in an organic solvent such as methylene dichloride, THF in the presence of a base such as triethylamine, DIEA at 0° C. to room temperature for 30 minutes to 12 hours.
- the compound (XVII) can be given by the reaction of the compound (XXII) with a corresponding alcohol, carboxylic acid, phenol, amine, thiol, thiophenol (IV) in an organic solvent such as DMF, THF, ethanol in the presence of a base such as potassium carbonate, sodium hydride at 0° C. to 100° C. for 1 hour to 48 hours.
- the compound (XVIII) can be given by the reaction of the compound (XVII) with a corresponding diboron (XXIII) or borane (XXIV) in a solvent such as dimethylsulfoxide, DMF, 1,4-dioxane in the presence of a base such as potassium acetate, triethylamine and a catalyst such as [1,1′-bis(diphenylphosphino)ferrocene]palladium(II) dichloride, bis(triphenylphosphine)palladium (II) dichloride at 50° C. to 120° C. for 10 minutes to 48 hours.
- a solvent such as dimethylsulfoxide, DMF, 1,4-dioxane
- a base such as potassium acetate
- triethylamine triethylamine
- a catalyst such as [1,1′-bis(diphenylphosphino)ferrocene]palladium(II) dichloride,
- the present compound (I)-(d) (the compound that A is methylene group, X is O, one of R 1 is OR 10 , R 10 is a lower alkyl group which may have at least a substituent, a lower alkylcarbonyl group which may have at least a substituent, an arylcarbonyl group which may have at least a substituent, a heterocyclic carbonyl group which may have at least a substituent, a lower alkoxycarbonyl group which may have at least a substituent or an aryloxycarbonyl group which may have at least a substituent, and the like in the general formula (1)) can be synthesized according to the synthetic route 9.
- the compound (I)-(d) can be given by the reaction of the present compound (I)-(e) (the compound that A is methylene group, X is O, one of R 1 is OH in the general formula (1)) with a corresponding halide (XXV) in an organic solvent such as THF, methylene dichloride, DMF in the presence of a base such as triethylamine, DIEA, potassium carbonate at 0° C. to 100° C. for 1 hour to 24 hours.
- a base such as triethylamine, DIEA
- the present compound (I)-(f) (the compound that A is methylene group, X is O, one of the R 1 is OCOR 11 , R 11 is a lower alkyl group which may have at least a substituent, an aryl group which may have at least a substituent or a heterocyclic group which may have at least a substituent, and the like in the general formula (1)) can be synthesized according to the synthetic route 10.
- the compound (I)-(f) can be given by the reaction of the present compound (I)-(e) (the compound that A is methylene group, X is O, one of R 1 is OH in the general formula (1)) with a corresponding carboxylic acid (XXVI) in an organic solvent such as DMF, methylene dichloride in the presence of a condensation agent such as N,N′-dicyclohexylcarbodiimide (hereinafter referred to as DCC), O-(7-azabenzotriazol-1-yl)-N,N,N,N-tetramethyl uroniumhexafluorophosphate (hereinafter referred to as HATU) and a base such as DIEA at room temperature to 50° C. for 1 hour to 3 days.
- a condensation agent such as N,N′-dicyclohexylcarbodiimide (hereinafter referred to as DCC)
- HATU O-(7-azabenzotriazol-1-y
- the present compound (I)-(g) (the compound that A is methylene group, X is O, one of the R 1 is OCONR 12 R 13 , R 12 and R 13 may be the same or different and are a lower alkyl group which may have at least a substituent, an aryl group which may have at least a substituent, and the like in the general formula (1)) can be synthesized according to the synthetic route 11.
- the compound (I)-(g) can be given by the reaction of the present compound (I)-(e) (the compound that A is methylene group, X is O, one of the R 1 is OH in the general formula (1)) with 1,1′-carbonyldiimidazole (hereinafter referred to as CDI) in an organic solvent such as methylene dichloride, THF at room temperature to 50° C. for 30 minutes to 12 hours followed by the reaction with a corresponding amine (XXVII).
- CDI 1,1′-carbonyldiimidazole
- the present compound (I)-(e) (the compound that A is methylene group, X is O, one of the R 1 is OH in the general formula (1)) can be synthesized according to the synthetic route 12. Namely, the present compound (I)-(h) can be given by the reaction of the compound (XVII) with a corresponding boronic acid or its ester (XXVIII) in a solvent such as DMF, 1,4-dioxane, ethanol, toluene, water in the presence of a base such as cesium carbonate, sodium carbonate, sodium hydrogen carbonate, tripotassium phosphate and a catalyst such as bis(triphenylphosphine)palladium (II) dichloride, tetrakis(triphenylphosphine)palladium (0) at 50° C.
- a solvent such as DMF, 1,4-dioxane, ethanol, toluene
- a base such as cesium carbonate, sodium carbonate
- the compound (I)-(e) can be given by the treatment of the compound (I)-(h) in an organic solvent such as 1,4-dioxane, methylene dichloride in the presence of an acid such as hydrogen chloride, trifluoroacetic acid at 0° C. to 50° C. for 1 hour to 24 hours.
- an organic solvent such as 1,4-dioxane, methylene dichloride
- an acid such as hydrogen chloride, trifluoroacetic acid at 0° C. to 50° C. for 1 hour to 24 hours.
- the present compound (I)-(e) (the compound that A is methylene group, X is O, one of the R 1 is OH in the general formula (1)) can be also synthesized according to the synthetic route 13.
- the compound (XXIX) can be given by the reaction of the compound (VII) with a corresponding boronic acid or its ester (XXVIII) in a solvent such as DMF, 1,4-dioxane, ethanol, toluene, water in the presence of a base such as cesium carbonate, sodium carbonate, sodium hydrogen carbonate, tripotassium phosphate and a catalyst such as bis(triphenylphosphine)palladium (II) dichloride, tetrakis(triphenylphosphine)palladium (0) at 50° C.
- the compound (XXX) can be given by the treatment of the compound (XXIX) in an organic solvent such as diethylether, THF in the presence of a reductive agent such as lithium aluminium hydride at ⁇ 30° C. to room temperature for 1 hour to 24 hours.
- the compound (XXXI) can be given by the treatment of the compound (XXX) with methanesulfonyl chloride in an organic solvent such as methylene dichloride, THF in the presence of a base such as triethylamine, DIEA at 0° C. to room temperature for 30 minutes to 12 hours.
- the present compound (I)-(i) can be given by the reaction of the compound (XXXI) with a corresponding alcohol, carboxylic acid, phenol, amine, thiol, thiophenol and the like (IV) in an organic solvent such as DMF, THF, ethanol in the presence of a base such as potassium carbonate, sodium hydride at 0° C. to 100° C. for 1 hour to 48 hours.
- a base such as potassium carbonate, sodium hydride at 0° C. to 100° C. for 1 hour to 48 hours.
- the present compound (I)-(h) can be given by the reaction of the compound (I)-(i) with a corresponding halide (II) in an organic solvent such as DMF, THF, 1,4-dioxane, methylene dichloride in the presence of a base such as cesium carbonate, potassium carbonate at 0° C. to 50° C. for 1 hour to 24 hours.
- the compound (I)-(e) can be given by the treatment of the compound (I)-(h) in an organic solvent such as 1,4-dioxane, methylene dichloride in the presence of an acid such as hydrogen chloride, trifluoroacetic acid at 0° C. to 50° C. for 1 hour to 24 hours.
- the present compound (I)-(j) (the compound that A is methylene group, X is O, one of the R 1 is OR 10 , R 7 is NHR 8 , R 10 is a lower alkyl group which may have at least a substituent, a lower alkylcarbonyl group which may have at least a substituent, an arylcarbonyl group which may have at least a substituent, a heterocyclic carbonyl group which may have at least a substituent, a lower alkoxycarbonyl group which may have at least a substituent, an aryloxycarbonyl group which may have at least a substituent, and the like in the general formula (1)), the present compound (I)-(k) (the compound that A is methylene group, X is O, one of the R 1 is OCOR 11 , R 7 is NHR 8 , R 1 ′′ is a lower alkyl group which may have at least a substituent, an aryl group which may have at least a substituent, a
- the compound (I)-(j), (I)-(k) and (I)-(l) can be given by the reaction of the present compound (I)-(m) (the compound that A is methylene group, X is O, one of the R 1 is OH, R 7 is NR 8 (Fmoc) in the general formula (1)) with a corresponding halide (XXV), a carboxylic acid (XXVI) or an amine (XXVII) according to the method of synthetic route 9, 10 or 11 respectively, followed by the treatment in an organic solvent such as DMF, methylene dichloride in the presence of a base such as piperidine at 0° C. to 50° C. for 5 minutes to 24 hours.
- an organic solvent such as DMF
- methylene dichloride in the presence of a base such as piperidine at 0° C. to 50° C. for 5 minutes to 24 hours.
- the present compound (I)-(m) (the compound that A is methylene group, X is O, one of the R 1 is OH, R 7 is NR 8 (Fmoc) in the general formula (1)) can be synthesized according to the synthetic route 15.
- the compound (XXXIII) can be given by the reaction of the compound (XXII) with a corresponding amine (XXXII) in an organic solvent such as DMF, THF, ethanol in the presence of a base such as potassium carbonate, sodium hydride at 0° C. to 100° C. for 1 hour to 48 hours.
- the present compound (I)-(o) can be given by the reaction of the compound (XXXIII) with a corresponding boronic acid or its ester (XXVIII) in a solvent such as DMF, 1,4-dioxane, ethanol, toluene, water in the presence of a base such as cesium carbonate, sodium carbonate, sodium hydrogen carbonate, tripotassium phosphate and a catalyst such as bis(triphenylphosphine)palladium (II) dichloride, tetrakis(triphenylphosphine)palladium (0) at 50° C. to 120° C. for 1 hour to 48 hours.
- a solvent such as DMF, 1,4-dioxane, ethanol, toluene
- a base such as cesium carbonate, sodium carbonate, sodium hydrogen carbonate, tripotassium phosphate
- a catalyst such as bis(triphenylphosphine)palladium (II) dichlor
- the present compound (I)-(n) can be given by the reaction of the compound (I)-(o) with 9-fluorenylmethoxycarbonyl chloride in a solvent such as 1,4-dioxane, water in the presence of a base such as sodium hydrogen carbonate at 0° C. to 50° C. for 1 hour to 24 hours.
- the compound (I)-(m) can be given by the treatment of the compound (I)-(n) in an organic solvent such as 1,4-dioxane, methylene dichloride in the presence of an acid such as hydrogen chloride, trifluoroacetic acid at 0° C. to 50° C. for 1 hour to 24 hours.
- the present compound (I)-(p) (the compound that A is methylene group, X is O, one of the R 1 is OR 10 , R 7 is OR 8 , R 10 is a lower alkyl group which may have at least a substituent, a lower alkylcarbonyl group which may have at least a substituent, an arylcarbonyl group which may have at least a substituent, a heterocyclic carbonyl group which may have at least a substituent, a lower alkoxycarbonyl group which may have at least a substituent, an aryloxycarbonyl group which may have at least a substituent, and the like in the general formula (1)) can be synthesized according to the synthetic route 16.
- the compound (XXXIV) can be given by the treatment of the compound (XXX) in an organic solvent such as 1,4-dioxane, methylene dichloride in the presence of an acid such as hydrogen chloride, trifluoroacetic acid at 0° C. to 50° C. for 1 hour to 24 hours.
- the compound (XXXV) can be given by the reaction of the compound (XXXIV) with a corresponding halide (XXV) in an organic solvent such as THF, methylene dichloride, DMF in the presence of a base such as triethylamine, DIEA, potassium carbonate at 0° C. to 100° C. for 1 hour to 24 hours.
- the compound (I)-(q) can be given by the reaction of the compound (XXXV) with a corresponding halide (VI) in an organic solvent such as DMF, THF, methylene dichloride in the presence of a base such as triethylamine, potassium carbonate at 0° C. to 50° C. for 1 hour to 48 hours.
- the compound (I)-(p) can be given by the reaction of the compound (I)-(q) with a corresponding halide (II) in an organic solvent such as DMF, THF, 1,4-dioxane, methylene dichloride in the presence of a base such as cesium carbonate, potassium carbonate at 0° C. to 50° C. for 1 hour to 24 hours.
- the present invention also relates to a method of preventing or treating a glucocorticoid receptor-related disease, for example, metabolic disorders such as diabetes and obesity, inflammatory diseases such as arthritis, enteritis and chronic obstructive pulmonary diseases, autoimmune diseases such as connective tissue diseases, allergic diseases such as asthma, atopic dermatitis, allergic rhinitis and conjunctivitis, central nervous system diseases such as psychiatric disorders, Alzheimer's disease and drug use disorders, cardiovascular diseases such as hypertension, hypercalcemia, hyperinsulinemia and hyperlipidemia, homeostasis-related diseases causing an abnormality of neuro-immune-endocrine balance, glaucoma, comprising administering to a patient a therapeutically effective amount of the present compound or a salt thereof.
- a glucocorticoid receptor-related disease for example, metabolic disorders such as diabetes and obesity, inflammatory diseases such as arthritis, enteritis and chronic obstructive pulmonary diseases, autoimmune diseases such as connective tissue diseases
- glucocorticoid receptor competitor assay kit In order to find the usefulness of the present compound as a pharmaceutical, by using a glucocorticoid receptor competitor assay kit, a glucocorticoid receptor competitor assay was carried out by a fluorescence polarization method. As a result, the present compound showed an excellent glucocorticoid receptor binding activity.
- the glucocorticoid receptor is associated with the occurrence of various diseases as described above, therefore, the present compound having an excellent binding activity to the glucocorticoid receptor is useful as a glucocorticoid receptor modulator.
- the present compound can be administered either orally or parenterally.
- the dosage form include a tablet, a capsule, a granule, a powder, an injection, an eye drop and the like.
- Such a preparation can be prepared using a commonly used technique.
- an oral preparation such as a tablet, a capsule, a granule or a powder can be prepared by optionally adding a necessary amount of an excipient such as lactose, mannitol, starch, crystalline cellulose, light silicic anhydride, calcium carbonate or calcium hydrogen phosphate; a lubricant such as stearic acid, magnesium stearate or talc; a binder such as starch, hydroxypropyl cellulose, hydroxypropylmethyl cellulose or polyvinylpyrrolidone; a disintegrant such as carboxymethyl cellulose, low-substituted hydroxypropylmethyl cellulose or calcium citrate; a coating agent such as hydroxypropylmethyl cellulose, macrogol or a silicone resin; a stabilizer such as ethyl p-hydroxybenzoate or benzyl alcohol; a corrigent such as a sweetener, a sour agent or a flavor, or the like.
- an excipient such
- a parenteral preparation such as an injection or an eye drop can be prepared by optionally adding a necessary amount of a tonicity agent such as sodium chloride, concentrated glycerin, propylene glycol, polyethylene glycol, potassium chloride, sorbitol or mannitol; a buffer such as sodium phosphate, sodium hydrogen phosphate, sodium acetate, citric acid, glacial acetic acid or trometamol; a surfactant such as polyoxyethylene sorbitan monoolate, polyoxy 40 stearate or polyoxyethylene hydrogenated castor oil 60; a stabilizer such as sodium citrate or sodium edetate; a preservative such as benzalkonium chloride, paraben, benzothonium chloride, p-hydroxybenzoate ester, sodium benzoate or chlorobutanol; a pH adjusting agent such as hydrochloric acid, citric acid, phosphoric acid, glacial acetic acid, sodium hydroxide, sodium carbonate or sodium hydrogen carbonate;
- the dose of the present compound can be appropriately selected depending on the symptoms, age, dosage form or the like.
- an oral preparation it can be administered in an amount of generally 0.01 to 1000 mg, preferably 1 to 100 mg per day in a single dose or several divided doses.
- a preparation containing the present compound at a concentration of generally 0.0001% to 10% (w/v), preferably 0.01% to 5% (w/v) can be administered in a single dose or several divided doses.
- Fmoc in the chemical structure in Production Examples represents 9-fluorenylmethoxycarbonyl group.
- Methyl 5-amino-2-bromobenzoate (Reference Compound No. 1-(1), 21.0 g, 91.2 mmol) was dissolved in anhydrous dichloromethane (450 mL), triethylamine (19.0 mL, 137 mmol) and acethyl chloride (13.0 mL, 182 mmol) were added dropwise over 30 minutes successively, and then the mixture was stirred at 0° C. for 2 hours.
- Lithium aluminium hydride (26.0 mg, 0.64 mmol) was suspended in anhydrous tetrahydrofuran (0.5 mL) under nitrogen atmosphere.
- An anhydrous tetrahydrofuran solution (1.5 mL) of 8-methoxycarbonyl-7-(2-methoxyphenyl)-3,3-dimethyl-3,4-dihydro-1H-quinoxalin-2-one (Reference Compound No. 2-1, 108 mg, 0.32 mmol) was added thereto at 0° C., and stirred for 3 hours at the same temperature.
- Litium aluminium hydride (38.5 mg, 1.01 mmol) was suspended in anhydrous tetrahydrofuran (0.5 mL) under nitrogen atmosphere.
- An anhydrous tetrahydrofuran solution (1.5 mL) of 7-bromo-8-methoxycarbonyl-3,3-dimethyl-3,4-dihydro-1H-quinoxalin-2-one (Reference Compound No. 1, 101 mg, 0.323 mmol) was added dropwise thereto at 0° C., and stirred for 1 hour at the same temperature.
- Ethyl acetate (10 mL), water (10 mL), and 1N aqueous hydrochloride solution (2 mL) were added thereto successively and the mixture was partitioned.
- Lithium aluminium hydride (442 mg, 11.7 mmol) was suspended in anhydrous tetrahydrofuran (10 mL) under nitrogen atmosphere.
- An anhydrous tetrahydrofuran solution (40 mL) of 9-chloro-2,2,4-trimethyl-1,4-dihydro-2H-6-oxa-1,4-diazachrysen-3,5-dione (Reference Compound No. 11-1, 1.99 g, 5.81 mmol) was added dropwise thereto at ⁇ 10° C. and stirred for 10 minutes at the same temperature.
- a tablet of the above-mentioned formulation is coated with 3 mg of a coating agent (for example, a conventional coating agent such as hydroxypropylmethyl cellulose, macrogol or a silicone resin), whereby an objective tablet can be obtained.
- a coating agent for example, a conventional coating agent such as hydroxypropylmethyl cellulose, macrogol or a silicone resin
- a desired tablet can be obtained by appropriately changing the kind and/or amount of the present compound and additives.
- a desired capsule can be obtained by appropriately changing the kind and/or amount of the present compound and additives.
- a desired eye drop can be obtained by appropriately changing the kind and/or amount of the present compound and additives.
- a receptor competitor assay was carried out by a fluorescence polarization method.
- a GR competitor assay kit manufactured by Invitrogen, cat No. P2816 was used, and a procedure was carried out according to the protocol attached to the kit.
- the specific method will be described.
- GR screening buffer A buffer containing 10 mM potassium phosphate (pH 7.4), 20 mM sodium molybdate (Na 2 MoO 4 ), 0.1 mM ethylene diamine tetraacetic acid (EDTA), 5 mM dithiothreitol (DTT), 0.1 mM stabilizing peptide and 2% dimethylsulfoxide was prepared.
- FluormoneTM GS1 which is a fluorescent glucocorticoid ligand, was diluted with GR screening buffer, whereby a 4 nM solution was prepared.
- Recombinant human GR was diluted with GR screening buffer, whereby a 16 nM solution was prepared.
- test compound solution was prepared.
- test compound solution was added in an amount of 25 ⁇ L into each well of a 96-well plate, and then, 4 ⁇ GS1 solution and 4 ⁇ GR solution were added in an amount of 12.5 ⁇ L into each well, respectively.
- a GR binding ratio (%) was calculated from the following equation.
- GR binding ratio (%) 100 ⁇ [1-(fluorescence polarization of test compound solution-fluorescence polarization of positive control solution)/(fluorescence polarization of negative control solution—fluorescence polarization of positive control solution)]
- the GR binding ratios (%) of the test compounds (Compound 1-4, Compound 2-2, Compound 2-9, Compound 2-16, Compound 3-7, Compound 3-10, Compound 3-15, Compound 3-16, Compound 3-17, Compound 4-5, Compound 4-7, Compound 4-10, Compound 4-11, Compound 5-1, Compound 5-9, Compound 5-14, Compound 5-18, Compound 5-19, Compound 5-21, Compound 5-22, Compound 5-24, Compound 6-4, Compound 6-8, Compound 6-10, Compound 6-12, Compound 6-15, Compound 6-19, Compound 6-23, Compound 6-27, Compound 6-32, Compound 6-38, Compound 8-2, Compound 9-1, Compound 11, Compound 13-2, Compound 14-2, Compound 14-4, Compound 14-11, Compound 14-21, Compound 14-22, Compound 14-30, Compound 14-33, Compound 14-35, Compound 14-36, Compound 14-37, Compound 14-44, Com
- the present compound showed an excellent GR binding activity. Accordingly, the present compound can be used as a GR modulator, and is useful for a preventive or therapeutic agent particularly for GR-related diseases, that is, metabolic disorders, inflammatory diseases, autoimmune diseases, allergic diseases, central nervous system diseases, cardiovascular diseases, homeostasis-related diseases, glaucoma and the like.
- GR-related diseases that is, metabolic disorders, inflammatory diseases, autoimmune diseases, allergic diseases, central nervous system diseases, cardiovascular diseases, homeostasis-related diseases, glaucoma and the like.
- 1,2,3,4-tetrahydroquinoxaline derivative or the salt according to the present invention has a binding activity to GR and is useful for GR modulator of nonsteroidal compound.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006069739 | 2006-03-14 | ||
JP2006-069739 | 2006-03-14 | ||
JP2006-255039 | 2006-08-22 | ||
JP2006255039 | 2006-08-22 | ||
PCT/JP2007/055122 WO2007105766A1 (ja) | 2006-03-14 | 2007-03-14 | グルココルチコイド受容体結合活性を有する新規1,2,3,4-テトラヒドロキノキサリン誘導体 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2007/055122 A-371-Of-International WO2007105766A1 (ja) | 2006-03-14 | 2007-03-14 | グルココルチコイド受容体結合活性を有する新規1,2,3,4-テトラヒドロキノキサリン誘導体 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/937,447 Division US8975256B2 (en) | 2006-03-14 | 2013-07-09 | 1,2,3,4-tetrahydroquinoxaline compounds having glucocorticoid receptor binding activity |
Publications (2)
Publication Number | Publication Date |
---|---|
US20090111807A1 US20090111807A1 (en) | 2009-04-30 |
US8551991B2 true US8551991B2 (en) | 2013-10-08 |
Family
ID=38509582
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/225,010 Expired - Fee Related US8551991B2 (en) | 2006-03-14 | 2007-03-14 | 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity |
US13/937,447 Expired - Fee Related US8975256B2 (en) | 2006-03-14 | 2013-07-09 | 1,2,3,4-tetrahydroquinoxaline compounds having glucocorticoid receptor binding activity |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/937,447 Expired - Fee Related US8975256B2 (en) | 2006-03-14 | 2013-07-09 | 1,2,3,4-tetrahydroquinoxaline compounds having glucocorticoid receptor binding activity |
Country Status (16)
Country | Link |
---|---|
US (2) | US8551991B2 (de) |
EP (1) | EP1995242B1 (de) |
KR (2) | KR20140063907A (de) |
CN (1) | CN101400659B (de) |
AU (1) | AU2007225693A1 (de) |
BR (1) | BRPI0708767A2 (de) |
CA (1) | CA2643070C (de) |
DK (1) | DK1995242T3 (de) |
ES (1) | ES2396711T3 (de) |
MX (1) | MX2008011779A (de) |
NO (1) | NO20084262L (de) |
PL (1) | PL1995242T3 (de) |
PT (1) | PT1995242E (de) |
RU (1) | RU2008140525A (de) |
SI (1) | SI1995242T1 (de) |
WO (1) | WO2007105766A1 (de) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130303537A1 (en) * | 2006-03-14 | 2013-11-14 | Santen Pharmaceutical Co., Ltd. | 1,2,3,4-tetrahydroquinoxaline compounds having glucocorticoid receptor binding activity |
US11093563B2 (en) * | 2018-02-05 | 2021-08-17 | Microsoft Technology Licensing, Llc | Sharing measured values of physical space parameters |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL2151436T3 (pl) * | 2007-05-29 | 2013-09-30 | Santen Pharmaceutical Co Ltd | Nowe pochodne 1,2,3,4-tetrahydrochinoksaliny, które jako podstawnik zawierają grupę fenylową z wprowadzoną strukturą estru kwasu sulfonowego lub amidu kwasu sulfonowego i które mają aktywność wiążącą wobec receptora glukokortykoidowego |
JP2009084273A (ja) * | 2007-09-13 | 2009-04-23 | Santen Pharmaceut Co Ltd | 1,3,3−トリメチル−7−フェニル−3,4−ジヒドロ−1h−キノキサリン−2−オン誘導体からなるグルココルチコイド受容体アゴニスト |
WO2009035068A1 (ja) * | 2007-09-13 | 2009-03-19 | Santen Pharmaceutical Co., Ltd. | 新規1,3,3-トリメチル-7-フェニル-3,4-ジヒドロ-1h-キノキサリン-2-オン誘導体 |
EA018420B1 (ru) * | 2008-09-12 | 2013-07-30 | Сантен Фармасьютикал Ко., Лтд. | Агонист глюкокортикоидного рецептора, содержащий новые производные 1,2,3,4-тетрагидрохиноксалина с фенильной группой, имеющей структуру эфира сульфоновой кислоты, введенной в нее в качестве заместителя |
WO2012120052A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
WO2012120053A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
EP2683705B1 (de) | 2011-03-08 | 2015-04-22 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
WO2012120055A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
US8871758B2 (en) | 2011-03-08 | 2014-10-28 | Sanofi | Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof |
EP2567959B1 (de) | 2011-09-12 | 2014-04-16 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridin-4-carbonsäureamid-derivate als kinaseinhibitoren |
JP2015057381A (ja) * | 2013-08-09 | 2015-03-26 | 参天製薬株式会社 | 3,3−ジメチル−3,4−ジヒドロ−1h−キノキサリン−2−オン誘導体の製造方法およびその製造方法の中間体 |
CN106061944A (zh) * | 2014-01-24 | 2016-10-26 | 普渡制药公司 | 吡啶类和嘧啶类物质及其用途 |
CN104628661A (zh) * | 2015-02-05 | 2015-05-20 | 北京理工大学 | 一类喹喔啉酮衍生物作为醛糖还原酶抑制剂的结构、制备方法及用途 |
CN105037425B (zh) * | 2015-07-28 | 2017-06-20 | 华侨大学 | 一种喹喔啉‑2(1h)‑酮c‑3位膦酸化合物的合成方法 |
KR20180043329A (ko) | 2015-08-25 | 2018-04-27 | 산텐 세이야꾸 가부시키가이샤 | [4-(1,3,3-트리메틸-2-옥소-3,4-디히드로-1h-퀴녹살린-7-일)페녹시]에틸옥시 화합물 또는 그의 염 |
AU2018283250B2 (en) | 2017-06-16 | 2022-09-01 | The Doshisha | mTOR-inhibitor-containing medicine for treating or preventing ophthalmic symptoms, disorders, or diseases, and application thereof |
US20200121652A1 (en) | 2017-06-16 | 2020-04-23 | The Doshisha | Compounds having caspase inhibitory activity, pharmaceutical agent containing said compounds and for treating or preventing corneal endothelial symptoms, disorders, or diseases, and application of said pharmaceutical agent |
TWI811400B (zh) * | 2018-07-20 | 2023-08-11 | 德商歌林達有限公司 | 經進一步取代之三唑并喹噁啉衍生物 |
CN109574811B (zh) * | 2018-11-22 | 2021-12-24 | 中山大学 | 一种阿尼芬净侧链中间体对戊氧基三联苯甲酸的制备方法 |
CN111138398A (zh) * | 2019-12-31 | 2020-05-12 | 陕西国际商贸学院 | 一种2-(2-氨基-3-甲氧苯基)色酮的合成工艺 |
EP4090660B1 (de) * | 2020-01-17 | 2024-01-31 | Grünenthal GmbH | Chinoxalinderivate |
WO2021144440A1 (en) * | 2020-01-17 | 2021-07-22 | Grünenthal GmbH | Quinoxaline derivatives as modulators of the glucocorticoid receptor |
CN115160348A (zh) * | 2022-07-06 | 2022-10-11 | 中山大学 | 一种光照下无金属催化的芳香c-h键直接硼化反应的方法 |
Citations (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6153607A (en) | 1995-12-04 | 2000-11-28 | University Of Miami | Non-preserved topical corticosteroid for treatment of dry eye, filamentary keratitis, and delayed tear clearance (or turnover) |
US6340758B1 (en) * | 1997-05-16 | 2002-01-22 | Warner-Lambert Company | Conformationally semi-constrained quinoxaline 2,3-diones as neuroprotective agents |
US6369057B1 (en) | 1991-04-15 | 2002-04-09 | Aventis Pharma Deutschland Gmbh | Quinoxalines, processes for their preparation and their use |
JP2002193955A (ja) | 2000-10-30 | 2002-07-10 | Pfizer Prod Inc | グルココルチコイド受容体モジュレーター |
WO2004099192A2 (en) | 2003-04-30 | 2004-11-18 | The Institutes Of Pharmaceutical Discovery, Llc | Heterocycle substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b |
US20040266758A1 (en) | 2003-06-11 | 2004-12-30 | Hadida-Ruah Sara Sabine | Modulators of the glucocorticoid receptor and method |
WO2006015259A2 (en) | 2004-07-28 | 2006-02-09 | Irm Llc | Compounds and compositions as modulators of steroid hormone nuclear receptors |
WO2007105766A1 (ja) | 2006-03-14 | 2007-09-20 | Santen Pharmaceutical Co., Ltd. | グルココルチコイド受容体結合活性を有する新規1,2,3,4-テトラヒドロキノキサリン誘導体 |
US20070249611A1 (en) * | 2006-03-28 | 2007-10-25 | Jun Feng | Dipeptidyl peptidase inhibitors |
JP2008074829A (ja) | 2006-03-14 | 2008-04-03 | Santen Pharmaceut Co Ltd | グルココルチコイド受容体結合活性を有する新規1,2,3,4−テトラヒドロキノキサリン誘導体 |
EP1944290A1 (de) | 2005-09-14 | 2008-07-16 | Santen Pharmaceutical Co., Ltd. | Neues 1,2-dihydrochinolinderivat mit glucocorticoidrezeptorbindender aktivität |
WO2008111632A1 (ja) | 2007-03-13 | 2008-09-18 | Santen Pharmaceutical Co., Ltd. | 2,2,4-トリメチル-6-フェニル-1,2-ジヒドロキノリン誘導体からなるグルココルチコイド受容体アゴニスト |
WO2008146871A1 (ja) | 2007-05-29 | 2008-12-04 | Santen Pharmaceutical Co., Ltd. | グルココルチコイド受容体結合活性を有する、スルホン酸エステル又はスルホン酸アミド構造を導入したフェニル基を置換基として有する新規1,2,3,4-テトラヒドロキノキサリン誘導体 |
WO2009035068A1 (ja) | 2007-09-13 | 2009-03-19 | Santen Pharmaceutical Co., Ltd. | 新規1,3,3-トリメチル-7-フェニル-3,4-ジヒドロ-1h-キノキサリン-2-オン誘導体 |
WO2009035067A1 (ja) | 2007-09-13 | 2009-03-19 | Santen Pharmaceutical Co., Ltd. | 1,3,3-トリメチル-7-フェニル-3,4-ジヒドロ-1h-キノキサリン-2-オン誘導体からなるグルココルチコイド受容体アゴニスト |
US20090298827A1 (en) | 2006-11-14 | 2009-12-03 | Mamoru Matsuda | Novel 1,2-dihydroquinoline derivative having substituted phenylamino lower alkyl group and ester-introduced phenyl group as substituents |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE59209965D1 (de) | 1991-04-15 | 2002-10-17 | Aventis Pharma Gmbh | Chinoxaline, Verfahren zu ihrer Herstellung und ihre Verwendung |
-
2007
- 2007-03-14 CA CA2643070A patent/CA2643070C/en not_active Expired - Fee Related
- 2007-03-14 US US12/225,010 patent/US8551991B2/en not_active Expired - Fee Related
- 2007-03-14 DK DK07738592.0T patent/DK1995242T3/da active
- 2007-03-14 SI SI200731097T patent/SI1995242T1/sl unknown
- 2007-03-14 RU RU2008140525/04A patent/RU2008140525A/ru not_active Application Discontinuation
- 2007-03-14 BR BRPI0708767-5A patent/BRPI0708767A2/pt not_active IP Right Cessation
- 2007-03-14 CN CN2007800089719A patent/CN101400659B/zh not_active Expired - Fee Related
- 2007-03-14 EP EP07738592A patent/EP1995242B1/de not_active Not-in-force
- 2007-03-14 ES ES07738592T patent/ES2396711T3/es active Active
- 2007-03-14 AU AU2007225693A patent/AU2007225693A1/en not_active Abandoned
- 2007-03-14 KR KR1020147012315A patent/KR20140063907A/ko not_active Application Discontinuation
- 2007-03-14 MX MX2008011779A patent/MX2008011779A/es active IP Right Grant
- 2007-03-14 PL PL07738592T patent/PL1995242T3/pl unknown
- 2007-03-14 WO PCT/JP2007/055122 patent/WO2007105766A1/ja active Application Filing
- 2007-03-14 KR KR1020087024004A patent/KR101426966B1/ko not_active IP Right Cessation
- 2007-03-14 PT PT07738592T patent/PT1995242E/pt unknown
-
2008
- 2008-10-10 NO NO20084262A patent/NO20084262L/no not_active Application Discontinuation
-
2013
- 2013-07-09 US US13/937,447 patent/US8975256B2/en not_active Expired - Fee Related
Patent Citations (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6369057B1 (en) | 1991-04-15 | 2002-04-09 | Aventis Pharma Deutschland Gmbh | Quinoxalines, processes for their preparation and their use |
US6153607A (en) | 1995-12-04 | 2000-11-28 | University Of Miami | Non-preserved topical corticosteroid for treatment of dry eye, filamentary keratitis, and delayed tear clearance (or turnover) |
US6340758B1 (en) * | 1997-05-16 | 2002-01-22 | Warner-Lambert Company | Conformationally semi-constrained quinoxaline 2,3-diones as neuroprotective agents |
JP2002193955A (ja) | 2000-10-30 | 2002-07-10 | Pfizer Prod Inc | グルココルチコイド受容体モジュレーター |
US6852719B2 (en) | 2000-10-30 | 2005-02-08 | Pfizer Inc. | Glucocorticoid receptor modulators |
WO2004099192A2 (en) | 2003-04-30 | 2004-11-18 | The Institutes Of Pharmaceutical Discovery, Llc | Heterocycle substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b |
US20040266758A1 (en) | 2003-06-11 | 2004-12-30 | Hadida-Ruah Sara Sabine | Modulators of the glucocorticoid receptor and method |
US7235662B2 (en) | 2003-06-11 | 2007-06-26 | Bristol-Myers Squibb Company | Modulators of the glucocorticoid receptor and method |
WO2006015259A2 (en) | 2004-07-28 | 2006-02-09 | Irm Llc | Compounds and compositions as modulators of steroid hormone nuclear receptors |
EP1944290A1 (de) | 2005-09-14 | 2008-07-16 | Santen Pharmaceutical Co., Ltd. | Neues 1,2-dihydrochinolinderivat mit glucocorticoidrezeptorbindender aktivität |
WO2007105766A1 (ja) | 2006-03-14 | 2007-09-20 | Santen Pharmaceutical Co., Ltd. | グルココルチコイド受容体結合活性を有する新規1,2,3,4-テトラヒドロキノキサリン誘導体 |
JP2008074829A (ja) | 2006-03-14 | 2008-04-03 | Santen Pharmaceut Co Ltd | グルココルチコイド受容体結合活性を有する新規1,2,3,4−テトラヒドロキノキサリン誘導体 |
US20070249611A1 (en) * | 2006-03-28 | 2007-10-25 | Jun Feng | Dipeptidyl peptidase inhibitors |
US20090298827A1 (en) | 2006-11-14 | 2009-12-03 | Mamoru Matsuda | Novel 1,2-dihydroquinoline derivative having substituted phenylamino lower alkyl group and ester-introduced phenyl group as substituents |
US20090298826A1 (en) | 2006-11-14 | 2009-12-03 | Mamoru Matsuda | Novel 1,2-dihydroquinoline derivative having (substituted phenyl or substituted heterocyclic) carbonyloxy lower alkyl group and ester-introduced phenyl group as substituents |
US20100056504A1 (en) | 2006-11-14 | 2010-03-04 | Mamoru Matsuda | Novel 1,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester- introduced phenyl group as substituents |
WO2008111632A1 (ja) | 2007-03-13 | 2008-09-18 | Santen Pharmaceutical Co., Ltd. | 2,2,4-トリメチル-6-フェニル-1,2-ジヒドロキノリン誘導体からなるグルココルチコイド受容体アゴニスト |
WO2008146871A1 (ja) | 2007-05-29 | 2008-12-04 | Santen Pharmaceutical Co., Ltd. | グルココルチコイド受容体結合活性を有する、スルホン酸エステル又はスルホン酸アミド構造を導入したフェニル基を置換基として有する新規1,2,3,4-テトラヒドロキノキサリン誘導体 |
EP2151436A1 (de) | 2007-05-29 | 2010-02-10 | Santen Pharmaceutical Co., Ltd | Neuartiges 1,2,3,4-tetrahydrochinoxalin-derivat mit einer als substituent eingefügten phenylgruppe, die eine schwefelsäureesterstruktur oder eine schwefelsäureamidstruktur aufweist, sowie mit glucocorticoidrezeptor-bindungswirkung |
WO2009035068A1 (ja) | 2007-09-13 | 2009-03-19 | Santen Pharmaceutical Co., Ltd. | 新規1,3,3-トリメチル-7-フェニル-3,4-ジヒドロ-1h-キノキサリン-2-オン誘導体 |
WO2009035067A1 (ja) | 2007-09-13 | 2009-03-19 | Santen Pharmaceutical Co., Ltd. | 1,3,3-トリメチル-7-フェニル-3,4-ジヒドロ-1h-キノキサリン-2-オン誘導体からなるグルココルチコイド受容体アゴニスト |
Non-Patent Citations (11)
Title |
---|
Hackam, et al., "Translation of Research Evidence from Animals to Humans," JAMA, 296(14), 2006, 1731-1732. |
Health, "Optometric Management of Anterior Segment Eye Disease: Dry Eye and Eyelid Disease," Continuing Education and Training: 2007, pp. 1 to 9, Johnson & Johnson Vision Care. |
Igaku Daijiten, Nanzando (Nanzando's Medical Dictionary), The 17th Edition, 1038-1040. |
Jeffrey N. Miner et al., "New and improved glucocorticoid receptor ligands," Expert Opinion on Investigational Drugs, Ashley Publications Ltd., London, GB, vol. 14, No. 12, Dec. 1, 2005, pp. 1527-1545. |
Jordan, V.C., "Tamoxifen: A Most Unlikely Pioneering Medicine," Nature Reviews: Drug Discovery, 2, 2003, 205. |
McNaught, A.D. et al: "Arenes", Compendium of Chemical Terminology, 2nd Edition, [Online] 1997, XP-002582726, IUPAC. |
McNaught, A.D. et al: "Aryl groups", Compendium of Chemical Terminology, 2nd Edition, [Online] 1997, XP-002582725, IUPAC. |
Nagelhout et al., "Preservation of Tear Film Integrity and Inhibition of Corneal Injury by Dexamethasone in a Rabbit Model of Lacrimal Gland Inflammation-Induced Dry Eye," Jour. of Ocular Pharmacology and Therapeutics, vol. 21, No. 2, (2005), pp. 139 to 148. |
Nawata, Hajime, "New horizone of glucocorticoid therapy in 21st century", Sougou Rinsyou, 2005, 1951-2076, 54(7), Japan. |
Patani et al. (Chem Rev. 1996, 96, 3146-76). * |
Williams et al. (Foye's Principles of Medicinal Chemistry, 5th edition, pp. 50 and 59-61, 2002). * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130303537A1 (en) * | 2006-03-14 | 2013-11-14 | Santen Pharmaceutical Co., Ltd. | 1,2,3,4-tetrahydroquinoxaline compounds having glucocorticoid receptor binding activity |
US8975256B2 (en) * | 2006-03-14 | 2015-03-10 | Santen Pharmaceutical Co., Ltd. | 1,2,3,4-tetrahydroquinoxaline compounds having glucocorticoid receptor binding activity |
US11093563B2 (en) * | 2018-02-05 | 2021-08-17 | Microsoft Technology Licensing, Llc | Sharing measured values of physical space parameters |
Also Published As
Publication number | Publication date |
---|---|
ES2396711T3 (es) | 2013-02-25 |
AU2007225693A1 (en) | 2007-09-20 |
RU2008140525A (ru) | 2010-04-27 |
PL1995242T3 (pl) | 2013-03-29 |
CA2643070A1 (en) | 2007-09-20 |
CN101400659B (zh) | 2012-02-29 |
BRPI0708767A2 (pt) | 2011-06-14 |
KR101426966B1 (ko) | 2014-08-06 |
DK1995242T3 (da) | 2012-12-17 |
EP1995242A1 (de) | 2008-11-26 |
WO2007105766A1 (ja) | 2007-09-20 |
EP1995242B1 (de) | 2012-11-07 |
CA2643070C (en) | 2016-01-26 |
KR20140063907A (ko) | 2014-05-27 |
US8975256B2 (en) | 2015-03-10 |
CN101400659A (zh) | 2009-04-01 |
PT1995242E (pt) | 2012-11-22 |
EP1995242A4 (de) | 2010-08-04 |
MX2008011779A (es) | 2008-09-25 |
US20090111807A1 (en) | 2009-04-30 |
KR20080100281A (ko) | 2008-11-14 |
SI1995242T1 (sl) | 2013-01-31 |
US20130303537A1 (en) | 2013-11-14 |
NO20084262L (no) | 2008-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8551991B2 (en) | 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity | |
US8420635B2 (en) | Method for preventing or treating a glucocorticoid receptor-related disease | |
US8440660B2 (en) | Method for treating a disease related to the glucocorticoid receptor | |
JP5054996B2 (ja) | グルココルチコイド受容体結合活性を有する新規1,2,3,4−テトラヒドロキノキサリン誘導体 | |
MX2008003347A (es) | Derivado novedoso de 1,2-dihidroquinolina que tiene actividad de union de receptor glucocorticoide. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: SANTEN PHARMACEUTICAL CO., LTD., JAPAN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MATSUDA, MAMORU;MORI, TOSHIYUKI;KAWASHIMA, KENJI;AND OTHERS;REEL/FRAME:021553/0657 Effective date: 20080901 |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
FEPP | Fee payment procedure |
Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
CC | Certificate of correction | ||
CC | Certificate of correction | ||
FPAY | Fee payment |
Year of fee payment: 4 |
|
FEPP | Fee payment procedure |
Free format text: MAINTENANCE FEE REMINDER MAILED (ORIGINAL EVENT CODE: REM.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
LAPS | Lapse for failure to pay maintenance fees |
Free format text: PATENT EXPIRED FOR FAILURE TO PAY MAINTENANCE FEES (ORIGINAL EVENT CODE: EXP.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
STCH | Information on status: patent discontinuation |
Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362 |
|
FP | Lapsed due to failure to pay maintenance fee |
Effective date: 20211008 |